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GENERAL INTRODUCTION 
G c N E S A I Ι Ν 1 Ρ O D d С Τ O N 
Сндгаі 
G F N C R A I I N I R ^ P J ^ ' I T K 
ΙΙ!1ι;Μ·ϋΜ,Μ!Ι 
In the last few years the efforts to improve cancer therapy have been directed at 
stimulating the natural immune system by means of biological response modifiers 
(BRM) or cytokines Genetic engineering has resulted in a growing number of recom­
binant BRM becoming available, including interferons (IFN), interleukins (IL), colony-
stimulating factors (CSF), and tumor necrosis factors (TNF) In the past decade the 
impact and results of immunotherapy have been such that, in addition to more conven­
tional treatment such as surgery, radiation therapy and chemotherapy, immunotherapy 
can be considered as the "Fourth Modality of Cancer Treatment" ( 1 ) High doses of 
single agent recombinant cytokines have resulted in antitumor effects both in murine 
models and in the treatment of humans with metastatic cancer (2-9) Unfortunately. 
high doses of cytokines were toxic when administered systemically. while the observed 
responses have been rather transient Since effectiveness appeared to be dependent on 
the tumor load, a logical next step was to combine this approach with chemotherapy 
Consequently improvements in experimental canter therapy have been made using 
recombinant cytokines to augment the action of anticancer drugs and reduce the doses 
necessary to achieve antitumor effects (10-16) 
Most anticancer drugs known were generally considered to exert their cflccts 
through antiproliferative and cytotoxic actions (17) but it has now become apparent 
that chemotherapy regimens can induce both immunological depression and specific 
immune activation of antineoplastic host defenses (18) The activity of the immune 
system depends upon the participation of a large number of highly specialized cells in 
the blood and tissues, each type performing a unique function Monocytes and macro­
phages play a central role in the immune response and are a first line of defense against 
the development and spread of tumors (19-21) Anticancer drug interactions with 
human monocyte/macrophage functions are complex and have been the object of limit­
ed investigation (22-29) The m vitro examination of the influence of cytokines and/or 
anticancer drugs on human monocytes at different stages of maturation in vitro is de­
scribed in this thesis This knowledge is necessary for a better understanding of com­
bined approaches to cancer treatment that may lead to further therapeutic advances 
MONOCYTES AND1VIACROPHÄGES 
Л r. 
Origin, ontogeny and distribution. Human macrophages are the final differentiated 
cells of the mononuclear phagocyte system (MPS) and are derived from peripheral 
blood monocytes via promonocytes and monoblasts that originate during bone marrow 
hematopoiesis (10-34) Newly formed monocytes move from the marrow into the 
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peripheral blood stream within a day (35) and distribute themselves between marginatmg 
and circulating pools (36) having a transit half-time in the circulation of approximately 
70 h (37,38). In some severe infections, monocytes may differentiate in the peripheral 
blood to become macrophages (39) In general, this transformation takes place after· 
diapedesis and migration into various extravascular tissues (40) Up to now, there is no 
evidence that monocytes are programmed for any particular tissue destination Howev-
er, both the quantity and velocity of monocyte recruitment to a particular organ may be 
strongly influenced by the production of several chemotactic factors as cytokines, 
growth factors, A/-formylmethionyl peptides and complement products which are in-
duced by inflammatory foci (41-44) Once in the 'issues, monocytes develop into macro-
phages characteristic of the different tissues (Table I) 
Table I. 
Localization of monocytes and different types of macrophages throughout the human body 
Cell Type 
Monocyte 
Macrophage 
Alveolar macrophage 
Epithelioid cell 
Exudate macrophage 
Histiocyte 
Kupffer cell 
Langerhans cell 
Microglial cell 
Multinucleate giant cell 
Osteoclast 
Peritoneal macrophage 
Pleural macrophage 
Red pulp macrophage 
Synovial type A cell 
Tumor-associated macrophage/ 
Tumor infiltrating macrophage 
Localization 
bone marrow, peripheral blood 
bone marrow, endocrine organs, gastrointestinal tract, 
genitourinary tract, lymph node (free and fixed), mucosa 
associated lymphoid tissue, thymus 
lung 
inflammatory tissue 
inflammatory tissue 
connective tissue, skin 
liver 
skin 
central nervous system 
inflammatory tissue 
bone 
serous cavity 
serous cavity 
spleen (free and fixed) 
synovium 
solid tumor 
The cell's morphology is influenced by innumerable tissue-specific stimuli which 
not only induce augmentation of lysosomal enzymes and granules but also increase the 
overall metabolic and functional potential in general (45,46) Macrophages can also be 
further induced to alter their metabolism and function (e g , phagocytosis and chemo-
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taxis) by many stimuli This additional activation is characterized by the presence of 
certain markers (47) Moreover they increase in size and their adherence and secretory 
capacity are enhanced (48) The functional heterogeneity associated with macrophages 
is, to a large extent, a reflection of their differentiation state (49,50) 
Monocyte differentiation in Vitro. The peripheral blood monocyte is the most acces-
sible cell of the MPS and differentiation in vitro of this cell type has been widely used 
as a model system to study macrophage development Many of the changes that accom-
pany the process of monocyte differentiation in vitro, appear to resemble the altera-
tions observed in vivo (51 60) Cultured monocytes (i e, monocyte-derived macro-
phages) seem to be largely representative of the tissue macrophages 
Isolation. Pure monocyte suspensions are recommended when investigating the biolog-
ical properties of monocyte differentiation Obviously, any cell separation procedure 
should not affect the viability or function of the cells In contrast to conventional isola-
tion techniques [e g, adherence (61), density (55), phagocytosis (62)], monocyte isola-
tion by counlerflow centnfugation (elutnation) has been shown to give large numbers 
of highly purified cells (>95%), good recovery (>95%), and excellent viability (>98%) 
In addition, this method has the advantage that the separation time is relatively short, 
and that functional properties are not adversely affected by the procedure (63-66) 
Culture. Culture systems impose major limitations when investigating the differentia-
tion and functional properties of cultivated monocytes Monocytes readily become 
firmly attached to plastic or glass surfaces which impedes their activation Suspending 
the cells requires physical manipulation by a rubber policeman, or chemical treatment 
with trypsin or chelating agents Any of which might well lead to a reduced recovery 
and loss of viability or function Cultunng monocytes in Teflon foil bags overcomes 
these problems since cells grow in suspension and can be recovered for experimentation 
at any stage of maturation Furthermore, this culture system has many other important 
advantages Teflon foil bags are cheap and disposable, they can be quickly made to any 
size, the risk of infection is reduced, the gas exchange is guaranteed and the cells can 
be easily harvested with minimal damage Therefore recovery is almost complete, the 
cells are not functionally impaired, and activation is minimal (56,57,61,66-70) Al-
though the precise signals responsible for the initiation of monocyte maturation m vitro 
are largely unknown, good results are obtained using medium supplemented with be-
tween 1 and 25% heat inactivated human serum (57,60,70) 
Morphology. Alterations in cell morphology are obvious during monocyte differentia-
tion in vitro although the structure, extent and rate of morphological changes may vary 
with the cultural conditions (e g, serum source and concentration, addition of BRM) 
However, in general, monocytes loosely attach to the Teflon surface and the majority 
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of cells appear rounded During culture they increase greatly in size and develop a high-
er cytoplasm to nucleus ratio Furthermore, the eccentrically placed horseshoe shaped 
nucleus differentiates into a spherical centrally located nucleus (56,57,60,70,71) (for 
covering photographs see chapter 5, page 84) 
Functional aspects and cell characteristics of monocytes and macrophages. 
Monocytes and macrophages can be regarded as multifunctional cells which play a 
central role in the host defense against neoplasia (19-21) A full account of the abun-
dant functions executed by the monocyte/macrophage is beyond the scope of this the-
sis Therefore only those that are of immediate relevance will be discussed 
Antigen presentation. Monocytes and macrophages assist in initiating and facilitating 
cell mediated immune responses After internalization, antigens are processed by intra-
cellular proteolysis and presented as peptides in association with Major Histocompati-
bility Complex (MHC) class II molecules on the cell surface (72) The quantity of 
these MHC class II molecules (e g, HLA DR) on the surface of monocytes/macro-
phages is of paramount importance to the initiation of an immune response that pro-
ceeds efficiently (73) The highly specific interaction of T-lymphocytes with class 
II/antigenic peptide-complexes in the presence of IL-1 will ultimately induce prolifer-
ation and differentiation of T-cells (74) 
CD14. Ninety percent of circulating blood monocytes (75) and the vast majonty of 
macrophages (76) possess the differentiation-associated antigen CD 14 (77) This is a 
receptor tor the complex formed of an acute phase serum lipopolysacchandc (LPS) 
binding protein and LPS of Gram-negative bacteria (78,79) In addition, CDI4 is in-
volved in LPS-induced TNF production (79) The gene for CDI4 is mapped to the long 
arm of chromosome 5, band q32, a region encoding for growth factors and receptors 
(80) Furthermore, the cellular consequences of CD 14 ligation are not yet clear but it is 
likely to be an important mechanism for the clearance of Gram-negative bacteria from 
the bloodstream and interstitial fluids 
Secretion of biologically active constituents. Monocytes and macrophages are capa-
ble of secreting a large number of well defined molecules (81) which include comple-
ment components, coagulation factors, cytokines, enzymes, enzyme inhibitors, growth 
factors, hormones and reactive oxygen intermediates Constituents are released either 
continuously (constitutive secretion), or after stimulation (regulated secretion) (82,83) 
allowing the cells to orchestrate a wide spectrum of activities (e g , destruction of 
tumor cells, secretion) of other cell types (e g , lymphocytes, granulocytes, natural kil-
ler cells) Alternatively they may become the target of a positive feedback loop when 
activated by their own secretory products (e g , IL-1, TNF) (84) 
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Mechanisms of cytotoxicity. Monocyte and/or macrophage-medialed lysis of tumor 
cells may be most efficient when cell-cell contact is established and the initial step in 
destroying neoplastic target cells occurs by selective recognition of the target The 
effector cell may recognize either neoplasticaliy transformed cells expressing a tumori-
gemc phenotype (85,86), or tumor cells opsonized with IgG antibodies (87-89). It is 
remarkable that the specificity of the latter event is determined by the antibody rather 
than any direct programming by the monocyte/macrophage itself This second mechan­
ism of lysis, known as antibody-dependent cell-mediated cytotoxicity (ADCC), is 
mediated via receptors capable of binding the Fc moiety of IgG (FcyR) (Fig I ) 
Antibody и ^ A - ^ - V 
Monocyte A n t i g ' ¿ n p 4 4 - ^ 
Figure 1 
The process of onhbody-dependent cell-
mediated cytotoxicity (ADCC) is illus-
trated Specific antibody binds to cell 
surface antigens on tfie target cell 
Monocytes possessing FCYR bind to the 
Fc moiety of these cell associated IgG 
antibodies, and kill the attached target 
cells by means of either phagocytosis or 
extracellular lysis 
Phagocytosis Extracellular lysis 
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Three major classes of FcyR have been identified in man FcyRI, FcyRII, and 
FcyRIII (for reviews 90-92) Both freshly isolated monocytes and macrophages 
express FcyRI (CD64) and FcyRII (CD32) In addition, human macrophages and a 
small subpopulation of monocytes (<10%) express a subclass of FcyRIII (CD 16), ι e , 
FcyRIHa (90,93,94) In vitro, FcyRIII (CD16) will be expressed on monocytes after at 
least 4 days of culture (95) and remarkable progress has been made in characterizing 
the protein and cDNA levels The genes for all FcyR classes have been cloned (96-98), 
and mapped to the long arm of chromosome 1, bands q23-24 (96) FcyRI, a 72 kDa gly­
coprotein, is the only human FcyR class with high affinity for both monomenc and 
complexed human (h)IgG FcyRII (40 kDa) has negligible affinity for monomenc 
hlgG, low affinity for hlgG complexes or hlgG-coated particles, and cross-reacts with 
murine (m)IgGl (99-101, for review 102 ) 
Table II. 
General characteristics of human monocyte/macrophage IgG 
Receptor doss 
Traimipls' 
CD design 
Molecular mass (kDa) 
Receptors/cell (x 1000): 
- monocytes 
- macrophages 
Affinity for monomeric IgG 
(KJ 
IgG isotype ligands'· 
- human 
-mouse 
Anli-FtyR mAb1 
ADCC 
FcyRI 
FcyRIa 
CD64 
72 
15-40 
50-100 
high 
MO'-IO'M') 
3>1>4»>2 
2a,3»>l,2b 
101,197,32.2 
Yes 
FcyRII 
FcyRlla"" 
CD32 
40 
30-60 
30-80 
low 
HO'M') 
1,3»2>4 
l>2b»>2a,3 
IV.3 
Yes 
FcR° 
ь 
FryRlla11 
CD32 
40 
30-60 
30-80 
low 
( d O ' M 1 ) 
3>1,2»>4 
2b»>l,2o,3 
IV.3 
Yes 
Frolli 
FcyRIHa 
CD16 
50-80 
l-5d 
40-100 
medium 
(-гЗхЮ'М') 
1,3»>2,4 
2a>2b»>l 
3G8,Leullb 
Yes 
° references 90,92,W06,107 
b
 polymrphism of FcyHII on monocytes/mocrophages FcyRlld' foils to support máuction of hell proliferation by 
mlgGl опШЗ mAb, whereas FcyRlld" supports this hell mtogenesis (references 99,100) 
' tronscnpts relevant to ее scope of this tees 
' present on a small subpopulation of monocytes (<W%) 
' speckihes denved from studies of one or a few cell types (may not be generally applicable) 
1
 antth·^ mAb used in the studies described in this thesis 
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Two allotypic variants of this receptor arc distinguished with respect to their abili­
ty to bind hlgG and mlgG complexes either strongly or weakly [i с , high-responders 
(FcYRIIaHR) and low-responders (FcyRIIa1-")] (99,100,10V 106, for review 107) 
FcyRIHa, a glycoprotein of 50-80 kDa, is a transmembrane receptor with a medium 
affinity for hlgG (90) Furthermore, all three classes of FcyR have been shown to 
mediate ADCC (108) The general characteristics of FcyR expressed on human mono 
cytes and macrophages are listed in Table II 
'Activation' of monocytes and macrophages. A remarkable feature of monocyte/ 
macrophage mediated tumor cytotoxicity is that these cells must be appropriately acti­
vated for such lysis to occur (109) Adams and Hamilton (110) defined the activation 
of monocytes and macrophages being the "aiquisition of competence lo complete a 
complex function" Performing a specific function (e g , ADCC) is dependent upon the 
acquisition of the requisite capacities (e g , FcyR), and activation may be either an 
enhanced or suppressed expression of genes encoding for proteins cardinal to the function 
being activated (111) In vivo, a resting tissue macrophage may come in contact with 
many inductive or suppressive compounds as cytokines, colony-stimulating factors, 
growth factors, and LPS (or other bacterial products) which induce activation However, 
it is important to note that an activated macrophage will return to the original basal 
state when the inductive signal either disappears or is exchanged by a suppressive signal 
Monocytes and macrophages can be activated both in vivo and in viiro by recombi­
nant glycoproteins (IL, IFN, CSF, TNF) (110) In the more natural context, these BRM 
are involved in regulating the functional state of the cells, and will selectively affect 
phenotype, and function (72,81,110,112-119), depending on the stage of maturation of 
these cells (118) Furthermore, different mediators may affect similar functions of 
monocytes For instance, both IFN-γ, and IL-4 enhance expression of MHC class II 
molecules on monocytes (70,112) However, the cell surface expression of FcyR is 
increased when monocytes are cultured with IFN-γ, and decreased when exposed to 
IL-4 (113,119) 
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AIM OFTHfôTUDKS 
The modulation by cytokines and anticancer drugs of m ν ¡tro cultured human 
monocytes and monocyte-denved macrophages is the subject of the current thesis 
Monocyte-denved macrophage FcyRI-medialed cytotoxicity is investigated in chapter 
2, and results presented show a profound effect of IFN-γ on both the inhibition by 
monomenc human IgG and the mechanism of FcyRI-mediated cytolysis Influences of 
IFN-γ on the expression and function of the most widely distributed receptor for IgG, 
ΡΰγΚΙΙ, are reported in chapter 3 Remarkably, effects on both allotypic variants of 
FcγRIIa, FcγRIIaHR and ΡΰγΚΙΐ31κ, are observed to occur only in an early stage of 
monocyte differentiation Chapter 4 deals with the effects of doxorubicin on human 
monocytes in adherent and non adherent cultures In an alternative approach of cell 
function analysis, attention is locusscd on some aspects of cell metabolism by meas­
uring three enzymes of the intermediary metabolism and two acid hydrolases as indica­
tors of monocyte maturation Chapter 5 describes in vitro studies on the influence of 
anticancer drugs in combination with cytokines on the maturation and differentiation 
process of human monocytes The observations indicate that doxorubicin does not 
negatively influence the activation state of monocytes/macrophages, induced by IFN-γ 
In the next two chapters, the immunomodulatory effects induced by either various 
cytokines (chapter 6), or major classes of anticancer drugs (chapter 7), on morphology, 
phenotype, FcγR-medlated cytotoxicity, and cytokine secretion at different stages of 
maturation during in vitro culture of human monocytes have been described 
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EFFECT OF RECOMBINANT IFN-γ (RlFN-γ) ON THE MECHANISM 
OF HUMAN MACROPHAGE IGG FcRI-MEDIATED CYTOTOXICITY. 
RlFN-γ DECREASES INHIBITION BY OTOPHILIC HUMAN IGG AND CHANGES THE 
CYTOLYTIC MECHANISM. 
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Different classes of receptors for the Fc moiety of IgG (FcyR) have been defined 
on human monocytes and macrophages FcyRI, FcyRII, and FcyRIII All three classes 
are capable of mediating antibody-dependent cell-mediated cytotoxicity (ADCC) 
FcyRI, which binds monomeric human IgG (hIgG) with high affinity, was shown an 
effective cytotoxic trigger molecule on different types of cells In vitro, the inhibition 
of FcyRI-mediated ADCC by hIgG is well documented The low affinity receptor clas­
ses, FcyRII and FcyRIII, are not blocked by monomeric hIgG Because monomeric 
hIgG is present at high concentrations in plasma and interstitial fluids it has been pos­
tulated inhibitory in vivo 
We investigated (he effect of rIFN γ on macrophage FcyRI-mediated ADCC in the 
presence of low doses hIgG With human erythrocytes (E) sensitized with hIgG as tar­
get cells, FcyRI was studied selectively We found that rIFN-γ enhances both expres­
sion and cell surface density of FcyRI on cultured peripheral blood monocytes Further­
more, this cytokine partially reversed the inhibitory effect of monomeric hIgG on ADCC 
More interestingly, we found that the cytolytic mechanism of monocyte-denved macro­
phages changed completely after prolonged culture with rIFN-γ Monocytes cultured 
for 9 days in control medium mediate predominantly phagocytosis After long-term 
rIFN-γ stimulation (9 days), monocyte-denved macrophages almost completely lost the 
capacity to perform phagocytosis Interestingly, they became highly efficient in medi­
ating extracellular lysis of human E sensitized with hIgG Short-term rIFN-γ stimulated 
monocyte-denved macrophages (for the last 40 h of culture) were found to mediate 
both phagocytosis and extracellular lysis 
Our findings suggest that in vivo rIFN-γ stimulated macrophages may be most effi­
cient in FcyRI-mediated cytolysis as a consequence of a changed cytolytic mechanism 
in combination with enhanced FcyRI density 27 
FcyR provide an important link between humoral and cellular branches of the 
immune response Three major classes of FcyR have been identified in man FcyRI, 
FcyRII, and FcyRIII (reviewed in Refs 1-3) Both monocytes and macrophages express 
FcyRI (CD64) and FcyRII (CD32) In addition, human macrophages and a small sub-
population of monocytes (<10%) express a subclass of FcyRIII (CD 16), ι e , FcyRIIIa 
(1,4) The genes for all FcyR classes have been cloned (5,6), and mapped to the long 
arm of chromosome I, bands q23-24 (5) FcyRI has a molecular mass of 72 kDa, binds 
both monomeric and complexed hIgG with high affinity, and is recognized by different 
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mAb including 197,32 2. and 10 1 (7-9) FcyRII is a 40 kDa glycoprotein, has hardly 
affinity for monomeric hIgG, and low affinity for polymenc hIgG (hlgG-coated particles 
or hlgG complexes) FcyRIIIa. a glvcoprotein of 50 to 80 kDa, is a transmembrane recep­
tor with a medium affinity for hlgG ( I ) 
Mononuclear phagocytes car be activated m m o and in cell cultures b) various 
cytokines (10) Incubation with rIFN-γ results in increased numbers of FcyRI (11-Π), 
and enhanced ability to mediate ADCC (13 15) The expression of FcyRII andFcyRIIIis 
hardly affected by incubation of cells with Γ[ΡΝ-γ(1,4,16 17) 
/η VÌVO, IgG-mcdialcd cllector responses most likely occur in an environment with 
excess hlgG In vitro, inhibition of FcyRI-mediated activities by monomeric hlgG is well 
documented (18,19) It has been hypothesized that this phenomenon may support an 
important physiological role for FcyRII, because this receptor is not blocked by mono-
meric hlgG, and proteolytic enzymes can significantly increase the affinity of this low 
affinity receptor (20) The question how monocytes and macrophages can overcome mono-
mene hlgG inhibition of FcyRI mediated functions has only been partially resolved (19) 
In ongoing studies on the influence of rIFN-yon human macrophage FcyRI-mediated 
cytotoxicity, we noted that cytophilic hlgG only blocked ADCC activity mediated by 
untreated cells Furthermore, we recently described that rIFN-γ treated human mono­
cytes. besides modulation of FcyRI expression, underwent alterations in morphology 
(13) Now we studied two FcyRI mediated processes in more detail, ADCC and anti­
body-dependent phagocytosis, in the presence of limited amounts of monomeric hlgG 
We observed a profound effect of rIFN-yon both the inhibition by monomeric hlgG 
and the mechanism of FcyRI mediated cytolysis 
Monocytes. Monocytes were isolated as described previously, by using cell scatter 
monitored counterflow centnfugation (21 ) Briefly, mononuclear cells obtained from 
buffy coals, or cytapheresis of healthy volunteers, were isolated by Percoli (Pharmacia, 
Uppsala, Sweden) centnfugation (δ=Ι 075 g/ml) at 40C Monocytes were purified from 
mononuclear cells by counterflow centnfugation Monocyte fractions were over 95% 
pure (as evaluated in cytocentnfuge preparations after staining for nonspecific esterase 
and May-Grunwald-Giemsa), and viability was higher than 98%, as assessed by trypan 
blue dye exclusion Isolated cells were cither cultured immediately or were cryopre-
served (22), and stored in liquid nitrogen until use Recovery and viability of cryopre-
served monocytes were >70% and >95%, respectively 
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Culture and Stimulation of monocytes With rlFN-γ. Freshly isolated or thawed cryo-
presened monocytes were cultured at concentrations of 3 χ IO' cells/ml in RPMI 1640 
medium with 20 mM HEPES (Flow Laboratories, Irvine, UK), 2 mM L-glutaminc 
(GIBCO, New York), 1 mM pyruvic acid (Sigma, St I ouis, MO), 40 μg/ml gentamicin 
(Boehrmger, Mannheim, FRG), and 10% heat-inactivated pooled human serum, in a 
humidified incubator with 5% CO, in air at 37°C Teflon foil bags (Dupont de Nemours 
and Co, Switzerland) were used for nonadherent culture of monocyte suspensions (23) 
Human rIFN-γ(specific activity 10 U/ml) was kindly provided by Boehrmger 
Ingelheim (Alkmaar, The Netherlands) Monocytes were cultured with rIFN-y(150 
U/ml) by adding it to the culture directly at day 0, or at day 7 This concentration of 
rlFN-ywas chosen after the performance of pilot experiments which indicated optimal 
FcyRI induction with minimal effect on cell viability at this dose (data not shown) 
Harvesting of monocyte-derived macrophages. After 9 days, cells were recovered 
by needle aspiration after cooling Teflon foil bags to 40C for I h and gentle kneading, 
and washed twice in RPMI 1640 medium (without serum) The cells exhibited a 
macrophage like appearance with increased cell sue and a higher cytoplasm to nucleus 
ratio (13) There was no difference in yield (>9()%) or viability {>%%) between con­
trol cultures and cells cultured with rIFN-γ for 9 days or 40 h Morphology was studied 
in May-Grunwald-Giemsa-stdincd cytocentnfugc preparations Cell size was estimated 
of ~5 χ IO6 cultured cells from 3 independent donors by forward light scatter by con­
tinuous flow cytometry and a calibration curve of monosizcd polymer particles (Dyno 
particles, Lillestrom , Norway) (13) To remove cell associated hlgG, collected cells 
were further incubated in polypropylene tubes for I h at 370C in RPMI 1640 medium 
This additional washing procedure was performed in all experiments except when indi­
cated otherwise (Figs I and 4) After incubation, tubes were cooled on iced water tor 
15 mm, and adherent cells were obtained by using a rubber policeman (Costar, 
Cambridge, MA), and washed thrice in RPMI 1640 medium Further incubation at 
3TC in hlgG free medium did not result in exposure of additional IgG binding sites 
Anti-FcyR mAb. Specific murine anti-FcvR mAb used were 197(CD64 purified 
IgG)(Medarex, W Lebanon, NH), which binds to an epitope outside the hgand-binding 
site on FcyRI (7), 10 I (CD64 culture supernatant)(generously provided by Dr Nancy 
Hogg, ICRF, London, UK), IV 3 (CD32 purified IgG)(Medarex), and 3G8 (CD16 
purified IgG)(Medarex) which compete with the FcyRI, FcyRII and FcyRIII ligand-
bmding sites, respectively (9,24,25) mAb 197 was used in both immunofluorescence 
and inhibition studies (10 μg/ml), mAb 10 1 (1 4), IV 3 (5 μg/ml) and 3G8 (7 μg/ml) 
were employed in inhibition analyzes 
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Immunofluorescence Studies. Monocyte-denved macrophages were suspended at 
2 x 1 0 ' cells/ml in PBS /1 0% BSA / 0 1 % NaN, (=IF buffer) Cell suspensions of 100 
μ] were incubated on ice for 45 mm with an equal volume of mAb Cells were washed 
once with IF buffer, supplemented with 10% heat-inactivated pooled human serum (to 
avoid nonspecific binding of antibodies) Cells binding the mAb were detected with 
FITC-conjugated goat F(ab)¡ anti-mouse IgG (H and L chain) (Cappel, Malvern, PA), 
diluted in IF buffer supplemented with 10% heat-inactivated pooled human serum 
After an additional incubation for 45 mm at 40C in the dark, cells were washed twice 
and analysed on an Ortho ЗОН flow cytometer The fluorescence intensity of 5000 cells 
was analyzed For all analyses, gatings (red forward and right angle scatter) were set 
around the macrophage population and the mean fluorescence intensity (expressed in 
arbitrary fluorescence units/tell) was calculated (linear) from the histograms (26) 
ADCC OSSOys. ADCC capacity of monocytc-denved macrophages from different 
donors was studied using a 5'Cr release assay as described previously (27), in which 
antibody-coated human E were used as target cells Briefly, a quantity of 10' E were 
suspended m 0 3 ml PBS containing 100 μΟ ''Cr (sodium Chromate, Radiochemical 
Centre, Amersham, UK), and incubated at 370C After 30 mm, the incubation volume 
was increased with PBS to 1 ml, and an equal volume of sensitizing antibody, or PBS / 
0 1% BSA alone (control for nonspecific binding), was added Rhesus D-positive '''Cr-
labeled E were sensitized with human alloserum against Rhesus D (Merz & Dade, 
Dudmgen, Switzerland) Antibodies were used at various dilutions, resulting in E sen­
sitized with a range of IgG molecules per cell (EA-hlgG), as described elsewhere (28) 
After incubation for 30 mm, cells were washed three times with PBS / 0 1 % BSA, sus­
pended in RPMI1640 medium plus 2 mM L-glutamine, 40 μg/ml gentamicin and 10% 
heat-inactivated FCS, and used immediately Cytotoxicity assays were performed in 
U-bottomed microtiter plates (Costar, Cambridge, MA) Equal volumes (100 μ]) of 
effector and target cells were mixed in the plates, in the absence or presence of graded 
amounts of either hlgG or mAb 10 1,197, IV 3, or 3G8, centnfuged (2 mm, 50 χ g, 
room temperature) and incubated for 18 h (or for different times, indicated in the text) 
in a humidified incubator at 37°C 
In some experiments we used the assay described by Boot et al (29) with minor 
modifications Briefly, 105 effector cells (50 μΐ) and 2 5 χ 105 "'Cr-labeled sensitized E 
(50 μΐ) were mixed The plates were centnfuged (2 mm, 50 χ g) at room temperature 
and incubated for 90 mm in a humidified incubator at 37°C Then ^'Cr release from 
damaged E was promoted by addition of 0 1 ml of hypotonic (17 mM) NaCl for 2 mm 
Plates were centnfuged (10 mm, 400 χ g, room temperature), and half the supernatant 
was removed for estimation of ''Cr release by an LKB gamma counter All tests were 
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carried out in triplicate The results were calculated as follows % cytotoxicity = 
(C - S)/(T - S) χ 100, where С = mean cpm of test sample S = mean cpm of spontane 
ous ''Cr release (i e, ''Cr release by labeled target cells in medium only), and Τ = 
mean cpm of the maximal ''Cr release, obtained by addition of 20% saponin (Coulter, 
Dunstable, UK) to the target cells The average spontaneous release of E was 3 ± \% 
(mean ± SD), and release from unsensitized E incubated with effector cells never 
exceeded spontaneous release 
IgG preparations. Monomerie hlgG was purified from human serum by ammonium 
sulphate precipitation and DEAE Sephadex (Pharmacia, Uppsala, Sweden) chromatog 
raphy (27) After isolation, all fractions were depleted of aggregates by ultracentnfu 
gation (1 h at 105 000 χ g, 40C) The proteins were rapidly snap-frozen in small ah-
quots in liquid nitrogen, stored at 20oC, and thawed once, just before use Aggregated 
hlgG was obtained by heating hlgG for 30 mm at 630C 
1-hlgG binding assays. Binding of monomenc hlgGl was studied on different cell 
types We used thawed cryopreserved monocytes, and monocyte-denved macrophages 
cultured in the absence or presence of rIFN-γ After removing all cell-associated hlgG, 
as described above, cells were resuspended in IF buffer 
Purified hlgG I myeloma proteins were generously donated by Dr Arjen Vlug 
(CLB, Amsterdam, The Netherlands) After labeling with n I (Amersham) by a mild 
oxidative method with Protag (J Τ Baker, Deventer, The Netherlands) followed by 
purification on Sephadex G-25 (Pharmacia), '25I-hIgGl was ultracentrifuged 
(I h, 105,000 χ g, 40C) and stored at 40C until use One hundred microliters of cells 
(-14 χ IO6 cells/ml) were incubated with increasing concentrations of '^I-hlgGI at 40C 
for 3 h to reach equilibrium The amount of cell-associated p,l-hlgGl was determined 
after washing twice with PBS/BSA (0 1%) Total activity was evaluated separately by 
counting total '2Ч input Nonspecific binding was defined as cell-associated activity in 
the presence of a 500 fold excess of unlabeled hlgG Data were analyzed using the 
method described by Scatchard (30) 
Phagocytosis assay. A 4Cr-based radioactive assay and microscopic assay were per 
formed to assess phagocytic capacity of monocytes and monocyte-denved macro 
phages (unstimulated or stimulated with rIFN-γ) from different donors Effector and 
target cells were prepared similarly as for ADCC (see above) 
In the radiometric method, equal volumes (100 μΐ) of 105 effector cells and 
2 5 χ 10s target cells (optimally sensitized with hlgG), were mixed in polypropylene 
tubes centnfuged (2 mm, 50 χ g, room temperature) and incubated for 0 (control), 0 5, 
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1, 2, 3, or 4 h in a humidified incubator at 37°C Nonengullcd EA-hlgG were lysed by 
addition of 3 ml warm (370C) lysis butter (8 29 g NH4C1.37 mg K:EDTA and 1 g/liter 
KHCO,, pH 7 3), and cells were washed twice with PBS / 0 1%- BSA Cell pellets con­
taining intact effector cells and phagocytozed '''Cr-labeled E served to quantify radio­
activity All tests were carried out in triplicate The results were calculated as follows 
9c phagocytosis = 100 χ (С - („(/Τ, where С = mean cpm о! test sample, l0 = mean cpm 
of phagocytozed "Cr labeled E at t=0 (Control), and Τ = mean cpm of maximal "Cr 
release obtained by addition of 20% saponin (Coulter) to the target cells. The average t0 ± 
SD of EA-hlgG was 6 ± I %, and phagocytosis of unscnsitized E incubated with effec­
tor cells never exceeded phagocytosis at t=0. 
The microscopic assay of phagocytosis was performed in U-bottomed microliter 
plates (Costar), in which 10^  effector cells (100 μΙ) and 2.5 χ IO' unlabeled sensitized E 
(100 μΐ) were mixed. Plates were cenlnfuged (2 mm, 50 χ g) at room temperature and 
incubated in a humidified incubator at VC, for 0 (control), 0 5,1, and 2 h. After differ­
ent incubation times, cell suspensions containing intact effector cells and phagotytozed 
unlabeled EA-hlgG, were fixed and stained (May-Grunwald-Giemsa) on cytocentrifuge 
preparations To determine the percentage of phagocytic ettcctor cells, 100 cells on 
each slide were counted in randomly chosen fields and scored for the number of 
engulfed EA-hlgG 
FCTRI-mediated ADCC activity. FCYRI and FcyRII can be independently assayed in 
experiments by employing E sensitized with hlgG, or murine IgGl, respectively. 
The specificity of these indicators for the two FcyR classes has been characterized 
previously in rosettmg assays (31), modulation analyses (32), and ADCC experiments 
(13,27). Monocytes were cultured for 9 days and cytotoxicity towards EA-hlgG was 
evaluated. The optimal E:T ratio was estimated to be 0.4 With this ratio we analyzed 
the effect of rlFN-γοη FcyRI-mediated ADCC activity. 
Human peripheral blood monocytes were cocultured with rIFN-γ cither for 9 days, 
or for the last 40 h (to 7-day cultured monocyte-derived macrophages) E used as targets 
were sensitized at different dilutions of hlgG anti-Rhesus D alloserum This resulted in 
sensitizations varying from -1.4(0 19 3 χ 10' molecules per target cell (28) ADCC 
activity mediated by the unstimulated monocyte-derived macrophages resulted in a half 
maximal cytotoxicity to EA-hlgG, when target cells contained approximately 2 5 χ 10' 
hlgG molecules. ADCC activity of both cell populations cultured with rlFN-ywas 
significantly enhanced (Fig. 1). 
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Figure 1. 
Effect of rlFN7on FcyRI-mediated long-
term (18 h) ADCC activity in the obsence 
or presence of cytophilic hlgG ADCC 
activity was meosured after cultunng 
monocytes for 9 days in medium alone 
( · , о ), or in medium supplemented 
with 150 U/ml of rlFtty, either for 9 days 
( • , n ) , o r for the last 4 0 h ( A , A ) 
ADCC tests (18 h) were performed using 
target E sensitized wilti vanable numbers 
of hlgG molecules/cell, in the absence 
(dosedsymtols) or presence (open sym-
bols) of cytophilic hlgG [no special efforts 
were taken to remove this cell-bound 
hlgG, pnor to the ADCC expenment [see 
Motenols and Methods)] Results repre­
sent data from 9 to 13 individual experi­
ments with cells from different donors 
The specificity of ADCC was evaluated in inhibition studies with an unique anti-
FcyRI mAb, 10 1, which reacts in/near the Iigand-binding site (9), and with mAb 197, 
which binds to an epitope outside the Iigand-binding site (7) This last anti-FcvRI mAb 
is of the mIgG2a isotype, a subclass which binds avidly to hFcyRI (1,33) This mAb 
can selectively inhibit ligand binding to this receptor via its Fc-part ("Kurlandcr phe­
nomenon") (1) In two individual experiments, with cells from different donors, 9-day 
cultured effector cells and optimally sensitized EA-hlgG were incubated with blocking 
mAb and subsequently tested for cytotoxicity ADCC activity mediated by monocyte-
denved macrophages cultured without, and with rIFN-γ, either for 9 days, or for the 
last 40 h was strongly inhibited by mAb 10 1 [96 3 ± 5 2% (without rIFN-γ), 83 4 + 
5 9% (long-term rIFN-γ), and 97 8 ± 0 7% (short-term rIFN-γ) inhibition, respectively] 
Incubation of the three difterent effector populations with mAb 197 resulted in complete 
(100%) inhibition of cytotoxicity to EA-hlgG Anti-FcyRII (mAb IV 3) mAb had only 
a marginal inhibitory effect on ADCC activity [4 6 ± 3 6% (without rIFN-γ), 5 5 ± 3 6% 
(long-term rIFN-γ), and I 5 ± 1 3% (short-term rIFN-γ) inhibition, respectively], and 
anti-FcYRIII (mAb 3G8) mAb did not inhibit cytotoxicity mediated by any of the three 
effector populations Taken together, these results indicate that lysis of the EA-hlgG 
target cells occurs predominantly via FcyRI In control experiments, we observed that 
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FcyRII-mediated ADCC activity towards EA-munne IgGl, was strongly inhibited by 
the same concentration of mAb IV 3, and was unaffected by the same amount of anti-
FcyRI mAb 197 (data not shown) 
Effect of monomeric IgG on FryRI-medioted cytotoxicity. Cytotoxicity mediated by 
unstimulated monocyte-derived macrophages to EA-hlgG is sensitive to low doses of 
monomeric hlgG Cytophilic hlgG still present on monocytes after culture in the pres­
ence of human scrum (when no special precautions were taken to remove this cell-
bound hlgG, see Materiali and Methods) almost totally blocked ADCC activity medi­
ated by the untreated population ADCC activity via FCYRI of the rIFN-γ stimulated 
monocyte-derived macrophages, was decreased only to a minor extend by the presence 
ot cell-bound hlgG (Fig 1) 
We next studied the effect of different amounts of hlgG on FcyRI-mediated cyto­
toxicity In the presence of monomeric hlgG, half maximal inhibition was observed for 
unstimulated monocyte-derived macrophages, and 9 day rIFN-γ stimulated populations, 
at concentrations of 11, and 33 μg/ml hlgG, respectively An almost complete inhibi­
tion was found at concentrations of 100, and over 300 μg/ml hlgG (Fig 2) 
Similar inhibition curves were found with monomeric hlgGl, or hIgG3 myeloma pro­
teins, aggregated hlgG, or with 'cold' sensitized targets (EA-hlgG) (data not shown) 
These results indicated that the affinity for hlgG did not change dramatically after cul­
ture of cells with rIFN-γ 
(%) 
100 
60 
40 
20 
Cytotoxicity 
0 1 
figure 2. 
FcyRI-mediated cytotoxicity in the 
presence of hlgG MonocytMlenved 
mocrophoges cultured for 9 days in the 
absence ( · , о ), or presence 
( • , . - , ) of rlFN-yd 50U/nil) were 
incubated with target E, sensitized with 
- 8 χ 103 hlgG molecules/cell, in the 
obsence {closed symbols) or presence 
(open symbols) of different amounts of 
hlgG Results represent mean + SD 
from three individual experiments wild 
cells from different donors 
100 1000 
Human IgG ( μ j/ml) 
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Effect of rlFN-γοη monocyte-derived macrophage morphology, and FcyRI 
expression. To further analyze the effect of rIFN-γ on cultured monocytes, we estimated 
cell sizes, FcyRI surface expression, and FcyRI receptor density We observed alterations 
in morphology, size, and FcyRI surface expression of monocyle-dcnved macrophages 
after culture for 9 days with rIFN-γ (150 U/ml) After short-term rlFN-γ stimulation, 
FcyRI expression increased dramatically (short-term long-term ratio is 1 6), nevertheless 
receptor densities after both stimulation modalities were in the same range (Table I) 
Table I. 
Effect of rIFN-γ on cell size and expression and density of FryRI 
Cell type0 Cell Diameter Surface Area Relalive FryRI Relalive FryRI 
[μπ)γ (цт')1 Expression11 Oensily" 
Macrophages 30+4 2827 І j 
Macrophages/rlFNyday,, 30+4 2827 5 8±3 2 SB 
Macrophoges/rlFNYdayM 24+4 1809 3 6 ± 2 5 56 
° Monocyfcdenved mocrophoges were obtomed by culture for 9 doys with or without 1 SOU of rlFN-y/ml 
' Cell diameter was estimated of ~S χ Iff wlWred cells from àree independent donors, by fon/ord light scatter 
using о flow cytometer as described in Motenols and Methods (data represent mean + SOj 
' Surface area farrf) was calculated from the mean cell diameter (top2), assuming that the cells were sphencol 
ά
 Expression of hyRI was evoluated on monocyte domed macrophages by immunofluorescence with тАЬІ97 
(data represent mean ± SO, from five seporate expenments) Relatwe expression offqfil was calculated as follows 
Mean fluorescence intensity оігІЩ cultured cells/mean fluorescence intensity of cells cultured in control medium 
' Relative density of hyRI was obtained by dividing relative expression of FcyRI by surface area fam2) 
Binding of '"l-labeled hlgGl to the different effector cells. We then checked 
affinities and number of binding sites for monomer hlgGl on monocytes, and mono 
cyte-denved macrophages, cultured in the absence or presence of rIFN-γ Specific bind­
ing of radiolabeled monomenc hlgGl to all cell types under equilibrium conditions 
was saturable Scatchard plots of the data were linear (Fig 3), indicating that there is 
only one class of binding sites, and binding affinities of the different cell populations 
were in the same range (Table II) 
Furthermore, the number of binding sites ranged on individual monocytes from 19,000 
to 37,000 sites/cell The increase in binding sites on monocyte-derived macrophages 
afterculture, in the absence or presence of rIFN-γ for 40 h, or 9 days was --3-, 18-, and 
12-fold, respectively (Table II) The number and attinily ol binding sites on rIFN-γ 
stimulated monocyte-derived macrophages could not provide an explanation for the 
observed decreased inhibition by cytophihc hlgG Therefore, we next analyzed the 
mechanism of cytolysis 
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Figure 3. 
Effect of rlFN^on the binding of mono-
menc l ! i l lobeled hlgGl to monocyte l^e-
nved mocrophoges Monocytes were cul· 
tured for 9 doys in medium alone ( · ), 
or medium supplemented with 150 U/ml 
of rlFN^, either for 9 days ( • ), or for 
the lost 40 h ( • ) Binding studies 
were performed with 14 χ 10* cells as 
described in Materials andMeàods 
Binding data were plotted according to 
Scatchord (30) Bound and free hlgGl 
on the ordinate are in counts/mm The 
equilibrium ossociotion constant (K,) was 
colculoted from die slope of the straight 
line The K, for monomenc hlgGl binding 
w e r e l ó x l O ' M ' J S x l O ' M ' . o n d 
5 3 χ 108 M ' for circles, triangles and 
squares, respectively One representative 
experiment out of three is shown 
Table II. 
Binding of monomerk ' 2 5 l-hlgGl to various types of cells 
Cell type0 Κ, Ιχ ΙΟ'Μ 1 ) 1 1 " Receplorc/Cell (x 1000) ñ 
Monocytes 5.4±2.0 24.6±8.4 4 
Macrophages 2.7±1.4 78 5±58.5 4 
Macrophages/rlFN-7day7, 5.0±2.3 437.7±137.2 3 
Macrophoges/rlFN-Ydayc, 7.0±0.7 285.5 ±17.3 3 
° Monocytes horn live different donors were used either directly oñer thawing, or oner culture for 9 days wá or 
wáoutl50UofrlFfh//ml 
' Ihedota were plotted according to Scatchord (30) to calculate affinities and number of binding sites per cell 
Results represent mean ±SD 
' Number of individual experiments 
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Effect of rlFN-γοη the kinetics of lysis. To investigate the influence of rIFN-γοη 
the mechanism of cytolysis, short term assays (90 mm) were carried out in order to 
decrease the contribution of phagocytosis (34) Monocyte-denved macrophages stimu­
lated with rIFN-γ showed to be active in extracellular lysis of EA hlgG, whereas the 
unstimulated population was hardly at all capable of mediating cytolysis over this time 
period (Fig 4) Furthermore, cytophilic hlgG did not significantly inhibit extracellular 
lysis of EA-hlgG target cells 
Cytotoxicity 
Antibody moltcules/erythrtxyle 
Figure 4. 
Effect of ιΙΡΝγοη ívfi\ medioted short 
term (90 mm) ADCC ochvily in the 
obsence or presence of cytophilic hlgG 
Monocytes were cultured for 9 doys in 
medium alone ( · , ), or medium 
supplemented with 150 U/ml of rlFN7, 
either for 9 doys ( • , ), or for the 
l o s t « h ( А , л ) ADCC tests (90 
mm) were performed using target E sen­
sitized with variable numbers of hlgG 
molecules/cell, m the obsence {closed 
symbols) or presence [open symbols) of 
cytophilic hlgG [no special efforts were 
token to remove this cell-bound hlgG 
prior to the experiment (see Matenols 
ond Methods)] Results represent doto 
from three individual experiments with 
cells from different donors 37 
To get more insight in the differences between the 18 h (Fig 1) and the 90 mm 
(Fig 4) ADCC assays, we performed time course experiments (over 18 h) Measurable 
soluble radioactivity in supernatants may be derived from both extracellular cytolysis, 
and exocytozcd products from digested E Figure 5 shows that monocytes stimulated 
continuously with rlFN-yare most efficient in killing of EA-hlgG After 2-2 5 h the 
5
 Cr concentration in the medium reached 50%, and optimal lysis was reached by 7 h 
(84 ± 7%) In the unstimulated monocyte-denved macrophage population we noted a 
slow increase of soluble radioactivity in the supernatant in time However, even after 
3 h the 5lCr activity in the medium was still only marginal compared to rIFN-γ stimulated 
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monocyte-derived macrophage populations After 18 h, 36 ± 7% of the total amount of 
S|Cr labeled E, appeared as extracellular medium-associated radioactivity ADCC 
activity of the short-term rIFN-γ stimulated monocyte-derived macrophage population 
showed the same pattern as the long term stimulated monocytes The 50% value was 
reached after 1 h incubation, and maximal effect (72 ± 2%) was not reached before ± 18 h 
g Cytotoxicity Figure 5. 
Kinetics of FCTRI mediated ADCC 
Monocytes were cultured for 9 days 
in medium alone ( · ), or medium 
supplemented with 150 U/ml of 
rlFN7, either for 9 doys ( • ), or for 
1 t i e l o s t 4 0 h ( A ) ADCC tests were 
run for vanable times, using optimally 
sensitized target E Results represent 
data from two individual experiments 
with cells from different donors 
16 18 
Time (hours) 
Effect of rlFN-γοΠ FcyRI phagocytosis. We next studied phagocytosis mediated by 
the different effector cell populations A time course experiment was performed over 4 h 
Monocyte-derned macrophages appeared highly active in phagocytosis, target cells 
were taken up rapidly and after 2 h the amount of ingested MCr was nearly maximal 
In contrast, phagocytic capacity of tells cultured for 9 days with rIFN-γ was low, even 
at 4 h of incubation Phagocytic activity of monocyte-derived macrophages exposed to 
rIFN-γ for 40 h was significantly lower than that of unstimulated cells (Fig 6) 
Monocyte-derived macrophages from different donors, cultured in the absence or 
presence of rIFN-γ. were also assayed microscopically for their ability to exhibit 
FcyRl-mediatcd phagocytosis of optimally sensitized E Table III shows that not all 
cells participate in the phagocytic process Most striking was the difference between 
the phagocytic activity mediated by the unstimulated and the long-term rIFN-γ stimulated 
monocyte-derived macrophages After 2 h, 21 ± 2 % of the unstimulated effector cells 
engulfed 1 3 target cells, and 29 ± 59c phagocylozed >4 target cells Of the monocyte-
derived macrophages continuously incubated with rIFN-γ, 95 ± 1% did not engulf any 
of the maximally sensitized E, and in only a small subpopulation (5 + \%) we observed 
one to three E intracellulary Phagocytic capacity decreased slightly (compared to 
unstimulated macrophages) when monocyte-derived macrophages were incubated with 
rlFN-γ for 40 h 
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Table III. 
Phagocytosis of EA-hlgG mediated by différent types of cells 
Percent oF effector cells at lime at which phagocytosis of EA-hlgG was scored: 
Cell type0 No. of E ingested 30 min Ih 2 h 
0 
1 
2 
3 
>4 
0 
1 
2 
3 
>4 
0 
1 
2 
3 
>4 
A 
74 
14 
10 
1 
1 
90 
6 
4 
0 
0 
97 
3 
0 
0 
0 
В 
77 
4 
8 
7 
2 
89 
8 
3 
0 
0 
96 
4 
0 
0 
0 
A 
80 
12 
6 
2 
0 
61 
12 
9 
3 
15 
88 
9 
3 
0 
0 
В 
59 
16 
9 
4 
12 
75 
7 
6 
3 
9 
87 
9 
4 
0 
0 
A 
46 
7 
8 
7 
32 
56 
18 
6 
2 
18 
94 
2 
2 
2 
0 
В 
56 
4 
9 
6 
25 
57 
14 
9 
1 
19 
96 
4 
0 
0 
0 
" Monocyteiìerived macrophages, cultured for 9 days with or without 150 U/ml of rf/W-y from two donors 
(named A and B) were used Ihe f J mho was 0 4 for all effector populohons After vanous hmes of mcubahon, 
cells were fixed and stained WayirunwaldGiemsa) on cytocenhifuge preparations 
To determine the percent of phogocyhc effector cells, 100 cells on each slide were counted in randomly chosen 
holds and scored for the number of engulfed EAblgG 
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Figure 6. 
Kinetics of Fc-yfll mediated phagocyto­
sis Monocytes were cultured for 9 
days in medium alone ( · ), or 
medium supplemented with 150 
U/ml of rlFN7, either for 9 days 
( • ) , o r f o r t h e l o s t 4 0 h ( A ) 
After different periods of time, cells 
were harvested and phagocytosis was 
evaluated using optimally sensitized 
target E Results represent data from 
two individual experiments with cells 
from different donors 
In this report we studied the effect of rIFN-γοη monocyte-denved macrophage 
FcyRI-mediated cytotoxicity against EA-hIgG in the absence and presence of monomeric 
hlgG Inhibition analyses with anti-FcyRI, anti-FcyRII, and anti-FcyRIII mAb showed 
that cytotoxicity against EA-hIgG (both before and after culture with rIFN-γ) was 
mediated via FcyRI We isolated large numbers of highly purified monocytes from 
mononuclear cells by counterflow elutnation, and cultured the cells in suspension in 
Teflon foil bags to minimize activation Our data confirmed that the expression of 
FcyRI (11-13) and FcyRI-mediated ADCC is strongly enhanced by culture with rIFN-γ 
(13-15) Shen et al (14) showed that the enhanced IgG antibody-mediated killing appears 
to be due to both increased FcyRI expression, and activation of the cellular mechanism 
of lysis In this study we found that prolonged (9 days) rIFN-γ treatment of monocytes 
resulted in a significantly smaller cell size, and lower FcyRI expression, than the short-
term (40 h) treated monocyte-denved macrophages With both Scatchard, and flow 
cytometric analyses, we found that receptor densities were similar for cells treated either 
for 9 days, or 40 h with rIFN-γ In addition we did not observe differences in affinity 
for monomeric hlgG between these situations Our results may, therefore, point to the 
rele\ance of receptor density next to number of FcyRI molecules for cytotoxic activity 
We noted that rIFN-γ partially reverses the inhibitory effects of monomeric hlgG 
on ADCC In studies with increasing concentrations of monomeric or aggregated hlgG 
preparations, we found inhibition of ADCC without changes in slopes or forms of the 
curves between rIFN-γ stimulated and unstimulated cells (Fig 2) This supports an 
r n a i y w c y w w » ! * 
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effect of rIFN-γ on the number of receptors involved, and not on their affinity A mathe­
matical model for multn aient binding of ligand to effectors, proposed by Segal et al 
(19), predicts that the interaction between hlgG-coated target cells and FcyRI will be 
inhibited by monomeric hlgG, but that inhibition can be counteracted by increasing the 
density of receptors on the surface. In other words, the presence of monomeric hlgG in 
plasma and interstitial fluids may increase the threshold levels of antibody on target 
cells, and FcyRI density on effector cells, to trigger effectors 
Number and affinity of FcyRI on rIFN-γ stimulated monocyte-denved macrophages 
did not adequately explain the observed increases in ADCC activity, and the diminish­
ing inhibitory effects of hlgG. The much smaller cell si¿e and the -40% lower FcyRI 
expression, after long-term, vs short-term rIFN-γ stimulation, focused our attention on 
the mechanism of cytolysis It has been demonstrated that macrophage-mediated 
ADCC activity, measured by the release of5lCr is an end result of both extracellular 
lysis, and phagocytosis (35,36) The first appearance of 5lCr in the supernatant after 
engulfment of EA-associated "Cr was found after only -2 h (34) In an attempt to dis­
sociate extracellular and intracellular lysis we performed a 90 mm assay (29). in addi­
tion to an 18 h cytotoxicity assay (27) and a specific phagocytosis test In combination, 
these assays clarified the lytic mechanisms of monocyte derived macrophages. Freshly 
isolated monocytes mediate both extracellular lysis, and phagocytosis (data not shown). 
We demonstrate here that prolonged culture of monocytes (9 days), either with or with­
out rIFN-γ, ultimately results in populations of monocyte-denved macrophages with 
different lytic mechanisms Short-term exposure to rIFN-γ leads to increased ADCC 
activity and decreased phagocytosis of EA-hlgG by monocyte-denved macrophages, 
which was also observed by Ruegg and Jungi (15). However, after 9-day (long-term) 
exposure to rIFN-y, a marginal phagocytosis and abundant extracellular lysis pattern 
was found (Fig. 5 and Fig 6) Our study suggests that after m vitro culture extracellu­
lar lysis and phagocytosis are mediated by different populations of monocyte-denved 
macrophages This may reflect the maturation and activation state of individual mono­
cytes Three arguments may support this hypothesis First, culture without rIFN-y 
results in a population which mediates predominantly phagocytosis, with marginal 
capacity for extracellular lysis. Second, short-term activation with rIFN-yof monocyte-
denved macrophages produces a population which mediates both phagocytosis and 
extracellular lysis Third, culture with rIFN-γ for a longer period (9 days) results in a 
more efficient killer cell, because extracellular lysis is no longer combined with the 
slower process of phagocytosis. 
Microscopic determination of the phagocytic capacity supported that not all cells 
participate in phagocytosis As our monocyte fractions were over 95% pure (and after 9 
days of culture viability was still >98%), interference of a contaminating nonphago-
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cylic/nonviable subpopulation is unlikely After 2 h, when phagocytic capacity was 
optimal (Fig 6), -%% of the unstimulated monocyte-denved macrophages were capa­
ble of engulfing one or more EA hlgG However, when stimulated with rIFN-γ for the 
whole culture period, only 5% of the effector population was mediating phagocytosis 
Connor et al (37) showed recently that only -58% of human peripheral blood mono 
cytes mediates extracellular lysis (i e , ADCC) A significant increase in the percentage 
of monocytes mediating ADCC could be observed after incubation with rIFN-γ 
Connor et al did not analyze whether the population active in extracellular lysis was 
also active in intracellular lysis of sensitized E (i e , phagocytosis) Our experiments 
now show that the population of unstimulated monocyte-denved macrophages pre­
dominantly mediates phagocytosis and that the long-term (9 days) rIFN-γ stimulated 
effector cells were incompetent in this respect However, populations of freshly isolat­
ed monocytes (data not shown) and monocyte derived macrophages stimulated with 
rIFN-γ for the last 40 h were executing both types of killing It is unknown, however, 
whether these events are mediated by the same or by different cells Our study under­
lines the existence of a monocyte population that is heterogeneous with respect to cyto 
toxicity as a consequence of maturation and activation 
A possible explanation for the change in cytotoxicity against EA hlgG after pro 
longed rIFN-γ treatment may be production of different FcyRI-isoforms Previous 
reports showed the existence of two different transcripts for FcyRI, one with a size of 
1 7 kb, and another of 1 6 kb. evident only after culture of cells with rIFN-γ (18-40) 
In addition, evidence was obtained recently for the existence of multiple FcyRI genes 
(6) Miettinen et al (41) described that the murine РсуКІІ-Ь2 isoform in contrast to 
FcyRII-bl, efficiently mediates internalization of bound ligand An alternate FcyRI 
form induced by rIFN γ may possibly provide an explanation for the differences ob­
served after rIFN-γ stimulation of monocyte-denved macrophages in their capacity to 
mediate FcyRI-phagocytosis 
A critical role has been postulated for FcyRI in vivo by Ruiz et al (42), who 
showed that dysfunction of macrophage FcyRI in patients with end-stage renal disease 
contributes to high prevalence of infection Furthermore, administration of rIFN-yis an 
established and effective therapy to reduce the frequency of serious infections in 
patients with chronic granulomatous disease (43) Induction of FcyRI on neutrophils 
from these patients m vivo was found (44) It is tentative to speculate that our in vitro 
study with prolonged rIFN γ stimulation of monocytes may provide an explanation for 
the effectivity of rIFN-γ therapy in patients with chronic granulomatous disease 
In vivo, FcyRI-mcdiated biological responses seem to be restrained by hlgG 
However, rIFN-γ may alter the threshold of hlgG inhibition as well as the mechanism 
of lysis via FcyRI This receptor may be an important effector molecule with respect to 
CHAPIER 2 
R I F N γ A N D V A C R O P H A G E F C 7 R I " Е Л А Т Е ^ С У Т О O X I C TY 
cytotoxicity towards solid tumors Steplewski et al (45) previously demonstrated 
FcyRI-mediated killing of tumor cells m vitro, and Herlyn and Koprowski (46) and 
Adams et al (47) showed FcyRI-mediated cytotoxicity of tumor cells in mo 
Furthermore, these last two studies underline the importance of FcyRI-mediated cyto­
toxicity, since the most effective destruction of tumor cells was seen with tumor-specific 
mAb of the mIgG2a subclass [which interact with FcyRI (1-3)] (45-47) 
Macrophages may become efficient in FcyRI mediated ADCC at tumor sites as a 
consequence of increased FcyRI density after activation by rlFN-γ The mechanisms of 
extracellular and phagocytic cytotoxicity and the increased resistance to the inhibitory 
effects of monomenc hlgG clearly require further investigation Furthermore, knowl­
edge of molecular details will be indispensable to understand the role of FcyRI on 
monocytes and macrophages 
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CHAPTER 3 
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AISTRACT 
Human monocytes and macrophages express an isoform of IgG Fc receptor II 
(FcyRII), FcyRIIa Two allotypic variants of this receptor could be distinguished with 
respect to their ability to bind murine (m)IgGl complexes either strongly or weakly, 
defined as high-rcsponder (HR) and low-responder (LR), respectively 
We investigated the effect of recombinant (Γ)ΙΡΝ-γοη the ability of freshly isolat­
ed monocytes, and those cultured for 40 h and 9 days, to mediated antibody-dependent 
cell-mediated cytotoxicity (ADCC) Using human erythrocytes (E) sensitized with 
mlgGl as target cells, FcyRII was studied selectively Cells which had been cultured 
for 40 h exhibit a significantly decreased FcyRII expression, and FcyRII-mediated 
ADCC activity as compared to freshly isolated monocytes Co culture with ΓΐΡΝ-γ(40 h) 
reversed this decrease Short-term rIFN-γ cultured cells, and fresh cells express similar 
numbers of FcyRII, and exhibit comparable FcyRII-mediated ADCC activity Phago­
cytic activity was not affected Prolonged culture of monocytes for 9 days, co-cultured 
with rIFN-γ either from day 0 or from day 7, did not affect expression or functional 
activity of FcyRII Furthermore, the effects were observed in both HR and LR individ­
uals 
Our results show that rIFN-yhas strong effects on FcyRII-mediated responses spe­
cifically during the early stages of monocyte maturation, most likely by affecting 
receptor expression levels 
INTRODUCTION 
Cell surface receptors for the Fc fragment of IgG (FcyR) provide an important 
bridge between cellular and humoral immune responses Expressed on cells of the 
mononuclear phagocyte system, FcyR mediate multiple biological functions, e g, 
phagocytosis (1), extracellular lysis of antibody-coated targets (2), and induction of 
human anti-CD3 T-cell proliferation (3) Ditfcrcnt classes of FcyR are recognized 
based on variation in size, specificity and affinity for hgands, mAb reactivity, and at 
protein and cDNA levels Human monocytes and macrophages express three distinct 
classes of FcyR FcyRI (CD64), FcyRII (CD32), and a subclass of FcyRIII (CD16), ι e , 
FcyRIIIa (for general reviews see refs 4 and 5) FcyRI, a 72 kDa glycoprotein, is the 
only human FcyR class with high affinity for both monomenc and complexed human 
(h)IgG FcyRII (40 kDa) has negligible affinity for monomenc hlgG, low affinity for 
hlgG complexes or hlgG-coaled particles, and cross-reacts with murine (m)IgGl) (6 8) 
FcyRIIIa, a glycoprotein of 50-80 kDa, is a transmembrane receptor with a medium 
affinity for hlgG (4) Remarkable progress has been made in characterizing FcyR at 
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protein and cDNA levels The genes for all FcyR classes have been cloned (9,10), and 
mapped to the long arm of chromosome 1, bands q23-24 (9) 
FcyRII is encoded by three different genes (FcyRIIA. B, and C) (4,9) For tran­
scripts of FcyRIIA, a genetically determined polymorphism was initially recognized by 
the failure of human monocytes of 30% of Caucasian individuals (low-responders 
(LR)] to support induction of T-cell proliferation by mlgGl anli-CD3 mAb, whereas 
monocytes from the other individuals [high-responders (HR)| supported this T-cell 
mitogenesis (6,7) Similar numbers of FcyRIIa molecules are expressed on monocytes 
from HR and LR (11,12). but isoelectric focussing analysis of the receptor molecules 
suggested the existence of two allelic forms of FcyRIIa (11) Recently, the molecular 
basis of this structural polymorphism for FcyRIIa was elucidated In the LR form, one 
amino acid in the second Ig-like domain was found critical for the strongly diminished 
binding of mlgG I-sensitized E (13,14) 
Mononuclear phagocytes can be activated m vivo and culture by various cytokines 
(15) Incubation with recombinant (r)IFN-y results in increased numbers oflcyRl 
(16,17), and enhanced ability to mediate antibody-dependent cell-mediated cytotoxicity 
(ADCC) (17,18) Furthermore, we recently described that rIFN-γ treated human mono­
cytes, besides modulation of FqfRI expression underwent alterations in morphology 
(19), and cytolytic mechanism (17) 
In this study we evaluated the effect of rIFN-γοη FcyRII-medialed cytotoxicity of 
monocytes, short-term cultured monocytes, and 9-day cultured monocyle-dcrned 
macrophages Monocytes were obtained both from HR and LR individuals We obser­
ved a profound effect of rIFN-γ on both cytotoxicity and FcyRII expression of short-
term cultured monocytes 
Monocytes. Monocytes were isolated as described previously, by using cell scatter 
monitored counterflow centrifugation (20) Briefly, mononuclear cells obtained from 
buffy coats, or cytapheresis of healthy volunteers, were isolated by Percoli (Pharmacia, 
Uppsala, Sweden) centrifugation (δ=1 075 g/ml) at 4 Τ Monocytes were purified from 
mononuclear cells by counterflow centrifugation Monocyte fractions were over 95% 
pure (as evaluated in cytocentnfugc preparations after staining for non-specific esterase 
and May-Grunwald-Gicmsa), and viability was higher than 98%, as assessed by trypan 
blue dye exclusion Isolated cells were cither cultured immediately or were cryopre-
scrved (21), and stored in liquid nitrogen until use Recovery and viability of cryopre-
scrved monocytes were >70%, and >95%, respectively 
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Anti-CD3 T-Cell proliferation. To identify HR and LR individuáis, T-cell proliferation 
induced by the mlgGl anti-CD3 mAb WT31 was measured as described previously (6) 
Briefly, mononuclear cells were cultured for 72 h together with mAb WT31 During 
the last 18 h, cells were pulsed with I^HJthymidme (Amersham, UK) Proliferation 
tests were performed in triplicate Stimulation indices were calculated by dividing 
[3H]thymidine incorporation obtained in the presence of mAb WT31, by background 
['Hjihymidine incorporation obtained in the absence of mAb HR were defined as 
having stimulation indices > 5 
Culture and Stimulation of monocytes With rlFN-γ. Freshly isolated or thawed cryo-
preserved monocytes were cultured at concentrations of 3 χ IO4 cells/ml in RPMI 1640 
medium with 20 mM HEPES (Flow Laboratories, Irvine. UK), 2 mM L-glutamine 
(GIBCO), 1 mM pyruvic acid (Sigma), 40 μ§/πι1 gentamicin (Boehrmger), and 10% 
heat-inactivated pooled human serum, in a humidified incubator with 5% CO, in air at 
370C Teflon foil bags (Dupont de Nemours and Co , Switzerland) were used for non­
adherent culture of monocyte suspensions (22) 
Human τΙΓΝ-γ(specific activity 10" U/ml) was kindly provided by Boehrmger 
Ingelheim (Alkmaar, The Netherlands) Monocytes were cultured with ΓΐΡΝ-γ(150 
U/ml) by adding it to the culture either at day 0, or at day 7 This concentration of 
rIFN-γ was chosen after performing pilot experiments, which indicated optimal FcyRI 
induction with minimal effect on cell viability at this dose (data not shown) 
Harvesting monocyte-derived macrophages. After culture for either 40 h, or 9 
days, cells were recovered by needle aspiration after cooling Teflon toil bags to 4°C 
for 1 h and gentle kneading, and washed twice in RPMI 1640 medium The cells exhi­
bited a macrophage-like appearance with increased cell size and a higher cytoplasm to 
nucleus ratio (19) There was no difference in yield (>90%) or viability (>98%) 
between control cultures and cells cultured with rIFN-γ for either 40 h, or 9 days 
Morphology was studied in May-Grunwald-Giemsa stained cytoccntnfuge preparations 
Anti-FcyR mAb. Specific murine anti-FcyR mAb used were 197 (CD64 purified IgG) 
(Medarex, W Lebanon, NH), which selectively inhibits ligand binding to FcyRI via its 
Fc-part ("Kurlander phenomenon") (4), IV 3 (CD32 purified IgG) (Medarex), and 3G8 
(CD16 purified IgG) (Medarex) which block FcyRII, and FcyRIII ligand-binding sites, 
respectively (23,24) 
Immunofluorescence Studies. Expression of FcyRII and HLA-DR on monocytes and 
cultured monocytes was assayed by indirect immunofluorescence as described (17). 
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using anti-Fc/RII mAb IV 3 (IgG2b). anti-HLA-DR mAb OK-DR (Ortho, Westwood, 
MA), and FITC-conjugated goat F(ab')2 anti-mouse IgG (H and L chain) (Cappel, 
Malvern, PA) Fluorescence intensity of 5000 cells was measured with an Ortho ЗОН 
flow cytometer For all analyses, gatings (red forward and right angle scatter) were set 
around the monocyte population and the mean fluorescence intensity (expressed in 
arbitrary fluorescence units/cell) was calculated (linear) from the histograms Relative 
expressions of FcyRII were calculated as follows 
(M, - MJ/iM,, - M
n
) χ 100%, where М
с
 = mean fluorescence intensity of cultured 
monocytes (in the absence or presence of rII-Ν-γ), M
n
 = mean fluorescence intensity of 
negative control, and M
u
 = mean fluorescence intensity of uncultured monocytes 
ADCC assays. ADCC capacity of monocyte-derived macrophages from different donors 
was studied using a '''Cr release assay as described previously (8) in which antibody-
coated human E were used as targets Briefly, E were suspended in PBS containing 
''Cr (sodium Chromate, Amersham), and incubated at 370C After 30 min, mlgGl mAb 
directed against glycophonn A, or PBS /0 1% BSA alone (control) was added 
Antibody was used at various dilutions, resulting in E sensitized with a range of mlgGl 
molecules per cell (EA-mlgGl), as described elsewhere (25) After incubation for 30 
mm, EA-mlgGl were washed thrice, suspended, and mixed with equal volumes of 
effector cells, in the absence or presence of graded amounts of either mAb 197, IV 3, 
or 3G8 After incubation for 18 h at 37Τ, half the supernatant was removed for esti­
mation of "Cr release All tests were carried out in triplicate The results were calculat­
ed as follows % cytotoxicity = (C - S)/(T - S) χ 100, where С = mean cpm of test 
sample, S = mean cpm of spontaneous 5'Cr release (i e , чСг release by labeled target 
cells in medium alone); and Τ = mean cpm of the maximal MCr release, obtained by 
addition of 20% saponin (Coulter, Dunstable, UK) to the target cells The average 
spontaneous release of E was 3 ± 1% (mean + SD), and release from unsensitized E 
incubated with effector cells never exceeded spontaneous release 
Phagocytosis assay. A 5'Cr-based radioactive assay was performed to assess phagocy­
tic capacity of monocytes and 40 h cultured monocytes (unstimulated or stimulated 
with rIFN-γ) from different donors, as described previously (17) Briefly, effector and 
target cells were prepared similarly as for ADCC (see above) Equal volumes (100 μΐ) 
of 3 75 χ 10' effector and 2 5 χ 10' target cells (sensitized with mlgGl I 250), were 
mixed, ccntnfuged and incubated for 0 (control), 0 5,1,2. 3, or 4 h in a humidified 
incubator at 37°C Non-engulfed EA-mlgG I were lysed, and cells were washed twice 
with PBS /0 1% BSA Cell pellets containing intact effector cells and phagocytozed 
5lCr-labeled E served to quantify radioactivity All tests were carried out in triplicate 
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The results were calculated as follows % phagocytosis = 100 χ (С - t0)/T, where С = 
mean cpm of test sample, t0 = mean cpm of phagocytozed ''Cr-labelcd E at t=0 (Control), 
and Τ = mean cpm of maximal '^Cr release obtained by addition of 20% saponin 
(Coulter) to the target cells The average to ± SD of EA-mlgG was 6 + 1 % , and phago­
cytosis of unsensitized E incubated with effector cells never exceeded phagocytosis at t=0 
FryRII-mediated ADCC activity. Using E sensitized with mIgGI (EA-mlgGl), or 
hlgG (EA-hlgG) as target cells, the cytolytic activity mediated by either FcyRII, or 
FcyRI, can be assayed independently The specificity of these types of indicators for 
the two FcyR classes has been characterized previously in ADCC experiments 
(8.17,19), roselting assays (26), and modulation analyses (27) Monocytes and 9-day 
cultured monocyte-denved macrophages expressing either Fc'/RUa™. or FcYRIIa'", 
were evaluated for cytotoxicity towards E sensitized with a 1 500 dilution (ascites) of 
mlgGl anti-glycophorin A mAb Figure 1 shows that the optimal effector to target cell 
ratio (h Τ ratio) for both HR and LR individuals was similar The optimal Ь Τ ratio of 
monocytes, and 9-day cultured monocyte-denved macrophages was estimated to be 
1 5, and 0 5, respectively These results showed that monocytes retain the functional 
HR/LR polymorphism of FcyRII in ADCC during culture 
Previously, it was shown that the degree of E sensitization obtained with anti-glyco-
phonn A mAb gives rise to large differences in FcyRH-mediated ADCC activity (8,9) 
Since the degree of target cell sensitization directly affects ADCC, we used E sensiti­
zed at different dilutions of mlgG I anti-glycophorin A, which results in sensitizations 
varying from -12 to 419 χ IO1 mlgGl molecules per target cell (25) 
Cytotoxicity 
I 2 3 
Effectoi to target ratio 
Figure I. 
Polymorphism in cytotoxic activity of 
monocytes from different individuals 
towards EA-mlgG 1 Monocytes were ob­
tained from HR (closed symbols), or LR 
(орел symbols) individuals ADCC activity 
of freshly isolated monocytes (A), or after 
9 days in culture (B) was tested Targets 
were human E sensitized with mlgGl 
mAb against glycophonn A ( 1 5 0 0 dilution 
of ascites) Results are average data from 
3-4 experiments witti cells from different 
donors SO were all smaller than 10% 
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The availability of specific anti-FcyRII mAb IV τ*, which reacts in/near the ligand-
bindmg site (23), enabled us to test the specificity of ADCC Using 9-day cultured 
monocyle-denved macrophages and EA-mlgGl (at an optimal Ε Τ ratio of 0 5, and 
1 250 dilution of anti-glycophorm A ascites), ADCC activity was strongly inhibited by 
mAb IV 3 (Fig 2) In this study, two more mAb were used, which selectively block 
either FcyRl, or FcyRHI Neither anti-FcyRI (mAb 197), nor anti-FcYRIU (mAb 3G8) 
mAb affected ADCC activity against E sensitized with mlgGl Furthermore, no quali­
tative differences were found between HR and LR individuals (Fig 2) This implies 
that, under the test conditions, lysis ot EA-mlgGl targets occurs primarily via FcyRII 
Additionally, we have previously demonstrated thai FcgRI-mediated ADCC activity 
against E sensitized with hlgG, was completely inhibited (100%) by mAb 197, margin­
ally inhibited (4 6 ± 3 67r) by mAb IV 3. and unaffected by mAb 3G8 (17) 
Figure 2. 
Identificohon of FcyR involved m cyto­
toxicity towoids [A-mlgGl Monocyte-
denved macrophages, cultured for 9 
days, and optimally sensitized EAmlgGl, 
were incubated in medium alone (con­
trol), or in medium containing either anti-
Fc7RllmAblV3(5mg/ml),anti-FcYRI 
mAbl97(10rng/ml),orantiFcYRIII 
mAb 3G8 (7 mg/ml) Results are dahi 
from one HR, and one LR 
Effect of rlFN-γοπ freshly isolated, and short- and long-term cultured monocytes. 
Differences between monocytes and macrophages are the result of their maturational or 
activation state (28) When monocytes are cultured in vitro, the cells differentiate and 
after? days of culture they acquire a macrophage-like appearance (19,29) In our ex­
periments we evaluated the effect of rIFN-γοη three stages of maturation freshly iso­
lated monocytes, short-term (40 h) cultured monocytes, and long-term (9 days) cultured 
monocytes 
Using short-term cultured monocytes at an optimal Ε Τ ratio of 1 5, we analyzed 
the effect of rIFN-γοη both FcyRIIa™ and FcyRIIa'"-mediated ADCC activity, and the 
expression of FcyRII Figure 3 shows that ADCC activity was significantly reduced 
when monocytes are cultured (40 h) in the absence of rIFN-γ When monocytes were 
cultured (40 h) in the presence of rIFN-γ. the decrease of FcyRII-mediated ADCC acti­
vity was not observed Compared to freshly isolated monocytes, half-maximal cvtolysis 
E r r r c T O F R I T N γ O N ν υ Ν о < Y ' fc F c y R l l A 
by unstimulated 40 h cultured HR and LR monocytes occurred only with targets which 
contained ~ 120%, and -25% higher numbers of mlgGl molecules/b, respectively 
(Table I) 
Cytotoxicity 
f 
l O 5 I O 4 
/ 
1 0 J 
mlgGl dilution 
Figure 3. 
Effect of short term culture ond r i f i o r ì 
monocyte FcvRII-medioted ADCC octivily 
Freshly isolated monocytes (circles) of 
HR (A) ond LR (В) donoß, monocytes 
cultured for 40 h in either medium alone 
[squares], or medium supplemented 
with 150 U/ml of rlFN-y (ftranj/ei), 
were evaluated for cytotoxic activity 
ADCC tests were perfoimed as described 
in Materials andMetiods, using target E 
sensitized with variable amounts of 
mlgGl onti-glycophonn A mAb (optimal 
Ε Τ ratio of 1 5 ) Results ore average 
data from individual experiments using 
cells f r a m ( « = 1 2 , B = 7 > = 4) 
different HR, and ( ^ = 8, -J = 3, 
л = 3) different LR donors SD were all 
smaller than 8% 
Table I. 
Target cell sensitization at half-maximal cytotoxicity with HR and LR monocytes 
mlgGl molecules/E (x 1000)' al hall-maximal cytoloxicily wilh cells from. 
Effeclor cells'' 
freshly isolated monocytes 
40 h cultured monocytes 
40 h cultured monocytes-i- rlFN-γ 
monocyte-derived macrophages 
monocyle-derived macrophages/rlFN-γ dayj., 
monocyte-derived macrophages/rlFN-γ day7, 
High Responders 
90+15 
200+45 
134±33 
85±18 
42±16 
80+21 
Low Responders 
320±30 
400±3B 
340±31 
360±25 
190±21 
250±26 
° Monocytes were cultured for 40 h with or wéout 150 U/ml of rlFN-γ 
1
 Monocyteiierived macrophages were obtained by cultunng monocytes for 9 days we or without 150 U/ml of 
rlFN-γ, either for 9 days, or for the last 40 h 
' Sensitization of E with mlgG I was performed as described previously (25) 
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Next, we examined whether reduced FcyRII-mediated ADCC activity was paral­
leled by lowered FcyRII expression. Cells from both FcyRII responder types express 
similar levels of FcyRII molecules ( 11,12). As a consequence of the 40 h culture 
period, the relative expression of FcyRII decreased dramatically to 53.0 + 6.7% (mean 
± SD of ten experiments) of the control value, and co-culture with rIFN-γ resulted in 
comparable relative FcyRII expression levels (112.1 + 12.6%), as compared with fresh­
ly isolated monocytes (mean ± SD often experiments). In Figure 4 one representative 
experiment out of ten is shown. In contrast, 40 h of culture resulted in a 2.3 ± 0.8-fold 
increase in the expression of HLA-DR (mean ± SD of six experiments), indicating that 
culture conditions did not cause a general reduction in membrane antigens. These data 
showed that reduction of both FcyRII-mediated ADCC activity, and FcyRII expression 
levels, could be reversed by culture of monocytes with rIFN-y. 
3 0 0 . 
150. 
0 
3 0 0 . 
150. 
η 
3 0 0 . 
150. 
0. 
Cell number -, 
; л 
χ ^ 
В 
i 
Л ^ 
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0 50 100 150 200 
Fluorescence intensity 
Figure 4. 
rIFN-γ culture prevents decreose in 
FcyRII expression on short-term cultuied 
monocytes The expression of FcyRII on 
freshly isoloted monocytes (A), mono­
cytes cultured for 40 h in either medium 
alone (B), or medium supplemented 
with 150 U/ml of rlFN^y (C) was meas­
ured by immunofluorescence onolysis 
using anft-FcyRII mAb IV 3 The fluores­
cence intensity (orbitrory units) wos 
recorded on the abscissa (linear scale) 
Negative control values are represented 
by dashed-lines One representative 
experiment oui of ten is shown. 
Next, we studied the effect of rIFN-γ on FcyRII-mediated ADCC activity, and the 
expression of FcyRII using long-term cultured HR and LR monocytes. Monocytes were 
cultured for 9 days. rIFN-γ was added either for 9 days, or for the last 40 h of culture. 
Monocylc-dcrived macrophages that had been cultured in the presence of rIFN-y, 
showed a slight enhancement of ADCC activity against EA-mlgGl, at an optimal E:T 
ratio of 0.5 (data not shown). The time at which rIFN-γ was added to effector cells did 
not result in a significantly different FcyRII-mediated cytolysis. 
E F F E C T O F R I F N γ O N M O N O C Y T C F c y R l l A 
When rIFN-γ was added at the start of the 9-day culture period, the target cell sen­
sitization required for half-maximal cytolysis was decreased by about 50% (for both 
HR and LR monocytes) The presence of rIFN-γ only during the last 40 h of culture did 
not dramatically affect the sensitization required for half maximal cytolysis (Table 1) 
In contrast to the 40 h rIFN-γ cultured monocyte population, the relative FcyRII 
expression of monocyte derived macrophages was not influenced by co-culture with 
rIFN-γ for either 9 days (82 4 ± 17 9%), or for the last 40 h (89 7 ± 11 9%) (mean ± SD 
of three individual experiments) 
FcyRII phagocytosis mediated by short-term cultured monocytes. Recently, we 
showed with respect to FcyRI mediated cytolysis, that 9-day cultured monocyte-denved 
macrophages predominantly mediate phagocytosis, and that long-term (9 days) rIFN-γ 
stimulated effector cells were more active in extracellular lysis (17) We evaluated 
whether in addition to FcyRII mediated ADCC activity, also phagocytic capacity of 
monocytes was impaired by short-term culture A time course experiment was per­
formed over 4 h with freshly isolated monocytes, and monocytes cultured for 40 h in 
the absence or presence of rIFN-γ All tested populations exhibited a comparable phag­
ocytic activity (Table II) Target cells were taken up rapidly and after 3 h the amount 
of ingested 5lCr was nearly maximal This suggested that the impaired ADCC activity 
observed after short-term culture was mainly caused by a decrease in monocyte 
FcyRII-mediated extracellular lysis 
Table 11. 
FcyRII-medrated phagocytosis of EA-mlgGI 
Percentage phagocytosis of EA mlgGl' 
after 3 h with cells from 
Cell type" High Respondéis Low Responden 
freshly isolated monocytes 30 B±61 16 3±3 9 
40 h cultured monocytes 29 5±4 5 17 5±4 2 
40 h cultured monocyles/rlFN γ 28 0 + 3 3 1 7 0 ± 3 1 
' Monocytes were either used directly after thawing, or after culture for 40 h with or without I SOU of rlFN-y/ml 
6
 Phagocytic capacity of oil effector populations was assessed as desenbed in Matenols and Methods, at on [ Τ 
ratio of 15 Data represent mean ±SD from three HR, and three LH 
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In this study we investigated the effects of rIFN-γ on a biological function medi­
ated by FcyRII, on short- (40 h), and long-term (9 days) cultured monocytes. Inhibition 
studies with specific anti-FcyR mAb confirmed that lysis of the EA-mlgGI target cells 
was specifically mediated via FcyRII. We show that short-term cultured monocytes 
(40 h) exhibit a significantly decreased FcyRII expression, and FcYRII-mcdiated ADCC 
activity towards EA-mlgGI as compared to freshly isolated human peripheral blood 
monocytes. Remarkably, this decrease in FcyRII expression and FcYRII-mcdiated 
ADCC activity was reversed by co-culture of monocytes with rIFN-γ. 
Cytokines are known to affect the activation state of mononuclear phagocytes, and 
rlFN-yis one of the strongest modulators (15). It has been observed that rIFN-γ enhan­
ces FcyRII-mediated cytotoxicity, without affecting the expression of FcyRII (2). In 
this report we demonstrate that under some conditions rlFN-yalso affects FcyRII 
expression levels (Fig. 4). However, modulation of FcyRII expression and activity by 
rIFN-γ seems to depend critically on the stage of monocyte maturation. We now show 
that, compared to freshly isolated monocytes, short-term (40 h) cultured cells exhibit a 
significantly lower FcyRII expression, and a reduced ADCC activity against EA-mlgGI. 
Both short-term (40 h) rIFN-γ cultured monocytes, and freshly isolated monocytes 
express similar numbers of FcyRII, and exhibit a comparable FcyRII-mediated ADCC 
activity. These observations indicate that rIFN-γ may affect FcyRII expression and 
furthermore, that receptor density correlates with FcyRII-mediated function, since 
freshly prepared monocytes, and monocytes cultured in the presence of rIFN-yhave a 
similar capacity to lyse EA-mlgGI. With a specific phagocytosis test, we focused our 
attention on the mechanism of cytolysis mediated via FcyRII. Surprisingly, monocyte 
phagocytic activity was not impaired after 40 h of culture. ADCC as measured in our 
assay may result from both extracellular lysis, and phagocytosis. Therefore, we deduce 
from the phagocytosis data that the observed impaired ADCC activity in short-term 
cultured cells is the result of decreased FcyRII-mediated extracellular lysis. The observed 
rIFN-γ modulation of FcyRII expression, is confirmed by a study of Becker and Daniel 
(29). These authors showed that rIFN-γ treated 40 h cultured monocytes expressed twice 
as many FcyRII molecules compared to unstimulated cells. The mechanism by which 
rIFN-γ affects FcyRII expression, and ADCC, however, remains unclear up to now. 
We also compared the two allotypic variants of FcyRIIa (HR and LR) for cytotoxic 
activity. Donor heterogeneity as found in the anti-CD3 T-cell proliferation assay, was 
also reflected in the ADCC assays. Cells expressing the FcyRIIaLR allotypic form needed 
a much higher degree of sensitization of E with mlgGl anti-glycophorin A mAbfor 
half-maximal lysis than the FcyRIIa"" monocytes. However, alterations in FcyRII-
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mediated ADCC activity, as a consequence of culture, either in the absence or presence 
of rIFN γ, were not different between the the FcyRIIa polymorphic forms Recently, 
two findings were reported which may be of clinical relevance with respect to the 
FcyRIIa polymorphism First, pronase or trypsin-treatment changes the affinity of both 
FcYRIIdHR, and rcYRIIaLk for hlgG on monocytes (30) Second, the rcYRIIa'" allotypic 
form was found, as the sole human FcyR class, to bind hIgG2 complexes effectively (31) 
Until now little is known about the physiological significance of FcyRll In \no, 
monocyte and macrophage mediated effector responses most likely occur in an envi­
ronment with excess hlgG The presence of hlgG will not be of a hindrance to FcyRII-
mediated cytotoxicity in contrast to FcyRI mediated activities (32) It has been hy­
pothesized that this phenomenon may support an important physiological role for the 
most widely distributed class of FcyR, FcyRII (33) Recently wc reported that rIFN-γ 
alters the threshold of hlgG inhibition, as well as the mechanism of lysis via FcyRI 
expressed on mature macrophages, which may be an important feature in areas of in­
flammation (17) In this respect it is of interest that FcyRII expression on short-term 
cultured freshly isolated monocytes, in contrast to more mature monocyte derived 
macrophages, was highly sensitive to rIFN-γ treatment It is tempting to speculate that 
during immune responses, an immunologically active dose of 1FN γ may induce altera­
tions in FcyRII expression and FcyRlI-mediated cytotoxicity, especially on monocytes 
which have recently left the peripheral blood circulation where they reside a short time 
in the tissues before becoming tissue macrophages FcyRII expression on resident 
macrophages may be less affected by this cytokine 
In conclusion in this report we document a strong effect of rIFN γ on the expres­
sion and function of FcyRII Remarkably, this effect was observed to be temporal and 
occurred only in the early stages of monocyte ditterentiation, revealing a new level of 
complexity in regulation of the receptor levels of this molecule 
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AISTRACT 
Purified human monocytes were cultured for 2 h, 88 h, and 10 days in plastic tubes 
(adherent) and for 10 days in Teflon foil bags (non-adherent) Monocytes were incuba-
ted with doxorubicin by two short-term exposures (750 or 1500 ng/ml) for 1 h or by 
continuous exposure (75 ng/ml) Maturation was monitored by measuring the intracel-
lular activity of three metabolic enzymes and two acid hydrolases Expression of recep-
tors for the Fc moiety of immunoglobulin G (FcyRI, FcyRII, FcyRIII), CD 14, and 
HLA-DR was assayed by indirect immunofluorescence with monoclonal antibodies In 
the presence of doxorubicin, the adherent capacity, the yield, and the enzyme activities 
reflecting growth and intermediary metabolism were similar to the control groups 
However, doxorubicin reduced the expression of FcyRI (32-45%), FcyRII (10-26%), 
CD14 (20-37%), and HLA-DR (25-34%) on the monocyte-denved macrophages 
Expression of FcyRIII was not detectable after 10 days of culture 
INTRODUCHON * 
Monocytes and macrophages, part of the mononuclear phagocyte system, are a 
first-line defence against the development and spread of tumors (1,2) Doxorubicin is 
active against a wide range of tumors, including leukemia, lymphoma, sarcoma, and 
breast, small cell lung, and ovarian cancers (3,4) In view of the limited progress so far 
with the use of cytostatic agents in metastatic disease, non-specific stimulation of the 
immune system by biological response modifiers has been studied (5) Cytotoxicity 
was synergistic when doxorubicin was combined with interferon (6,7) However, can-
cer chemotherapy can both immunosuppress and actuate the mononuclear phagocyte 
system (8) 
We have investigated in vitro the effects of doxorubicin on the maturation and dif-
ferentiation of human monocytes We assayed five enzyme activities as indicators of 
monocyte maturation glucose-6-phosphate dehydrogenase (G 6 PDH), phosphohexose 
isomerase (PHI), isocitrate dehydrogenase (1CDH), acid phosphatase (ACP), and 
N-acetyl-ß-glucosaminidase (NAG) We also examined the expression of three distinct 
classes of receptors for the Fc moiet) of immunoglobulin G [FcyRI (CD64). FcyRlI 
(CD32) and FcyRIII (CD 16)] which have been identified on human mononuclear phag-
ocytes (9,10) and allow killing of antibody-coated target cells ( 11 13) We also studied 
gp55 (CD14), a membrane protein which is expressed in abundance on the surface of 
mature monocytes and macrophages (14,15), and HLA DR which is expressed on anti-
gen-presenting cells (16) 
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Peripheral blood monocytes. Monocytes were purified from mononuclear cells of 
healthy volunteers with counterflow centrifugation monitored by continuous flow cy<o 
metry (17) Monocyte fractions were over 95% pure and viability was more than 98% 
Monocyte Cell cultures. Freshly isolated monocytes were cultured at 3 \ lOVml in 
RPMI 1640 (Dutch modification) with 20 mmol/1 HEPES buffer (Flow) supplemented 
with freshly added 2 mmol/1 L glutamme (GIBCO), 1 mmol/1 pyruvic acid (Sigma), 40 
цд/ті gentamicm (Bochnnger) and 10% heat inactivated pooled human serum in a 
humidified incubator with 5% CO, in air at 370C For adherent culturing 1 ml of the 
cell suspension was seeded in plastic flat bottomed tubes (Costar no 3393, 16 χ 93 mm, 
Cambridge) and harvested at different times (2 h, 88 h, and 10 days) Cultures were 
done in duplicate The supernatant and the non adherent cells were decanted and the 
loosely adherent cells removed by rinsing six times with 1 ml phosphate buffered 
saline/1% bovine serum albumin (PBS/BSA) at 370C By addition of 0 5 ml 2 mmol/1 
EDTA/0 1% BS A the adherent cells were lysed to release their enzyme content The 
lysates were stored at 80oC for later measurement of enzyme activity and DNA con-
lent Teflon foil bags (Dupont de Nemours) were used for culturing 10 ml non-adherent 
monocyte suspensions (18) After 10 days cells were recovered by needle aspiration 
after cooling the bags to 40C (or 1 h and gentle kneading The cells were washed and 
resuspended in PBS Samples were taken tor enzyme measurements ( 10' cells), and 
stored at -80oC after pelleting and lysing in 1 ml EDTA/BSA 
Doxorubicin exposure. Doxorubicin was purchased from Laboratoire Roger Bellon 
(Neuilly sur Seme France) and diluted in sterile saline Two schedules were used con­
tinuous exposure for 10 days and a short term exposure for I h For continuous expos 
ure, monocytes were added directly to culture medium containing doxorubicin I 1000 
ng/ml For the short term exposure, IO6 monocytes per ml were incubated with doxoru 
bicin 10-10 000 ng/ml Culture without doxorubicin served as control Incubation tubes 
were cooled on iced water the cells were collected with a rubber policeman and washed 
four times with culture medium before seeding them into the plaslic tubes or Teflon 
foil bags After culture for 10 days we measured the doxorubicin and doxorubicmol 
concentrations in the culture supernatants of the cells grown in Teflon foil bags by 
high-pressure liquid chromatography (19) 
Flow Cytometry. Flow cytometry was done on an Ortho ЗОН flow cytometcr (Ortho 
instruments Westwood, Massachusetts) and the data were recorded linear in list mode 
CHAPTER 4 
D O X O R U B C I N A N D V Ü N O C Y \ i\, н Τ Ι < Λ 1 Ι Ο Ν 
on a MINC computer using linear converters (Digital Electronic Company. Maynard. 
MA) Because doxorubicin autofluoresces it is possible to measure doxorubicin assimi­
lation by monocytes and macrophages We measured uptake of this drug in short-term 
incubated monocytes before and after 10 days' culture, and in cells co-cultured with 
doxorubicin for 10 days Binding of specific monoclonal antibodies (mAbs) to FcyRI, 
FcyRII, FcyRIII, CD14, and HLA DR on doxorubicin-treated cells was assayed by in­
direct immunofluorescence (IF) with 197 (anti-FcYRI, Medarex, West Lebanon, New 
Hampshire), IV 3 (anti-FcyRII, Medarex), anti Leu I lb (anti-FcvRIH, Becton Dickinson), 
WT14 (which reads strongly with human monocytes and macrophages and belongs to 
the CD14 cluster of differentiation) (15), and OK-DR (anti HLA-DR, Ortho) Aftercul­
ture in Teflon foil bags monocytes were harvested washed and suspended (3 χ 106/ml) 
in IF buffer (PBS/BSA 1 0% containing 0 1% sodium azide) Hundred μΙ cell suspen­
sion was incubated with an equal volume of saturation levels of mAb for 30 mm at 40C 
Cells binding the mAb were detected with goat anti-mouse Ig (heavy and light chain) 
conjugated to fluorescein isothiocyanate (Cappel, Malvern, Pennsylvania), diluted 1 50 
in IF buffer After 30 mm at 40C in the dark, the cells were washed twice and fixed 
with 1% paraformaldehyde for analysis The fluorescence intensity from 5000 cells 
was measured For all analyses, gatings (red forward and right angle scatter) were set 
around the macrophage population and the mean fluorescence intensity (expressed in 
arbitrary fluorescence units/cell) was calculated (linear) from the histograms (20) 
Enzyme and DNA measurements. G - 6 - P D H , PHI, and i c o n were assayed by fluori­
metrie measurement of NADPH generated from NADP in the presence of appropriate 
substrates with either direct or coupled systems, NAG and ACP were measured by 
fluorimetrie assay of 4-methylumbelliferone released from linked derivatives (21) 
Preliminary experiments verified the linearity of the system with respect to incubation 
time and enzyme activity After subtraction of appropriate blanks (2 mmol/l EDTA/ 
0 1% BSA), activity was expressed in nmol/min per μg DNA The DNA content of the 
lysate was measured by fluorescence of the complex with fluorochrome 4,6-diamidino-
2-phenylindole-2-HCI (22) 
Intracellular doxorubicin in Поп-adherent monocytes. After both short-term exposure 
to 10-10,000 ng/ml and in cells continuously exposed for 10 days to lower doses (1-1000 
ng/ml) cellular fluorescence was linearly correlated with the concentration of doxorubicin 
The mean fluorescence of the short-term exposed monocytes before and after culturing, 
was similar to that of the cells which were continuously cultured (data not shown) 
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Extracellular doxorubicin in supernatants of non-adherent monocytes. No drug 
metabolites were found in the supernatants when monocytes were continuously exposed 
to doxorubicin at 1-250 ng/ml. However, at 500-1000 ng/ml, we measured doxorubicinol 
concentrations of 15.6-32.1 ng/ml (i.e. 3.2 ±0.1%) of the originally added doxorubicin 
concentration. The residual amount of parent compound after 10 days of continuous 
exposure to 1-1000 ng/ml was, for all measured points, still 24 ± 2% of the original 
quantity. In the short-term exposures to 10-10,000 ng/ml, no derivatives were found, 
and the doxorubicin concentrations in the culture supernatants were always less than 
0.25% of the original. 
Doxorubicin and Cell recovery. When doxorubicin was used at concentrations above 
200 ng/ml in continuous exposure, and above 2000 ng/ml in the short-term, cell recovery 
was halved, and most (over 70%) of the harvested cells were dead. The monocytes had 
not matured into large macrophages but remained small with vacuoles (data not shown). 
For further studies we used doxorubicin concentrations that were comparable to those 
clinically, i.e. 75 ng/ml for continuous exposure, and 750 or 1500 ng/ml for the short-term. 
Compared with control cells, no significant changes were seen in adherence capac­
ity of the plastic-cultured monocytes after the short-term or continuous exposures 
(Table I). In the controls, 19.2% of the seeded monocytes adhered after 2 h of culturing 
and with doxorubicin, adherence ranged from 17.4% to 20.5%. Thus, doxorubicin did 
not affect cell recovery in adherent cultures. The total amount of cells harvested after 
10 days was over 100% at all concentrations of drugs studied. Cell recovery and via­
bility of the non-adherent monocytes were 83,6 and over 95%, respectively (Table I). 
Tablet. 
Percentage ceil recovery after doxorubicin exposure in adherent and non-adherent cell cultures 
Adherent Non-adherent 
2 h SBh 10 days 10 days 
Control 
Short-term 750 ng/ml 
Short-term 1500 ng/ml 
Continuous 75 ng/ml 
19.2±3.9 
20.5±2.7 
17.1+6.2 
17.4±3.3 
27.7±5.1 
28.5+4.3 
23.9±2.2 
22.9±2.6 
31.8±12.1 
30.7±9.4 
24.0±5.5 
23.9±β.2 
83.6±5.0 
84.4 ±6.3 
86.9+7.0 
78.1 ±9.0 
Recovery = DNA content in lysote/content in Ì ml lysed uncultured monocytes lor odherent, and homted 
cells/cells initially seeded for non-adherent. Results represent mean ± SO from six individual experiments using 
cells from different donors. 
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Effects of doxorubicin OR enzyme activities. After culture without doxorubicin for 
10 days in plastic tubes, G-6-PDH increased 25 times compared with the level observed 
after 2 h culture The corresponding figures for PHI and ICDH were 6 and 4 times 
respectively ACP and NAG activity increased 33 and 10 times Compared with 1 h 
non-adherent incubation (polypropylene tubes, 370C). enzyme activities of monocytes 
cultured in Teflon foil bags after 10 days were increased as follows G-6 PDH, 27 
times. PHI, 5 times, ICDH. 8 times ACP, 19 times, and NAG. 28 times (Tabic II) 
In the presence of doxorubicin, in short-term exposure (750 and 1500 ng/ml) or contin­
uous exposure (75 ng/ml), епгуте activities of adherent or non-adherent monocytes 
were similar to the control values (Table II) 
Effect of doxorubicin on FcyR, GDI 4, and HLA-DR expression. We characterized 
the cultured macrophages, which were continuously exposed to doxorubicin 75 ng/ml 
or underwent short-term exposure to 750 or 1500 ng/ml. before culturing All schedu­
les and doses of doxorubicin diminished the expression of FcyRI (32-45%), FcyRII 
(10-26%), CD14 (20-37%), and HLA-DR (25-34%) (Fig 1) The reductions were all 
significant (f test) at Ρ < 0 05, with exception of the effect on the FcyRII expression 
after continuous exposure (P < 0 154) Expression of FcyRIII was not affected, because 
this receptor was not present on our 10 day cultured macrophages 
12 
10 
08 
06 
04 
02 
00 
Relative expression 
Η 75 ng/ml Doxorubicin 
Η 750 ng/ml Doxorubicin 
• 1500 ng/ml Doxorubicin 
Figure 1. 
Expression of FcyRI, FcyRII, COM, 
and H LA DR on monocyteKienved 
macrophages Monocytes were cui 
tured for 10 days in Teflon foil bogs 
without drug or with continuous 
exposure to doxorubicin 75 ng/ml, 
or after short term exposures to 750 
or 1500 ng/ml Relahve expression 
= doxorubicin-treated non treated 
ratio Results represent mean ± 50 
from five individual experiments using 
cells from different donors 
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Table II. 
Effects of doxorubicin on enzyme activities ir 
Enzyme 
G-6 PDH 
odherent 
2h 
88 h 
10 days 
nonadherent 
Oh 
Ih 
10 days 
PHI 
adherent 
2h 
88 h 
10 days 
non-adherenl 
Oh 
Ih 
10 days 
ICDH 
adherent 
2h 
88 h 
10 days 
non-adherent 
Oh 
Ih 
10 days 
Control 
4.47+0.56 
41.1+8.5 
112+23 
1.38+0.32 
3.14±0.90 
83.3+16.5 
25.5±3.1 
62.8±18.1 
157±61 
B.73±3.95 
32.1 ±9.9 
154±27 
2.27±0.35 
4.95±0.85 
9.46±2.91 
0.30±0.04 
0.93±0.45 
7.21 ±1.74 
ι adherent and non 
Doxorubicin (ng/mlj 
Short-term 
750 
4.65±0.86 
39.6±14.1 
113±23 
-
4.08+1.70 
79.1+12.6 
28.1 ±5.0 
56.8±19.5 
148±49 
-
42.B±18.3 
147±25 
2.22±0.17 
4.51 ±1.30 
8.52±2.28 
-
1.32±0.89 
6.94±1.79 
1500 
4.94±0.81 
38.6±15.8 
116±21 
-
3.36±0.76 
74.9±12.5 
27.9+10.9 
61.5+22.8 
162±52 
-
35.9±6.2 
137+22 
2.73+0.43 
4.61 ±1.24 
9.18±1.81 
-
0.91 ±0.69 
6.27±1.49 
-adherent cultur 
1 
Continuous 
75 
5.21 ±0.80 
35.1±10.6 
I04±30 
-
3.41 ±0.99 
79.8±13.3 
33.9±3.5 
59.2±17.6 60. 
156±65 
-
36.4±9.6 
142±25 
2.99±0.95 
5.24±1.14 
9.03±2.66 
-
1.12±0.58 
6.31 ±1.75 
ed monocytes 
Total 
4.B0±0.82 
38.3±13.2 
112±25 
1.38±0.32 
3.51±1.14 
79.2±12.4 
28.9±6.8 
1 ±19.7 
156±57 
8.73±3.95 
36.9±11.4 
143±22 
2.53±0.64 
4.83±1.19 
9.05±2.47 
0.30±0.04 
1.08 ±0.60 
6.69±1.51 
(continued) 
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Enzym« 
ACP 
adherent 
2h 
88 h 
10 days 
non-adherent 
Oh 
Ih 
10 days 
NAG 
adherent 
2h 
88 h 
10 days 
non-adherent 
Oh 
Ih 
10 days 
Control 
0.22+0.02 
3.04±1.03 
7.23±2.78 
0.18 ±0.03 
0.29±0.03 
5.50±1.11 
1.20±0.35 
3.63±1.09 
11.6±2.6 
0.60±0.11 
0.78±0.05 
21.7±7.9 
She 
750 
0.22+0.03 
3.17+1.16 
6.92±2.06 
-
0.35+0.07 
5.73±1.37 
1.12±0.31 
3.52±1.26 
12.5±1.β 
-
0.9B±0.21 
23.9±9.2 
Doxorubicin (ng/ml) 
irt-term 
1500 
0.22+0.04 
2.90+0 83 
6.93±1.75 
-
0.37+0.05 
5.75±1.96 
1.18+0.40 
3.59±1.60 
14.2±2.1 
-
0.94+0.13 
26.5±]1.1 
Continuous 
75 
0.23±0.03 
2.8410.75 
6.01 ±1.61 
-
0.31 ±0.03 
5.48±1.52 
1.32±0.56 
3.51 ±0.91 
14.6±3.2 
-
0.79±0.05 
23.1 ±11.6 
Total 
0.22±0.03 
2.99±0.97 
6.77+2.15 
0.18±0.03 
0.33±0.05 
5.61 ±1.32 
1.20±0.42 
3.56±1.24 
13.2±2.8 
0.60±0.11 
0.87±0.14 
24.0±8.9 
Enzyme activities were measured m ûe lysates of the adherent cell cultures oner 2 h, 88 h, and 10 days. Non-
adherent cells were determined for enzyme activity by measunng lysates of cryopreserved monocytes, 1Λ incubated 
monocytes, and at day 10 haivested cells Activities are expressed in nmol/min per ущ DNA. Results represent 
mean ± 50 from six individual experiments using cells from different donors. 
CHARIER 4 
D O X O R U B I C I N A N D \ О М О С ' Т Ь D A T U R A I O N 
As part of the investigation of the influence of cytostatic agents on the immune 
system, we evaluated the effects of doxorubicin on human monocytes in adherent and 
non-adherent cultures We measured extracellular and intracellular drug concentra­
tions, because doxorubicin can be rapidly metabolized into doxorubicinol and doxoru­
bicinone (23) Since doxorubicinone is not cytotoxic (24) and the cytotoxic potential of 
doxorubicinol is only a tenth that of the parent compound (25), we needed to know 
whether formation of these derivatives could be excluded In our systems, no metabolites 
were found In many in vitro experiments cell death is related to cellular doxorubicin 
concentrations (26) It is not clear whether free radical formation, intercalation of doxo­
rubicin into DNA, induction of DNA breaks and chromosomal aberrations, or drug-
induced alterations of cell membranes actually kill the cell 
At high concentrations of doxorubicin obtainable only in vitro, negative effects 
were seen on cell recovery, viability, and morphology after 10 days of culture To 
mimic the clinical situation, we used two schedules of non-toxic incubation contin­
uous exposure to doxorubicin 75 ng/ml (akin to continuous infusion), and short-term 
exposure to 750 or 1500 ng/ml before culture (akin to bolus infusion) 
Doxorubicin did not influence the adherent capacity or yield of the cultured mono­
cytes Our observation that adherence was unaffected was different from the results 
described by Athlin and Domellof (27) They described a significant reduction of 
monocyte glass attachment one week after patients had been treated with combination 
chemotherapy of fluorouracil. doxorubicin, and mitomycin However, these discrepan­
cies can be explained by the ditferent drugs administered, and in vivo versus ш vitro 
conditions Another point is that, one week after treatment, Athlin and Domellof were 
looking al a monocyte population that was not present in the peripheral blood at the 
time of the combination chemotherapy When these patients were treated, this cell pop­
ulation were still precursor monoc)tes Patients with solid tumors also showed a marked 
decrease in yield of adherent macrophages after a week of culture (28,29) In our study, 
the amount of adhered cells increased slight!) with the time of culture independently of 
the doxorubicin treatment After 10 days the overall yield of suspension-cultured 
macrophages was more than 2 5 times higher than plastic-cultured macrophages These 
observations indicate the existence of adherent and non-adherent monocytes, both 
capable of maturation to macrophages, and suggest that at least some monocytes can 
become adherent macrophages as a consequence of maturation and age Our finding 
that after 2 h nearly a fifth of the plastic-seeded monocytes adhered contradicts our 
earlier report (18) Prev lously. we found about half the cells adhered after 2 h, however, 
the yield of adherent macrophages after 15 days was 70 ± 20% of those originally seeded, 
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which is similar to our yield after 10 days (31,8 ± 12 1%) It is not easy to explain these 
differences because we used the same conditions on both occasions Depending on the 
conditions there is considerable variation in the adherent yield, resulting in marked 
differences in the relative amounts of adherent and non-adherent cells Results of studies 
of monocyte function should be critically regarded in this respect Monocyte isolation 
by countcrflow centrifugation (17) has an advantage here since selection is minimal 
There are reports of changes in enzymes and receptors as indicators of the in vitro 
maturation of non-treated monocytes (18,21,30-33) No information is, however, avail­
able about the effects of doxorubicin on the maturation as reflected in the enzyme 
levels of highly purified and in vitro cultured monocytes We found that in the pres­
ence of doxorubicin, the intracellular level of G-6-PDH was unaltered, which indicates 
that hexose monophosphate shunt activity was similar to unexposed cells The activi­
ties of PHI, of the glycolytic pathway, and of ICDH, of the Krebs' cycle, were also 
unaffected NAG and ACP activity, important for the hydrolytic degradation of glyco­
proteins, mucopolysaccharides, and glycolipids, remained the same when cells were 
exposed to doxorubicin continuously or in a short-term schedule 
Tntton and Yee (34) showed that doxorubicin can act solely by interaction with the 
cell surface, so it may be important to consider the cell surface as a target We examined 
possible alterations of the cell membrane by doxorubicin by study of the expression of 
FcyRI, FcyRII, ΡογΚΙΙΙ, CD14, and HLA-DR FcyRs and HLA antigens can be affected 
by biological response modifiers (35,36) Modulation of CD 14, a membrane protein 
expressed on the surface of mature monocytes and macrophages (14,15), has not been 
previously described We found that doxorubicin caused a slight but significant decrease 
in FcyRI, FcyRII, CD14, and HLA-DR expression on in vitro cultured monocytes (with 
the exception of FcyRII in the continuous exposure experiments) That FcyRIII expres­
sion was not measurable in our study can be explained by the observation of Clarkson 
and Ory (12), that FcyRIII, which is not present on monocytes, will appear on macro­
phages in measurable quantities after 14 days of culture How doxorubicin modulates 
the expression of surface molecules and whether it will affect function are not known 
Our preliminary experiments indicate that doxorubicin does not influence the FcyRI and 
FcyRII mediated antibody-dependent cellular cytotoxicity Alterations in the membrane 
molecules will be counteracted by the de novo synthesis of the original membrane 
molecules, unless inhibited by DNA intercalation 
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The maturation and differentiation process of human monocytes and human mono-
cyte-denved macrophage cytotoxicity mediated by receptors for the Fc moiety of 
immunoglobulin G (FcyRs) were studied m utro using the chemotherapeutic drug 
doxorubicin in combination with the biological response modifier (BRM) recombinant 
interferon-gamma (rlFN-γ) Human monocytes were cultured for 9 days and treated 
with doxorubicin belore, after, or on day 7 of the culture rIFN-γ was added continuous­
ly on day 0 or on day 7 of the culture, either alone or in combination with doxorubicin 
In the presence of doxorubicin, all measured intracellular enzyme activities were at the 
same level as the controls and the rIFN-γ treated cells However, when monocytes were 
co-cultured for 9 days with rIFN-γ alone or in combination with doxorubicin, enzyme 
levels decreased to between 45% and 61% of the controls In control cultures, antibody-
dependent cell-mediated cytotoxicity (ADCC) activities against maximally sensitized 
hRBC mediated by FcyRI and FcyRII were 41 7 ± 8 8% and 42 7 ± 11 6%, respectively 
When monocytes were exposed to rIFN-γ continuously or 40 h before harvesting, 
FcyRI ADCC activity increased to 78 9 ± 9 8% and 68 1 ± 8 1%, respectively, and 
FcyRII ADCC activity to 56 3 ± 8 4% and 554 + 7 3%, respectively The addition of 
doxorubicin to monocyte cultures in the presence or absence of rlFN-ydid not influence 
the lysis of the two types of sensitized hRBC These observations indicate that doxoru­
bicin does not negatively influence the activation state of monocytes/ macrophages, 
induced by rIFN-γ 
During the past decade, renewed interest in immunotherapy has been aroused The 
mam reasons are the availability of highly purified biological response modifiers (BRMs), 
and the limited progress recently made with the use of chemotherapeutic agents in 
many neoplastic diseases Under certain conditions BRMs and chemotherapeutic agents 
could be combined, resulting in additive or synergistic tumoncidal cytotoxicity (1-6) 
Because chemotherapeutic agents may have detrimental effects on the immune sys­
tem, knowledge regarding the influence of chemotherapeutic agents as well as of BRMs 
on the mononuclear phagocyte system (MPS) is compulsory for a better understanding 
of this combined approach We have investigated whether chemotherapy can inhibit 
activations of the MPS elicited by BRMs We studied the in vitro effects of doxorubi­
cin on recombinant interferon-gamma (rIFN-Y)-induced activation of human monocyte-
derived macrophages The evaluated parameters were morphology, maturation, differ­
entiation, and functional processes rlFN-yis a strong activator of the MPS that induces 
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а о the expression of receptors for the Fc moiety of immunoglobulin G (FcyR) and of 
class II MHC antigens on monocytes (7-9) 
Furthermore it possesses a strong antiviral activity (10), antitumor activity, and is 
an important cytokine released upon treatment with IL-2 and TNF (11) Doxorubicin is 
a chemotherapeutic agent with antitumor activity against a wide spectrum of malignan­
cies (12-14) In a recent study with human monocytes we could show that doxorubicin 
treatment significantly impaired the expression of the surface markers FcyRI, FcyRII, 
CD 14, and HLA-DR, which are invoked in cellular immunoregulation Monocyte 
maturation was qualitatively and quantitatively normal (15) 
In the present work we assayed three enzymes of the intermediary carbohydrate 
melabolism glucose-6-phosphale dehydrogenase (G-6-PDH), phosphohexose isomerase 
(PHI), and isocitrate dehydrogenase (ICDH), and two lysosomal enzymes acid 
phosphatase (ACP) and /V-acetyl-ß-glucosaminidase (NAG) as markers for the cell 
growth Wc examined the expression of FcyRI (CD64) and FcyRII (CD32) which have 
been identified on human mononuclear phagocytes (16,17), and are important media-
tors in immune defense processes (18,19) We also studied the antibody-dependent 
cell-mediated cytotoxicity (ADCC) against human red blood cells (hRBC) mediated by 
FcyRI and FcyRII of human monocyte-denved macrophages 
Peripheral blood monocytes. Monocytes were isolated as described previously with 
the use of cell scatter monitored counterflow centnfugation (20) Briefly, mononuclear 
cells were obtained from buffy coats or by cytapheresis of healthy volunteers and isolated 
by Percoli (Pharmacia, Uppsala, Sweden) centnfugation (δ=Ι 075 g/ml) at 40C Mono­
cytes were purified from mononuclear cells with counterflow centnfugation monitored 
by continuous flow cytometry Monocyte fractions were over 95% pure (evaluated in 
cytocentnfuge preparations after staining for non-specific esterase and with May-Grun-
wald-Giemsa), and viability was more than 98%, as assessed by trypan blue dye exclusion 
Monocyte Cell cultures. Freshly isolated monocytes were cultured (singular) at a con­
centration of 3 χ 105/ml in RPMI1640 medium (Dutch modification) with 20 mM 
hepes buffer (Flow Laboratories, Irvine, UK) supplemented with freshly added 2 mM 
L-glutamine (GIBCO Laboratories, NY), 1 mM pyruvic acid (Sigma Chemical Co, St 
Louis, MO), 40 μg/ml gentamicin (Boehrmger, Mannheim, FRG), and 10% heat-inacti-
vated pooled human serum, in a humidified incubator with 5% COi in air at 370C 
Teflon foil bags (TFB)(Dupont de Nemours and Co, Switzerland) were used for culturing 
10 ml non-adherent monocyte suspensions (21) 
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Harvesting of the monocyte-derived macrophages. After 9 da)s, matured cells 
were recovered by needle aspiration after cooling to 40C for 1 h and gentle kneading 
Morphology was studied in May Grunwald Giemsa stained cytocentnfuge preparations 
Cell size was estimated with forward light scatter by continuous flow cytometry and a 
calibration curve of monosized polymer particles (Dyno particles, Lillestrom, Norway) 
To remove all cell-associated human IgG from the surface, collected cells were washed 
twice and incubated for 60 mm at 37Τ in RPMI medium (Dutch modification), in 
polypropylene tubes After incubation, the lubes were cooled on iced water for 15 mm, 
adherented cells were scraped off with a rubber policeman (Costar, Cambridge, MA), 
and washed thrice in RPMI medium (Dutch modification) 
Samples were taken for enzyme and DNA content measurements (106 cells), and 
stored at 80oC after pelleting and lysing in 1 ml 2mM bDTA supplemented with 0 1% 
bovine serum albumin (BSA) (Cohn fraction V Sigma, St Louis, MO) 
Doxorubicin and rlFN-γ exposure. Doxorubicin was purchased from Laboratoire 
Roger Bellon (Neuilly sur Seme, France), dissolved in water and diluted in sterile 
saline Two schedules of doxorubicin exposure were used a long-term from day 0 or 7, 
and a short-term for 1 h before or after culture We used doxorubicin concentrations 
comparable to the serum concentrations found in the clinical setting, ι e 75 ng/ml for 
the long-term exposure (added directly to the culture), and 750 ng/ml for the short-term 
exposure (IO6 monocytes per ml) The short-term incubation tubes were cooled on iced 
water, the cells were collected with a rubber policeman and washed 4 times with culture 
medium before being seeded into the TFB, or washed once before being used in further 
experiments Cultures without doxorubicin served as a control Human rIFN-γ was 
kindly provided by Boehrmger Ingelheim (Alkmaar, The Netherlands) Monocytes were 
co-cultured with rIFN-y(150 U/ml) by adding it directly to the culture at day 0 or 7 
Enzyme and DNA measurement. The three intracellular enzymes of intermediary 
metabolism, G-6-PDH, PHI and ICDH, were assayed by fluorimetrie determination of 
NADPH generated from NADP in the presence of appropriate substrates using either 
direct or coupled systems The acid hydrolases NAG and ACP were measured by fluor­
imetrie determination of 4-melhylumbelliterone released from linked derivatives 
Enzyme measurements were performed with fluorimetrie micro-assays, which have 
been described in detail (22) Preliminary expenments verified the linearity of the system 
with respect to incubation time and enzyme activity After subtraction of appropriate 
blanks (2 mM EDTA/BSA 0 I %), activity was expressed in nmol/min per μg DNA 
The DNA content of the lysate was determined by fluorescence of the complex 
with the fluorochrome 4'6-diamidino 2-phenylindole-2-HCl (23) 
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Cell-SUrface immunofluorescence. Binding of specific monoclonal antibodies (mAbs) 
to the FcyRs was assayed by indirect immunofluorescence (IF) with 197 (anti FcyRI, 
Medarex, West Lebanon, NH), and IV 3 (anii-FcyRII, Medarex) Cultured monocytes 
were harvested, washed and suspended (3 χ lOVml) in IF buffer [phosphate buffered 
saline (PBS)/BSA 1,0% containing 0 1% sodium azide] Cell suspensions of 100 μΐ 
were incubated on ice for 45 mm with equal volumes of the various mAb The cells 
were then washed once with 2 ml IF buffer Cells binding the mAb were detected with 
goat anti-mouse Ig (heavy and hghl chain) conjugated lo fluorescein isothiocyanate 
(Cappel, Malvern, PA), diluted 1 200 in IF buffer After an additional 45 mm at 40C in 
the dark, the cells were washed twice and fixed with 1% paraformaldehyde for analysis 
Flow cytometry. Cells were analysed on a flow cytometer (ЗОН Cytofluorograf, Ortho 
Diagnostic Systems, Westwood, MA) The 488 nm line of a 5-W Argon laser at 0 4 W 
output was used for excitation and right angle scatter (RAS) A 0 8 mW HeNe laser 
was used for red forward scatter (RFS) and a band-pass filter 515/30 for green fluores­
cence (GFL) The fluorescence intensity trom 5,000 cells was analysed al a flow rate of 
100 cells/s, and recorded linear in list mode on a MINC computer using linear converters 
(Digital Electronic Company, Maynard, MA) For all analyses, the gatings (RFS and 
RAS) were set around the macrophage population and the mean fluorescence intensity 
(expressed in arbitrary fluorescence units/cell) was calculated from the histograms (24) 
Cytotoxicity QSSOy. ADCC capacity of monocyte-denved macrophages from different 
donors was studied using a '''Cr release assay as described previously (25). in which 
antibody-coated hRBC were used as target cells Briefly, a quantity of 108 hRBC were 
suspended in 0 3 ml PBS containing 100 μ ΰ "Cr (sodium Chromate, Radiochemical 
Centre, Amersham, UK), and incubated at 370C After 30 mm. the incubation volume 
was increased with PBS lo 1 ml, and an equal volume of sensitizing antibody or, as a 
control for nonspecific binding, with PBS/BSA 0 \9c alone, was added To sensitize 
the 5ICr labeled hRBC, two types of antibodies were used Rhesus D-positive hRBC 
were sensitized either with human ailoserum against rhesus D (Mer? & Dade, Dudingen, 
Switzerland) or with mouse IgGl mAb specific for glycophorin A on hRBC (a kind gift 
of M Bos from the Dcpart-ment of Immunohaematology, University ot Amsterdam, 
The Netherlands) Both types of mAb were used in various dilutions, resulting in hRBC 
sensitized with a range of IgG molecules per cell (EA-IgG), as has been described in 
detail (26) After incubation for 30 mm, cells were washed thrice with PBS/BSA 0 1%, 
suspended in RPMI 1640 medium plus 2 mM L-glutamine. 40 μg/ml gentamicin and 
10% heat-inactivated FCS and used immediately Cytotoxicity assays were performed 
in U-bottomed microliter plates (Costar, Cambridge, MA) bqual volumes (100 μΐ) of 
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10s effector cells and 2.5 χ IO5 target cells were mixed in the plates, centrifuged 
(2 min, 50 χ g, room temperature) and incubated for 18 h at 370C. After incubation, 
plates were centrifuged (10 min, 400 χ g, room temperature), and half the supernatant 
was removed for estimation of "Cr release in a LKB gamma counter. The results were 
calculated as follows: % cytotoxicity = (E - S)/(T - S) χ 100 where E = mean cpm of 
lest sample; S = mean cpm of spontaneous ^'Cr release (i.e. ''Cr release by labeled tar­
get cells in medium only); and Τ = mean cpm of the maximal 5 lCr release that was 
obtained by addition of 2{)c/c saponin (Coulter, Dunstable, UK) to the target cells. The 
average spontaneous release ± SD of hRBC was 3 ± 1%, and release from unsensitized 
hRBC incubated with effector cells did not exceed spontaneous release. 
Statistics. The Mann-Whitney two sample lest is used to test the statistical significance 
of differences in the relative enzyme activities between the means of the untreated and 
the with doxorubicin and/or rIFN-γ treated cells. Significance is accepted at the Ρ < 0.05 
level. 
Effects of doxorubicin and rlFN-γοη size and morphology of cultured monocytes. 
Monocytes cultured in TFB loosely attach to the surface and the majority of cells appear 
rounded, increase greatly in size (30 ± 4 μιη) and develop a higher cytoplasm to nucleus 
ratio (Fig. IB). After doxorubicin-treatment the morphology does not differ from that 
of monocytes cultured in the absence of doxorubicin. Co-culture with гІР.\-у(150 U/ml) 
for 9 days causes homolypic monocyte adhesion which ultimately results in big clumps 
of cells being in suspension, and in addition cell size was increased to a lesser extent 
(24 + 4 μιη). Beside the smaller cell size, the horseshoe shaped nucleus does not differ­
entiate into a round shaped centrally located nucleus, but in a flattened lobed and more 
juxta membranal located nucleus (Fig. 1С). When rlFN-yis added on day 7 of the cul­
ture, a plurality of monocytes acquire a dendritic-like appearance, however, cell mor­
phology (cytocentrifugc preparations) and size are not altered. After their initiate slate 
of spreading, we could also observe clumping on day 12, when the culture period of the 
monocyte-derived macrophages stimulated on day 7 with rlFN-ywas prolonged after 
day 9. 
Effects of doxorubicin and rlFN-γοη enzyme activities of cultured monocytes. 
Monocytes cultured in the presence or absence of doxorubicin and or rIFN-γ were tes­
ted for the intracellular enzyme activities of G-6-PDH, PHI, 1CDH, ACP, and NAG. 
Monocytes co-cultured with rIFN-γ for 9 days showed a reduced level in their relative 
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enzyme activities. Compared with the control cultures, the relative enzvme activities 
decreased to G-6-PDH.46 6+ 12.6%. PHI. 44.8 ± 8.8ft: ACP.6I.0+ 10.6%; and 
NAG. 57.3 ± 10.6%. The enzyme activity oflCDH was not affected (Fig. 2). The 
reductions were all significant at Ρ < 0.001 (n=8) When rIFN-yvvas added on day 7, 
only the at day 9 measured intracellular ACP activity diminished with significance 
(P < 0.05). The relative values are : G-6-PDH. 87 9 ± 11.8%. PHI. 87.4 ± 15.1%: ACP. 
78.1 + 13.3%: NAG. 89 7 + 9.4%: and ICDH. 110 2 + 30 0% (Fig 2). In the presence 
of doxorubicin, in long-term or short-term exposures, neither the enzyme activities of 
the control cells nor the alterations in сплme activities pro\oked by rIFN-γ signifi­
cantly changed (Fig. 2). 
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figure 2. Effects of doxorubicin and/or rlFN^yon the intracellular levels of G-6-PDH, PHI, ICDH, ACP, and NAG in 
humon monocytedenved mocrophoges Monocytes were cultured for 9 doys in RPMI 1640 medium or co-cultured for 9 
days or the lost 40 h with 150 U rlFN7/ml Doxorubicin treatment (75 ng/ml) was m long-term schedules for 9 days 
or the lost 40 h Enzyme activity was meosured in nmol/min per μ g DNA Results show the mean ±SD (n-8) of rela­
tive enzyme activities obtained by treated non-treated activity ratios 
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Effects of doxorubicin and rlFN-γοη FcyRI and FcyRII expression by cultured 
monocytes. Expression of the surface markers FcyRI and FcyRll is diminished after 
both long-term and short-term culture in doxorubicin (15). We cultured monocytes for 
9 days in the presence of doxorubicin and/or rIFN-γ. Co-culture with 150 U/ml rIFN-γ 
from day 0 and from day 7 induced a 3.6 ± 2.5- versus a 5.8 ± 3.2-fold increase in the 
expression of FcyRI, as compared with control cultures (mean ± SD of 7 experiments). 
The expression of FcyRII was not influenced by rIFN-γ. Short-term and long-term 
exposures to doxorubicin did not affect the expression of either of the FcyRs on the 
human monocyte-derived macrophages activated with rIFN-γ. 
Effects of doxorubicin and rlFN-γοη ADCC activities of cultured monocytes. To 
determine whether doxorubicin and rlFN-γ, alone or in a combined approach, alter 
functional Fc-mediated activity of the cultured monocytes, we investigated for cyto­
toxicity against two types of sensitized hRBC. In control cultures ADCC activity 
against maximally sensitized hRBC mediated by FcyRI and FcyRH was 41.7 ± 8.8% 
and 42.7 ± 11.6c/r, respeciivcly (Fig. 3). When monocytes were co-cultured with rIFN-y 
(from day 0), ADCC activity against maximally sensitized EA-hlgG increased to 78.9 
± 9.8<7r and for macrophages (stimulation at day 7) cytotoxicity increased to 68.1 ± 
8.1%. Co-culture with rIFN-γ caused an increase to a lesser extent in the cytotoxicity 
mediated by FcyRII against maximally sensitized EA-mlgGl. ADCC activity rose to 
56.3 + 8.4% and 55.4 ± 7.3%, respectively (Fig. 3). 
The short-term and long-term exposures, to doxorubicin did not affect the ADCC 
activity mediated by either of the FcyRs of the control cells, nor of the human mono­
cyte-derived macrophages activated with rIFN-y(Fig. 3). 
Biological treatment may be considered the "Fourth Modality of Cancer Treatment" 
(27). The past decade of research has demonstrated that there is indeed a role for bio­
logical agents in cancer treatment. Over the next decade, the combination of BRMs 
with chemotherapeulic agents is one of the modalities that could lead to advances in 
cancer treatment (1-6). 
As part of our investigations on the influence of cytostatic agents in combination 
with BRMs on the MPS, we evaluated possible modulations induced by doxorubicin on 
the activation of human monocytes provoked by rIFN-y. rIFN-γ appears to be the major 
monocyte-activating lymphokine (7-9). Doxorubicin is active against a variety of 
malignancies (12-14); it can act solely with the cell surface (28), and it is therefore 
important to consider the cell surface as a target. 
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In our experiments rIFN-γ but not doxorubicin treatment, induced morphological 
changes Most strikingly was the smaller cell size when monocytes were cultured in the 
presence of rIFN γ from the start of culture Previously. Becker (29) found that human 
monocytes, isolated by adherence and cultured with 59c autologous serum m plastic 
culture plates, slightly increased in volume by IFN-γ during the first 3 days of culture, 
whereas later in the maturation process the volume of the IFN-γ treated macrophages 
was smaller than that of the non-treated macrophages In our studies, both adherent and 
non adherent monocytes were cultured as we isolated highly purified monocytes from 
mononuclear cells with counterflow centrifugation Furthermore the culture took place 
in suspension in the presence of 10% pooled human serum Except for the serum factors. 
all other influences were excluded in our study which therefore allows a more definite 
judgement to be made concerning the cell size of the monocytes cultured with rIFN-γ 
The phenomenon of monocyte clumping which appears when they are cultured in 
the presence of rIFN-γ for 9 days can be explained by an upregulation of adhesion 
molecules Weinberg el al (30) and later Mentzcr el al (31) reported that IFN γ selce 
lively enhances the leukocyte function adhesion-1 antigen (LFA-1) and its Iigand the 
intercellular adhesion molecule 1 (ICAM-I), which mediate homotypic monocyte 
adhesion We could also demonstrate an increased presence of these molecules in this 
study (data not shown) 
There are reports of changes in enzymes and receptors as indicators of the in vitro 
maturation of non-treated monocytes (21,23,32 35) Some information has been published 
on the effects of IFN-γ on enzyme levels of mouse peritoneal macrophages (36,37) No 
information is, however, available on the effects of doxorubicin in combination with 
rIFN-γοη maturation, as reflected on enzyme levels of highly purified and in vitro cui 
tured monoevtes In an earlier report we found that the intracellular levels of the key 
enzymes G-6-PDH, PHI. ICDH, ACP and NAG remained the same when cells were 
exposed to doxorubicin in both short-term and long-term schedules (15) In this study 
we found that the intracellular enzyme levels were also unaltered when cells treated 
with rIFN γ were exposed to doxorubicin in the long-term or the short-term schedule 
This shows that doxorubicin exposures do not affect the rIFN γ induced monocyte acti­
vation However, when monocytes were co-cultured for 9 days with rIFN-γιη the pres­
ence or absence of doxorubicin, all measured enzyme levels, with the exception of the 
ICDH activity, decreased significantly as compared with the controls G 6-PDH and 
PHI are both enzymes of the intermediary metabolism, since we measured the enzyme 
activities in nmol/mm per μg DNA, this phenomenon can be explained by the decreased 
cell volume of the monocytes co-cultured continuously with rIFN-γ, because these 
enzyme activities were reduced in a comparable ratio However, the bulk enzymes 
NAG and ACP, important for hydrolytic degradation of mucopolysaccharides, glyco-
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proteins, and glycohpids, decreased in enzyme activity to a lesser extent, and a change 
in volume is therefore not the only possible explanation The anomalous behavior of 
the ICDH activity may in all likelihood be caused by variations of the very small 
amounts of the ICDH activities measured Monocytes co-cultured with rIFN-γ from 
day 7 showed a tendency towards slightly decreasing enzyme levels for G-6-PDH, PHI, 
and NAG Only ACP activity diminished significantly These results are in contradic­
tion with observations of Pierangeli et al (36), who showed an increase in ACP content 
per cell of IFN-γ treated murine peritoneal macrophages, with a maximum at 24 h of 
incubation Moreland et al (37) described initially a rise and thereafter a drop in ACP 
content when murine peritoneal macrophages were treated with IFN γ for 48 -72 h The 
disparity observed between the results of Pierangeli et al (46) and the present study 
with rIFN-γ co-cultured from day 7 could be the consequence of I the origin of the 
cell population human peripheral blood monocytes versus murine peritoneal macro 
phages, 2 the way in which the cells were obtained isolation of the whole monocyte 
population by means of elutnation versus the selective isolation of peritoneal macro­
phages via plastic adherence, 3 the duration of stimulation 40 h \enus 24 h All our 
measurements were expressed in nmol/min per μg DNA not per cell and a difference 
based on methodological factors is unlikely 
It is well known that IFN-γ increases both the number of FcyRI (8,38) and the abil 
ity of monocytes to perlorm ADCC of red cell targets through this receptor (39) The 
finding that monocytes to cultured with rIFN-γ for the last 2 days, showed a 1 6 fold 
higher increase in FcyRI expression and a 10 8% lower ADCC activity versus the 
monocytes co-cultured for 9 days with rIFN-γ seems to be in disaccordance with this 
theory However, cell size after continuous co-culture with rIFN-γ was increased to a 
lesser extent (24 \m) as compared with the monocytes cultured from day 7 with rIFN-γ 
(30 μτη), which ultimately results, assuming that the cells were spheres, in a FcyRI sur­
face density comparable to the ADCC activity 
We have previously published that doxorubicin caused a slight but significant 
decrease in FcyRI expression on in \itro cultured monocytes (15) When combined 
with rIFN-γ, we could not observe any modulation induced by doxorubicin in both the 
number of FcyRI or FcyRII expressions, or in functional activities mediated by those 
receptors 
Finally, these observations indicate that in a combined approach, doxorubicin does 
not negatively influence the activation state of monocytes/macrophages induced by 
rIFN γ The results obtained appear to allow the combination of optimal doxorubicin 
administration with rIFN-γ immunotherapy 
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We evaluated the capacity of interferon (ΙΡΝ)-γ, tumor necrosis factor ( ΓΝΡ)-α, 
interleukm (IL)-4. macrophage colony stimulating factor (M-CSF), granulocyte-macro­
phage (GM)-CSF, and IL-2 to modulate freshly isolated monocytes at different stages 
of maturation during m vitro culture, ι e, long-term (9 days) and short term (40 h) cultured 
When long-term (9 days) cultured monocytes were incubated with IFN-yfor the last 
40 h of culture, IgG Fc receptor (FcyR)! expression was found to be increased dramati­
cally, whereas FcyRII and FcyRllI were not affected In cultures with IL-4 or TNF-a, 
reduced expression of all three FcyR classes was observed With exception of the TNF-a-
cultured cells, the altered FcyRI and FcyRII expression was paralleled by the antibody-
dependenl cell-mediated cytotoxicity (ADCC) of the long-term cultured monocytes 
Short-term (40 h) cultured monocytes exhibited a strongly decreased FcyRI and FcyRII 
expression and ADCC as compared to freshly isolated monocytes FcyRIII expression 
was hardly detectable When co-cultured with cytokines, IFN-γ could reverse this 
decrease in both FcyRI and FtyRII expression IntercstingU. GM-CSF and TNF-a were 
capable of re\ersing the decrease only in FcyRII expression IFN-γ and IL-4 were the 
only cytokines that influenced the 40-h cultured monocyte FcyRII-mediated ADCC 
activity Furthermore, all tested cytokines up-rcgulated the HLA-DR expression on 
40-h cultured monocytes Supernatants of both short- and long-term (cytokine) cultured 
monocytes were negative for IL-lß, and TNF-a activity 
These results show strong effects of cytokines on the expression of various cell 
surface antigens, and FcyR-mediated cytotoxicity Specific effects were varying with 
the stage of monocyte differentiation 
Immunotherapy with recombinant cytokines is a promising treatment modality for 
metastatic cancer (1,2) Human macrophages probably have an important contribution 
in such therapies, because of their central role in the immune response Tissue macro-
phages are known to derive from peripheral blood monocytes, which arc intermediate 
cells in terms ot differentiation These easy accessible monocytes are developing to 
mature macrophages when cultured under appropnate conditions m vitro (3-5) Both 
freshly isolated human monocytes, and mature monocyte-derived macrophages express 
IgG Fc receptor (FcyR)! (CD64), and FcyRII (CD12) (reviewed in refs 6,7) In vitro, 
FcyRIIl (CD16) will be expressed on monocytes after at least 4 days of culture (8) All 
these classes of FcyR have been shown to mediate antibody-dependent cell-mediated 
cytotoxicity (ADCC) (9) The amount of MHC class II molecules (HLA-DR) on the 
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monocyte/macrophage membranes is crucial for the initiation of an immune response 
(10), and CD14, a differentiation antigen expressed on mature monocytes, is a receptor 
for lipopolysacchande (LPS) complexed with LPS binding protein (11) 
Precise signals involved in regulating the functional state of monocytes/macrophages 
are incompletely understood Recombinant glycoproteins, which include interleukins 
(IL), interferons (IFN), colony-stimulating factors (CSF), and tumor necrosis factors 
(TNF) selectively affect phenotype, and function of monocytes/macrophages (12-15), 
merely depending on the stage of maturation of these cells (16-18) Different mediators 
may affect similar functions of monocytes \ or instance, both IFN γ, and IL-4 enhance 
expression of class II antigens on monocytes (19,20) However, the cell surface expres­
sion of FcyR is increased when monocytes are cultured with IFN-γ, and decreased when 
exposed to IL-4 (21,22) Furthermore, we recently described that IFN γ treated human 
monocytes also underwent alterations in morphology (3). and cytolytic mechanism (17) 
For the present study, we have investigated to what extent various cytokines, to be 
used m cancer immunotherapy, affect the above-mentioned phenotypic and functional 
characteristics of freshly isolated monocytes in an early stage of maturation in vitro 
(40 h), and of monocyle-demed macrophages m ulro 
Isolation and culture of human monocytes. Monocytes were isolated as described 
(23) Briefly, mononuclear cells obtained from buffy coats, or cytapheresis of healthy 
volunteers, were isolated by Percoli (Pharmacia, Uppsala, Sweden) centnfugation 
Monocytes were purified from mononuclear cells by cell scatter monitored counterflow 
centrifugalion Monocyte fractions were over 95% pure (as evaluated by staining for 
non-specific esterase and May-Grunwald-Gicmsa), and viability was higher than 98%, 
as assessed by trypan blue dye exclusion Isolated cells were either cultured immedi­
ately or were cryopreserved (24), and stored in liquid nitrogen until use Recovery and 
viability of cryopreserved monocytes were >70%, and >95%, respectively 
Freshly isolated or thawed cryopreserved monocytes were cultured for 40 h or 9 
days at concentrations of 3 χ 10'cells/ml in RPMI 1640 medium with 20 mM HEPES 
(Flow Laboratories, Irvine, UK), 2 mM L-glulamine (GIBCO, NY), I mM pyruvic acid 
(Sigma, St Louis, MO), 40 |ig/ml gentamicin (Boehnnger, Mannheim Germany), and 
5% heat-inactivated pooled human serum, in a humidified incubator with 5% CO, in air 
at 370C Cytokines were added to cultures during 40 h. either directly at day 0 (40-h 
cultured population), or at day 7 (9-day cultured population) Teflon foil bags (Dupont 
de Nemours and Co, Switzerland) were used for non-adherent culture of monocyte 
suspensions (25) 
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Harvesting monocyte-derived macrophages. After culture for either 40 h, or 9 
days, cells were recovered by needle aspiration after cooling Teflon foil bags to 40C 
for 1 h and genlle kneading After removal of the culture supernalant (collected for 
delcrmination of IL-Iß and TNF-α), the cells were washed twice in RPM1 1640 medi­
um (without serum), and kept on ice until use There was no difference in the number 
(>9()'7r) or viability (>98%) between cells recovered after culture with cytokines and 
those recovered from control cultures For the benefit of FcyRI-mediatcd ADCC ex­
periments, an additional washing procedure at 37°C in RPMI 1640 medium was per­
formed in order to remove cytophilic human IgG (hlgG), as described (17) 
Humon recombinant cytokines. Human granulocyte-macrophage (GM)-CSF, and 
human IL-4 were a kind gift of Dr Ρ Trotta (Schering-Plough Research) Human 
macrophage (M)-CSF was generously donated by Cetus (EmeryuIIe, CA) Human IL-2 
produced by Biogen was a kind gift of Glaxo (Geneva, Switzerland) Human TNF-a 
and human IFN-γ were kindly provided by Boehrmger Ingelheim (Alkmaar, The 
Netherlands) Monocyles and 7-day cultured monocytes were incubated with 150 U 
IFN-y/ml, chosen following the performance of pilot experiments (17) (data not 
shown) Optimal concentrations of the other cytokines were determined by adding 
these cytokines at three concentrations ю 7-day cultured monocytes The ultimately 
concentrations were chosen lo give optimal phenotypic responses with minimal effects 
on cell viability of the at day 9 harvested monocyte-derived macrophages 
Immunofluorescence Studies. Expression of FcyRI, FcyRII, FcyRIII, CD14, and 
HLA DR on cultured monocytes was assayed by indirect immunofluorescence as 
described previously (17) using specific mAb 32 2 [CD64 purified murine (m)IgGl] 
(Medarex, W Lebanon, NH), 197 (CD64 purified mIgG2a) (Medarex), which bind to 
different epitopes outside Ihe ligand-binding site on FcyRI (26), IV 3 (CD32 purified 
mIgG2b) (Medarex), which competes with the FcyRII ligand-binding site (27), 3G8 
(CDI6 purified mlgGI) (Medarex), and Leu llb(CD16 purified mlgM) (Becton 
Dickinson, Mountain View, CA), which identify different epitopes close to the FcyRIII 
ligand-binding site (28), WT14 (CD14 culture supernatant mlgGI) (provided by 
Dr W J M Tax, University Hospital Nijmegen, The Netherlands) which reacts strongly 
with CD 14. expressed selectively on human monocytes and macrophages (29). anti 
HLA-DR (purified mIgG2a) (Becton Dickinson) detects HLA-DR, a common determi­
nant of the MHC class II antigen, and FITC-conjugated goat Fiab'), anti-mouse IgG 
(H and L chain) (Cappcl, Malvern, PA) Fluorescence intensity of 5,000 cells was 
measured with an Ortho ЗОН flow су lomeler For all analyses, gatmgs (red forward and 
right angle scatter) were set around the monocyte/macrophage population Relative 
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expressions were calculated as follows (M
c
 - MJ/fM,,, - MJ, where Μ
ς
 = mean fluores­
cence intensity (arbitrary units) of cytokine cultured monocytes, M
n
 = mean fluores­
cence intensity of negative control, and M
m
 = mean fluorescence intensities of mono­
cytes cultured in control medium 
FcyR mediated cytotoxicity. Л о с е capacity of monocyte-denved macrophages from 
different donors was studied using a "Cr release assay as described previously (17,18), 
in which antibody-coated human erythrocytes (E) were used as targets Briefly, E were 
suspended in PBS containing s lCr (sodium Chromate, Amersham, UK), and incubated 
at 370C Alter 30 mm, sensitizing antibody or PBS /0 1% BSA alone (control), was 
added To sensitize the "Cr labeled E two types of antibodies were used Rhesus D* 
"Cr-labclcd E were sensitized cither with human alloserum against Rhesus D (Merz & 
Dade, Dudingen, Switzerland) or with ascites of mlgGl mAb directed at glycophonn 
A Both types of antibodies were used at various dilutions, resulting in E sensitized 
with a range of IgG molecules per cell (EA IgG), described in (30) After incubation 
for 30 mm, cells were washed thrice, suspended, and 2 5 χ 10' target cells were mixed 
with equal volumes of effector cells (freshly isolated monocytes/40-h cultured mono­
cytes = 3 75 χ ΙΟ' cells, 9-day cultured monocytes = I 25 χ IO1 cells) After incubation 
for 18 h at37°C, half the supernatant was removed for estimation of "Cr release All 
tests were carried out in triplicate The results were calculated as follows 7r cytotoxicity 
= (C - S)/(T - S) χ 100. where С = mean cpm of test sample, S = mean cpm of sponta­
neous "Cr release (i e , "Cr release by labeled target cells in medium alone), and Τ = 
mean cpm of the maximal "Cr release, obtained by addition of 209Í- saponin (Coulter, 
Dunstable, UK) to the target cells The average spontaneous release of E was 3 ± 17c 
(mean ± SD), and release from unsensitized E incubated with effector cells never 
exceeded spontaneous release 
Radioimmunoassays (RIA) for IL-1 β and TNF-a. The concentrations of extracellular 
IL-1 β and TNF α in the supernatants of monocytes cultured for 40 h or 9 days, either 
in the absence, or presence of cytokines were measured by specific RIA, as described 
previously (31-33) Briefly, on day one samples of the monocyte-culture supernatants 
were incubated with rabbit allosera against human IL-Iß or TNF-ct (room temperature) 
On the same day. radioiodinated cytokine tracer was added, and finally sheep anti-rabbit 
IgG antiserum on day 4 Antibody-antigen complexes were precipitated by centnfuga-
tion Radioactivity was determined in a gamma counter and expressed as a percentage 
of the total binding of IL-1 β, or TN'F α Cytokine concentrations were calculated with 
a four parameter method, obtained with serial dilutions of known standards in mono­
cyte culture medium 
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Modulation by cytokines of surface expression of 9-day cultured human mono-
Cyte-derived macrophages. The result of in wtm monocyte/macrophage activation 
by cytokines may depend on the duration of cell culture (34) In our study we first 
screened a number of cytokines, at \arious concentrations, for their ability to modulate 
the phenotype of long term cultured monocytes 
Monocyte derived macrophages were stimulated after? days of culture for 40 h, 
with IFN-yat one concentration, and with TNF-a, IL-4, M CSF, GM-CSF and IL-2 at 
three different concentrations On day 9, cell size and viability of monocyle-denvcd 
macrophages cultured with the various cytokines did not differ from those cultured in 
the absence of cytokine IFN-γ appears to increase FcyRI expression dramatically 
(575 ± 318%) (Fig I) A dose-dependent but small decrease in expression of FcyRIII 
was observed when monocyte-denved macrophages were treated with GM-CSF Both 
IL-4 and TNF-a reduced the membrane expression of all three FcyR classes In addi­
tion, IL-4 also decreased CD14 expression in a dose dependent manner However, 
enhancement ot HLA-DR antigen expression on 9-day cultured monocyte-denved 
macrophages which were treated with IL-4, indicated that IL-4 did not cause a general 
reduction in expression of antigens 
Effect of cytokines on FcyR-medioted cytotoxicity by 9-day cultured human 
monocyte-derived macrophages. We investigated whether effects on FcyRI and 
FcyRII expression were paralleled by functional activities ot the cells ADCC activity 
of FcyRI and II can be independently assayed using E sensitized with hlgG or mlgGl, 
respectively In previous studies, the specificity of monocyte and macrophage FcyRI 
and FcyRII-mediated cytotoxicity has been evaluated, using unique anli-FcyR mAb 
(17,18,35) 
Monocytes were cultured for 9 days in medium alone, or with cytokine for the last 
40 h, and cytotoxicity towards EA-hlgG and EA-mlgGl targets was evaluated Both 
FcyRI and FcyRII-mediated ADCC activity of 9-da) cultured monocytes were sigmfi 
cantly reduced after IL-4 (100 U/ml) treatment (FcyRI from 40 5 ± 3 9% to 19 6 ± 1 4%, 
FcyRII from 45 4 ± 3 7% to 28 0 ± 2 8%) (Fig 2) Monocyte-denved macrophages 
that had been cultured in the presence of IFN-y (150 U/ml) showed an enhancement of 
ADCC activity against EA-hlgG (to 71 1 + 5 8%) Contrary to expectation, where 
TNF-a strongly reduced FcyR expression, ADCC activity via FcyRI and FcyRII was 
not affected Except for TNF-a, these results suggested that for 9 day cultured mono­
cyte-denved macrophages FcyR expression and ADCC activity arc strongly related 
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Dose effect of cytokines on 9-(lay cultured monocytes Monocyte-denved macrophages were obtained by cultunng mono­
cytes for 9 days in medium alone (control), or in medium supplemented with three different concentrations of the indi-
coted cytokines for the last 40 h of culture Expression of FcyRI, FcyRII, FCTRIII, CD14, and HLA DR was evaluated by 
immunofluorescence staining wilh specific mAb Relative expression of the surfoce molecules was calculated as described 
in Motenals andMeàods Results represent mean +SD from three experiments with cells from different donors 
6 
С Y 1 Χ Ι Ν (· ч ^ ι Ι Α Π / V " ^ N C C v I l · P H t N O T Y k l · Α Κ ύ 
• Control 
л IFNy(150U/ml) 
-TNFa(33ng/nil) 
^ IL4(100U/nil) 
• MCSF(100U/ml) 
• GMCSF(20ng/ml) 
IL2(1000U/ml) 
Cytotoxicity 
10 
ίο
1
 ιο'Ίο
4 
hlgG dilution 
10J 
figure 2. 
Effect of cytokines on monocyte-denved 
macrophoge Fryu mediated ADCC activi­
ty ADCC activity was assessed after cuF 
tunng monocytes for 9 doys in medium 
olone (control), or in medium supple­
mented with the indicated cytokines for 
the last 40 h of culture ADCC tests 
were performed as described in 
Materials and Methods, using target E 
sensitized with vanoble amounts of 
either hlgG onh-Rhesus D olloserum or 
102 mlgGl onti-glycophorm AmAb (optimal 
mlgGl dilution Ε Τ ratio of 0 5) Results represent dota 
from thtee individual experiments with 
cells from different donors SD were all 
smaller thon 10°o 
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Expression of FcyRI ond FryRIII on 
short term cultured monocytes The 
expression of FcyRI ond FcyRIII on 
freshly isolated monocytes, ond mono­
cytes cultured for 40 h in medium 
alone, was measured by immunofluo­
rescence analysis using specific onti 
FcyR mAb The fluorescence intensity 
(orbitrary units) wos recorded on the 
abscissa (linear scole) Negative control 
values are represented by doshed-lines 
One representative experiment out of 
six is shown using antt-FcyRI mAb 
32 2,ondonti-FcYRIIImAbleullb 
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Effect of different cytokines on 40-h cultured monocyte surfoce antigen expression Monocytes were cultured for 40 h in 
medium olone (control), or in medium supplemented with the indicated cytokines Expression of FcyRI, FcyRII, CD14, 
and HLA DR was evaluated by immunofluorescence staining with specific mAb Relative expression of the surface 
molecules was calculated as described in Materials and Methods Results represent mean ± SD from three experiments 
with cells from different donors 
Modulation by cytokines of surface expression of 40-h cultured monocytes. We 
previously demonstrated that, as a consequence of culture, FcyRII expression on 40-h 
cultured monocytes was decreased (18) In six separate experiments with cells from 
different donors, we also compared freshly isolated to 40-h cultured monocytes for 
FcyRI and FcyRIII expression With the use of specific anti-FcyRl mAb (197 and 32 2), 
we showed that FcyRI expression on 40-h cultured monocytes decreased dramatically 
to 25 8 ± 10 7% (mean + SD), as compared to freshly isolated monocytes Lsing two 
anti-FiyRHI mAb (3G8 and Leu lib), which recognize different CD 16 epitopes, we 
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showed that FcyRIII on 40-h cultured monocytes was still hardly detectable (Fig 3) 
Next, we evaluated the effects of IFN γ(150 U/ml), TNF-a (Л ng/ml), IL-4 (100 
U/ml). M-CSF (100 U/ml), GM-CSF (20 ng/ml), and IL-2 (1000 U/ml) on the pheno-
typc of monocytes at the short-term cultured (40 h) maturation stage Cell size and via­
bility ol cytokine-treated, and control monocyte populations was found to be similar 
The préexistent low expression after 40 h of culture did not permit a reliable assessment 
of FcyRIII modulation by cytokines As depicted in Figure 4, IFN-yand IL-4 had an-
tagonistic effects on the expression of both the classes of FcyR Compared to the 40-h 
cultured control monocyte population, FcyRI and FcyRII expression were increased 
when cultured in the presence of IFN-γ, and decreased when cultured with IL-4, 
respectively Surface expression of FcyRII was also increased by TNF-a and GM-CSF 
With exception of TNF-a-lreated cells, all cytokine-treated populations exhibited a 
decreased CD 14 expression, although, the influence of M-CSF was minimal On the 
other hand, all tested cytokines up-regulated the expression of HLA-DR molecules on 
40-h cultured monocytes 
• Control 
• Monocytes 
л IFN γ ( 1 5 0 U/ml) 
/y TNF α (33 ng/ml) 
о IL 4 (100 U/ml) 
• M CSF (100 U/ml) 
• GM CSF (20 ng/ml) 
ι 11-2(1000 U/ml) 
(%) 
60 
40 
20 
Cytotoxicity 
0 L -
10 
figwe 5. 
ADCC activity of short term cytokin«ul· 
hired monocytes against mlgGl-sensiti­
zed human E Freshly isolated monocy­
tes, or monocytes cultured for 40 h in 
either medium alone (control), or medi­
um supplemented with the indicated 
cytokines, were evaluated for cytotoxic 
activity ADCC tests were performed as 
desenbed in Mmk ond Methods, 
using target E sensitized with variable 
amounts of mlgGl anti-glycophorin A 
1 0 2 mAb (optimal Ε Τ ratio of 1 5 ) Results 
mlgGl diluhon are mean data from three individual 
experiments with cells from different 
donors SD were all smaller than 8% 
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Effect of cytokines on FryR-mediated cytotoxicity by 40-h cultured human 
monocytes. Next, we investigated whether the found bcyR expressions are manifested 
in FcyR-mediated cytotoxicity of the short term cultured monocytes Freshly isolated, 
and 40-h (cytokine) cultured monocytes were evaluated for cytotoxicity towards EA* 
hlgG and EA-mlgGl, using an optimal effector to target cell ratio 1 5 FcyRl-mediated 
ADCC activity by monocytes cultured for 40 h, either without (control), or with TNF-a 
(33 ng/ml), IL 4 (100 U/ml), M-CSF (100 U/ml), GM-CSF (20 ng/ml), or IL-2 (1000 
U/ml), never exceeded а 10% cytotoxicity level towards optimally with hlgG sensitized 
E However, when monocytes were cultured for 40 h in the presence of IFN-γ ( 150 U/ml), 
FcyRI-mediated ADCC activity was enhanced to 70 ± 6 3% (not shown) In Figure 5 
we show that monocytes treated with IL-4 (100 U/ml) during the 40 h culture period, 
exhibited a reduced FcyRII-mediated ADCC activity against EA-mlgGl (from 315 + 
2 \9c to 6 2 ± 2 8%) When cultured m the presence of ΙΡΝ-γ(150 U/ml), this activity 
was strongly enhanced (to 75 6 ± 5 7%) However, when the 40-h IFN-y-cultured 
monocytes are compared with freshly isolated monocytes (65 1 ± 4 7), lysis of LA-
mlgGl was almost similar (Fig 5) 
Effect of cytokines on the production of IL-1 β and TNF-a by cultured monocytes. 
Production and secretion of IL-Iß and TNF-α by monocytes and monocyte-dcnved 
macrophages is not constitutive but is induced by a variety of endogenous and exoge­
nous stimuli In this study, strict precautions were taken with respect to the isolation 
(Percoli centnfugation and elutnalion), and the in vitro culture (non-adherent) of high­
ly purified monocytes to minimize IL-Iß and TNF-α synthesis Under these conditions, 
it was possible to induce a profound IL-Iß and TNF-α synthesis/release via stimulation 
with LPS (unpublished results) Monocytes were incubated in suspension for 40 h or 9 
days, either in the absence, or presence of recombinant cytokines, as described in 
Materials and Methods Compared with the recombinant cytokine-free populations, 
neither IFN-γ (150 U/ml), IL-4 (100 U/ml). M-CSF (100 U/ml), GM-CSF (20 ng/ml). 
nor IL-2 (1000 U/ml) induced any IL-lß or TNF-α secretion by monocytes at different 
stages of maturation, as detected in the various culture supernatants by the specific 
RIA (Table I) The concentration of TNF-α measured in the supernatant was always 
lower than originally added to the cell cultures On the contrary, in two out of three 
supernatants of 40-h cultured monocytes stimulated with TNF-a (33 ng/ml), a slight 
increase in the concentration of IL-lß was detected 
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Table I. 
Analysis of TNF-a and IL-1 β production by short-, and long-term cytokine cultured monocytes 
control ¡TZ ІИ Ша ¡ЙГу ІШ GM-CSF 
Donor - (1000 U/ml) (100U/ml) (ЗЗпд/т!) (150U/ml) (IQOU/ml) (20ng/ml) 
TNF-a present in supernatant of 40-h cultured monocytes' (ng/ml) 
Á 1.2Í TOT <0.19 25.2 108 № 1.38 
В <0.19 <0.19 <0.19 26.76 0.36 <0.19 0.39 
С 0.43 0.36 <0.19 21.0 - 0.29 052 
IL- Iß present in supernatant of 40-h cultured monocytes (ng/ml) 
A 043 025 OlO Î.40 ОАО 027 0.66 
В 0.13 0.15 0.13 0.43 0.19 0.17 0.11 
С 0.12 <0.08 <0.08 0.10 - <0.08 0.10 
Ш а present m supernatant of 9-day cultured monocyte-derived macrophages'1 (ng/ml) 
D 026 022 (Г25 Í9 6 - Í27 <0.19 
E 0.65 0 59 0 70 26 5 - 0.48 0.27 
F 0.24 0.33 0.25 19.3 - <0.19 0.39 
/Í- Iß present ¡η supernatant of 9-day cultured monocyte-derived macrophages (ng/ml) 
D 009 0.12 0 7 ΤΪ2 ~ 09 0.11 
E 0.53 031 0 35 0.23 - 0.43 0.25 
F <0.08 0.15 010 <0.08 - <0.10 0.15 
' Supernatant m obtained from monocytes (3 χ I'If/ml) cultured in suspension lor 40 h with or without cytokine 
' Supernatant from monocyteiienved macrophages was obtained by in suspension cultunng of monocytes 
(3 χ 10s/ml) for 9 days in medium, or medium supplemented with cytokine for the last 40 h of culture 
' Concentrations of IL- Iß and W-α in the supemotants of cultured cells were measured by specific Ш 's, as 
descnbed previously (31-33) 
It is of relevance to assess the putative effects of cytokines on various differentiation 
stages ot human monocytes Differences between monocytes, and monocyte-derived 
macrophages are incontestable the result of their maturational or activation state (5,34). 
Therefore, our studies have focused on the process of monocyte differentiation at dif­
ferent stages of maturation, ι e , freshly isolated monocytes, short- (40 h) and long-term 
(9 days) cultured monocytes In the present report, immunomodulatory effects induced 
by IFN-γ, TNF-a, IL-4, M-CSF, GM-CSF, and IL-2, on phenotype, FcyR-mediated cyto­
toxicity, and cytokine secretion during in vitro culture of human monocytes were studied. 
We first screened the modulatory effects of the indicated cytokines on long-term cultured 
monocytes, in the second part of our study we monitored on short-term cultured cells. 
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Monocyle-denved macrophages showed sensitmty for modulation of the quantità 
live expression of some cell surface molecules when stimulated, for the last 40 h of 
culture, with IFN-γ, TNF-a, or IL-4 Most obvious arc the effects caused by IFN-γοη 
the expression of FcyRI (increased), and the decreased expression of all three FCYR 
classes after culture with either IL-4, or TNF α Relc\ant, and most intriguing are the 
consequences, of the by the cytokines changed quantitative expression of FcyR mole­
cules, for akin FcyR-medialed ADCC activity For both the with IFN-γ and IL-4 cul­
tured monotytc-denved macrophages there was a good relationship between the altered 
membrane expression of the FcyR, and the capacity to lysc ЬА-IgG (Fig 2) In con­
trast, similar FcyRI- and Fc7RII-mediated ADCC activities were observed with both 
untreated, and TNF-a-treated monocyte-denved macrophages, although the latter cells 
express less FcyR These results suggest that provoked changes in either FcyRI, or 
FcyRII expression levels are not always related to FcyR-mediated functional activities 
A possible interpretation for this discrepancy in the putative 'action-reaction' model 
may be the initiation of additional changes in mechanisms which are not aftihatcd 
directly with the number of FcyR by which the function is assumed to be attained 
Another example is the stimulation by IFN-γ of the FcγRII-medlated cellular cytotox­
icity of neutrophils, monocytes and myeloid cell lines without increasing FcγRII 
expression (9) 
A changing monocyte phenotype is inherent to culture Recently, we compared 
freshly isolated monocytes with 40-h cultured monocytes for the expression of FcγRII 
and HLA-DR (18) As a consequence of the 40 h culture period. FcγRII expression on 
monocytes was halved, whereas the amount of HLA-DR antigens doubled These data 
imply that the appropriate culture conditions did not cause a general reduction in mem­
brane molecules Others showed that FcγRI expression was down regulated on mono­
cytes after 1 day of culture (16), and that expression of FcγRIII on freshly isolated 
monocytes is negligible but will increase with length of time in culture (8) Before study­
ing any modulatory effects of cytokines on 40-h cultured monocyte FcγR expression, 
we therefore first measured FcγRI and FcγRIII expression on both freshly isolated 
monocytes, and on m utro differentiated, unstimulated 40 h cultured monocytes Also 
a strong reduced FcγRI expression on 40-h cultured monocytes was observed (Fig 3), 
and this seemed to correlate well with the observed decrease in FcyRI-mediated ADCC 
activity against E sensiti7ed with hlgG Until now, the phenomenon of the ' ^ R dis­
appearing" remains unclear Tripalhi et al (36) supposed that there is a mechanism of 
rapid internalization of the FcγR However, knowledge about recycling of human FcγR 
is limited In contrast to the recycling capability of FcγRII (37) Jones et al (38) 
demonstrated that human FcγRI, neither on the U937 cell line, nor on monocytes recycles 
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Next, we will discuss effects of cytokines on short-term cultured (40 h) monocytes 
Highly remarkable were our obser\ations with respect to the effects of IFN-γοη the 
expression levels of FcyRI and FcyRll When 40-h IFN-y-cultured cells are compared 
with freshly isolated monocytes for FcyR expression, FcyRI expression increased two 
times, and the expression level of FcyRII was unchanged (18) In addition we show that 
under these defined conditions, ΓΝΡ-α-, and GM-CSF-cultured monocytes express also 
higher FcyRII levels than their unstimulated counterpart (Fig 4) Our data clearly 
demonstrate that the reduction of FcyRII expression levels could be reversed complete­
ly by culturmg monocytes with IFN-γ, or GM-CSF, and was reversed marginally when 
cultured in the presence of TNF-a Furthermore, modulation of FcyRII expression by 
these cytokines seems to depend critically on the stage of monocyte maturation, 
revealing a new level of complexity in regulation of FcyR expression levels The 
mechanism by which cytokines affect FcyR expression remains unclear up to now 
Freshly prepared monocytes, and monocytes cultured in the presence of IFN-γ have 
an almost equal capacity to lyse EA-mlgGl However, 4()-h cultured monocytes (con­
trol), and monocytes cultured in the presence of GM-CSF, or TNF-a are comparable in 
lysing EA-mlgGl (Fig 5) As described above, these observations also show that an 
altered FcyRII expression level not necessarily has functional consequences 
All tested cytokines, IFN y, TNF-a, IL 4, M CSF, GM-CSF, and IL-2, positively 
affected the level of HLA-DR expression The cytokine-induced increase in this antigen 
expression is in fact cumulative to the previously described doubling of HLA-DR anti­
gens, as a consequence of the 40 culture period only (18) The amount of HLA-DR anti­
gens on the monocyte is crucial for the antigen presenting cell function of this cell type 
The capacity of normal human monocytes, either short-term or long-term cultured, 
to produce and secrete cytokines such as IL-I and TNF is regulated by various stimuli 
including endotoxin and exogenous pyrogens We quantified the IL-Iß (secreted form 
of IL-1) and TNF-a (by monocytes secreted form of TNF) concentration in supcrna-
tants of monocytes incubated with multiple cytokines, by specific RIA to avoid confu-
sing factors introduced by the use of bioassays In this study, under the conditions as 
described, in medium cultured monocytes did induce neither IL-Iß, nor TNF-α secre­
tion This finding is of importance, because both IL-1 and TNF induce monocytes to 
produce CSF and other cytokines (39), which m turn may interfere with the originally 
added specific cytokine 
In conclusion, in this report we document strong effects of cytokines on the 
expression of various cell surface antigens, and FcyR-mediatcd cytotoxicity These 
effects were different, depending on the stage of monocyte differentiation 
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We e\ aluated the effects of various classes of cytostatics (antibiotics, alky lating 
agents, antimetabolites, protein synthesis inhibitors, and miscellaneous agents) on 
human monocytes at different stages of maturation ІП н/го, ι e, long-term (9 days) and 
short-term (40 h) cultured 
During culture in Teflon foil bags, monocytes flattened and spreaded out on the 
surface When long-term cultured, and incubated for the last 40 h with cisplatin (ш-
DDP), the flattening and spread out of cells disappeared In addition, the protein syn­
thesis inhibitor ethyldeshydroxysparsomycin (EdSm), and fluorouracil (5-FU) induced 
homotypic monocyte adhesion When short-term cultured with ш-DDP, 4-hydroxycy-
clophosphamide (4-OHCY), EdSm, or 5-FU, monocytes lost spreading capabilities 
Expression of immunoglobulin G Fe receptor (FcyR)! and FcyRIII decreased when 
long-term cultured monocytes were treated with ш-DDP, 4-OHCY, EdSm, or 5-FU 
Moreover, EdSm reduced the expression of FcyRII. CD 14, and HLA-DR Short-term 
EdSm co-cultured monocytes were reduced in FcyRI, FcyRII, and CD14 expression 
4-OHCY, however induced an increase in CD14 expression The antibody-dependent 
cell-mediated cytotoxicity via FcyRI and FcyRII of long-term cultured monocytes was 
unchanged after culture with anticancer drugs Interestingly, EdSm was the solely drug 
that could reduce FcyRII-mediated ADCC activity of 40 h cultured monocytes 
Our results indicate that specific effects of chemotherapeutic agents on monocyte 
morphology, differentiation-associated antigens, and FcyR-mediated cytotoxicity are 
depending on the class of drugs, and the stage of monocyte differentiation 
Human monocytes and macrophages contribute in initiating and regulating host 
defense responses against the development and spread of neoplasia (for review see 1) 
The maturation stage along the monocytc/macrophage-lmeage, and environmentally 
interactions (e g, cytokine treatment, inllammatory processes) may critically affect the 
expression of cell surface molecules, and functional activities mediated by these cells 
(2,3) Both freshly isolated human monocytes, and monocyte-denved macrophages 
express immunoglobulin G Fe receptor (FcyR)! (CD64), and FcyRII (CD32) (reviewed 
in refs 4,5) In vitro, FcyRIII (CD 16) will be expressed on monocytes after at least 4 
days of culture (6) All these classes of FcyR have been shown to mediate antibody-
dependent cell-mediated cytotoxicity (ADCC) (7) The amount of MHC class II mole­
cules (HLA-DR) on the monocyte/macrophage membrane is crucial for the initiation of 
an immune response (8), and CD14, a differentiation antigen expressed on mature 
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monocytes, is a receptor for lipopolysacchande (LPS) complexed with LPS binding 
protein (9) 
Cancer immunotherapy is increasingly important However, the effectiveness of 
this treatment modality is more or less dependent on the tumor load Therefore it is 
likely that this approach will be combined with chemotherapy Chemotherapy may 
however affect the functional integrity of the immune apparatus Anticancer drug inter­
actions with human monocyte/macrophage functions are complex, and have been stud­
ied to some extent, but the available information in this respect is generally limited 
(10-20) Morphology and function of monocytes can be influenced on one hand by a 
host of factors pertaining to the classes of anticancer drugs employed, and on the other 
hand the stage of monocyte development Although until recently it was thought that 
anticancer drugs induce only immunosuppression because of their antiproliferative and 
cytotoxic actions, it is now well established that some of them can also cause selective 
and rather specific immunoaugmentation (for review see 21) 
We concentrated on compounds of ma]or classes of chemotherapeutic agents 
Possible mechanisms of antineoplastic drugs at play are numerous Doxorubicin hydro­
chloride (Dox) and bleomycin sulphate (Bleo) belong to the antibiotics The elfects of 
Dox include intercalation with DNA, effects on topoisomerase, and formation of toxic-
free radicals (22) The molecular target of Bleo is DNA (23), and its cleavage is depend­
ent on oxygen and ferrous ions (24) Cisplatin ( ш DDP), a miscellaneous agent, kills 
tumor cells in culture by damaging the DNA template (25) Cyclophosphamide, an 
alkylating agent, is not active per se, but requires to be 'activated' with the formation 
of metabolites (26) We used the metabolite 4-hydroxyc>clophosphamide (4-OHCY) 
Fluorouracil (5 FU), a pynmidine antimetabolite, is cytotoxic by inhibiting DNA syn­
thesis, incorporating into nuclear RNA and DNA (27) Ethyldeshydroxysparsomycm 
(EdSm), an analogue of sparsomycin (28) is a strong inhibitor ot the protein synthesis 
(29) 
For the present study, wc have investigated to what extent the above-mentioned 
anticancer drugs, to be used in cancer chemotherapy, affect morphologic, phenotypic 
and functional characteristics of freshly isolated monocytes in two stages of maturation 
in vitro (ι e , cultured for 40 h and 9 days) 
Isolation and culture of human monocytes. Monocytes were isolated as described 
(30) Briefly, mononuclear cells obtained from buffy coats, or cytapheresis of healthy 
volunteers, were isolated by Percoli (Pharmacia, Uppsala. Sweden) centnfugation 
Monocytes were purified from mononuclear cells by cell scatter monitored counterflow 
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centnfugation Monocyte fractions were o\er 9Wc pure (as evaluated by staining for 
non-specific esterase and May-Grunwald-Giemsa). and viability was higher than 98%, 
as assessed by trypan blue dye exclusion Isolated cells were either cultured immedi­
ately or were cryoprescrvcd (31), and stored in liquid nitrogen until use Recovery and 
viability of cryopreservcd monocytes were >70%, and >95%, respectively 
Freshly isolated or thawed cryopreserved monocytes were cultured for 40 h or 9 
days at concentrations of 3 χ IO5 cells/ml in RPMI1640 medium with 20 mM HEPES 
(Flow Laboratories, Irvine, UK), 2 mM L-glutamine (GIBCO. NY), 1 mM pyruvic acid 
(Sigma, St Louis, MO), 40 μg/ml gentamicm (Boehrmger, Mannheim Germany), and 
5% heat inactivated pooled human serum, m a humidified incubator with 5% CO, in air 
at 370C Anticancer drugs were added to cultures during 40 h, either directly at day 0 
(40-h cultured population), or at day 7 (9-day cultured population) Teflon foil bags 
(Dupont de Nemours and Co, Switzerland) were used for culture of monocyte suspen­
sions (II) 
Harvesting monocyte-derived macrophages. After culture for either 40 h, or 9 
days, cells were recovered by needle aspiration ahcr cooling Teflon foil bags to 40C 
for 1 h and gentle kneading After removal of the culture supernatant [collected for 
determination of interleukin (IL)-Iß and tumor necrosis factor (TNF)-a], the cells were 
washed twice in RPMI 1640 medium (without scrum), and kept on ice until use There 
was no difference in the number {>%%) or viability (>90%) between cells recovered 
after culture with the finally selected drug concentration, and those recovered from 
control cultures For the benefit of FcyRI-mediated ADCC experiments, an additional 
washing procedure was performed in order to remove cytophilic human (h)IgG, as 
described (2) 
Anticancer drugs. Dox (Adnblastina1, Farmitaha Carlo Erba, France), Bleo (Lundbcck, 
Denmark). 4-OHCY (Asta Germany), and EdSm [provided by the Dept of Organic 
Chemistry, University of Nijmegen, The Netherlands, and synthesized as described 
(28)] were obtained as lyophilized powders, and reconstituted sterile with distilled 
H,0 CIÍ-DDP (Cyanamid, UK), and 5-FU (Hoffmann-La Roche, Switzerland) were 
purchased in solution All drugs were further diluted aseptically with phosphate-buffered 
(PBS) to stock solutions Dox, Bleo, and 4-OHCY were stored deep frozen at -20°C, 
cii-DDP and 5-FU at room temperature, and EdSm at 4°C Prior to incubation, the anti-
cancer drugs were diluted with growth medium to working concentrations as indicated 
We did strive after drug concentrations comparable to the serum concentrations 
found in the clinical setting Concentrations were calculated as described previously 
(32) (C χ S)/(V χ W), where С = concentration of the drug in blood or plasma per nr, 
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S = surface area (2 пГ) which is related to mean body weight and length V = total 
body volume of distribution at steady state (liters/kg), and W = body weight (76 kg) 
Calculated concentrations for m \itro use were Dox (40 ng/ml), Bleo (2 μg/ml), cis-
DDP (5 μg/ml), 4 OHCY (27 μg/ml), EdSm (1 μΜ), and 5-FL (63 μg/ml) Anticancer 
drugs were added at three to five concentrations, between 10 ' to 10' limes the calcula­
ted value, to 7-day cultured monocytes For further studies, ultimately concentrations 
were chosen as optimally tolerated doses, with minimal effects on cell viability (>90%') 
of the at day 9 harvested monocyte-denved macrophages 
Immunofluorescence Studies. Expression of FcyRI, FcyRII, FcyRlII, CD 14, and 
HLA DR on cultured monocytes was assayed by indirect immunofluorescence as 
described previously (2) using specific mAb 197 [CD64 purified murine (m)IgG2a] 
(Medarex, W Lebanon, NH), which bind to an epitope outside the ligand-binding site 
on FcyRI (33), IV 3 (CD32 purified mIgG2b) (Medarex), which competes with the 
FcyRII ligand-bmding site (34), 3G8 (CD 16 purified mlgGl) (Medarex), which identi­
fies an epitope close to the FcyRIII ligand-bmding site (35). WTI4 (CDI4 culture 
supernatant mlgGI) (provided by Dr W J M Tax, University Hospital Nijmegen, The 
Netherlands) which reacts strongly with CD14 molecules, expressed selectively on 
human monocytes and macrophages (36), anti HLA-DR (purified mIgG2a) (Becton 
Dickinson) detects HLA-DR, a common determinant of the MHC class II antigen, and 
FITC-conjugated goat F(db')2 anti-mouse IgG (Heavy and Light chain) (Cappel, 
Malvern, PA) Fluorescence intensity of 5000 cells was measured with an Ortho ЗОН 
flow cytometer For all analyses, galings (red forward and right angle scatter) were set 
around the monocyte/macrophage population and the mean fluorescence intensity 
(expressed in arbitrary fluorescence units/cell) was calculated (linear) from the histo­
grams Relative expressions were calculated as follows (M, - M
n
)/(M
m
 - M
n
), where 
Mj = mean fluorescence intensity of anticancer drug-cultured monocytes, M
n
 = mean 
fluorescence intensity of negative control, and M
m
 = mean fluorescence intensities of 
monocytes cultured in control medium 
FcyR-medioted cytotoxicity. ADCC capacity of monocyte-denved macrophages from 
different donors was studied using a 5 lCr release assay as described previously (2,37), 
in which antibody-coated human erythrocytes (E) were used as targets Briefly, E were 
suspended in PBS containing s lCr (sodium Chromate, Amersham, UK), and incubated 
at 370C After 30 mm, sensitizing antibody, or PBS / 0 1 % bovine serum albumin alone 
(control), was added To sensitize the 31Cr labeled E, two types of antibodies were used 
Rhesus D+ '''Cr-labeled E were sensitized either with human alloserum against Rhesus 
D (Mer? & Dade. Dudingen, Switzerland) or with ascites of mlgGl mAb directed at 
I N F l U t Ν ' F Ο Γ л Ν 1 I fi Ν г Ζ H D R J V J ' Î O N H J 'ν A N ^ Ν ^ т с с , 
glycophorin A Both types of antibodies were used at various dilutions, resulting in Ь 
sensitized with a range of IgG molecules per cell (EA-IgG), as described (38) After 
incubation for 30 mm, cells were washed thrice, suspended, and 2 5 χ 10' target cells 
were mixed with equal volumes of effector cells (freshly isolated monoc\tes/40-h cul­
tured monocytes = 3 75 χ IO5 cells. 9-day cultured monocytes = I 2S χ 10s cells) After 
incubation for 18 h at 37'C. half the supernatant was removed for estimation of ''Cr 
release All tests were tamed out in triplicate The results were calculated as follows 
% cytotoxicity = (C S)/(T - S) χ 100, where С = mean cpm of test sample, S = mean 
cpm of spontaneous '^Cr release (i e, 4Cr release by labeled target cells in medium 
alone), and Τ = mean cpm of the maximal '^Cr release, obtained by addition of 20% 
saponin (Coulter, Dunstable, UK) to the target cells The average spontaneous release 
of E was 3 + 1 % (mean ± SD), and release from unsensiti/ed E incubated with effector 
cells never exceeded spontaneous release 
Radioimmunoassays (RIA) for IL-1 β and TNF-a. The concentrations of extracellu­
lar IL-Iß and TNF-α in the supernatants of monocytes cultured for 40 h or 9 days, ei­
ther in the absence, or presence of anticancer drugs were measured by specific RIA, as 
described previously (39-41) Briefly, on day one samples of the monocvte-culture 
supernatants were incubated with rabbit allosera against human IL-1 β or TNF-α (room 
temperature) On the same day, radioiodinated cytokine tracer was added, and finally 
sheep anti-rabbit IgG antiserum on day 4 Antibody antigen complexes were precipitat­
ed by centnfugation Radioactivity was determined in a gamma counter and expressed 
a percentage of the total binding of IL-Iß, or TNF-α Cytokine concentrations were 
calculated with a four parameter method, obtained with serial dilutions of known 
standards in monocyte culture medium 
Viability and morphology of anticancer drug-cultured monocytes. Preliminary to 
the study on the modulation by anticancer drugs of phenotypic and functional proper-
tics of human monocytes, we first scrutinized cell viability and morphology Mono-
cytc-denved macrophages were stimulated at day 7 of culture, for 40 h with Dox, Bleo, 
civ-DDP, 4-OHCY, EdSm, and 5-FU at concentrations between 10 ' to 10' times an 
optimally calculated value (see Materials and Methods) On day 9, ν lability of recovered 
cells, either cultured in medium alone, or being exposed to various concentrations of 
Dox. Bleo, or 5-FU, was always higher than 90% However, the for ш-DDP. 4-OHCY, 
and EdSm optimally and tenfold concentrations resulted either in at least 20% or 90% 
cell death, respectively (Table I) 
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Table 1. 
Effect of anticancer drugs o 
Cell population0 
Control 
Dox 
Bleo 
аіШ 
4-OHCY 
EdSm 
S-FU 
η viability of 9-day cultured human ι 
Concentration anticancer drugs 
-
4,40*, 400 (ng/ml) 
0 2,2*,20(ю/тІ) 
0 5,1,25 (цв/т!) 
5* (Mg/ml) 
50 (щ/ті) 
27,54,108 (ю/ml) 
27* (Hj/nil) 
270 (ц/ті) 
01,03,06 И ) 
1* Щ 
10 И ) 
6 3,63*, 630 (n/ml) 
monocytes 
Perce ntage viability0 
>90 
>90 
>90 
>90 
70 
0 
>90 
60 
10 
>90 
80 
0 
>90 
° Monocyteiiemed macrophage populations, cultured for 9 days m medium alone, or with different anticancer 
drugs for the last 40 h of culture ^comparable to serum concentration found in clinical setting, as described in 
Meteríais and MethodsJ 
' Cells recovered after culture were assessed for viability by trypan blue dye exclusion Jo determine the percent of 
viability, 100 cells of each population were counted in randomly chosen fields 
Next we studied effects of anticancer drugs on cell morphology during the last 40 h 
of a long-term (9 days) culture period, using those drug concentrations which resulted 
in at least %9c viable cells During culture in Teflon foil bags, a subpopulation (11) of 
monocytes loosely attach to the surface, and the majority of these cells flatten and 
spread out Pending the culture with Dox (40 ng/ml) or Bleo (2 μg/ml), morphology of 
the monocyte-denved macrophages was similar to cells during culture in medium 
alone When cultured with ш-DDP (2 5 μg/ml), cells normally kept attached to the 
Teflon surface, but the flattening and spread out disappeared The majority of mono­
cyte-denved macrophages co-cultured with 4-OHCY (10 8 μg/ml) went in suspension, 
and co-culture with FdSm (0 6 μΜ) or S-FU (63 μg/ml) for the last 40 h of the culture 
period, caused homotypic monocyte adhesion which ultimately resulted in big clumps 
of cells being in suspension 
When short-term cultured (40 h), we observed that before harvesting, monocytes 
were in a state of spreading However, when to-cultured with ш-DDP (2 5 μg/ml), 
4-OHCY (2 7 μg/ml), EdSm (0 6 μΜ), or 5-FU (63 \¡glm\), monocytes lost their 
spreading capability, and appeared rounded towards the end of the culture period 
Ι Ν - ι U ИМ С I О с ^ N І С Л Ч ^ Г І ? D R t C ^ O N Ч J А \ V О Ν ϋ ^ Y 1 I Ь 
Furthermore, after treatment with 4-OHCY (10 8 μg/ml), viability of the monocyte 
population was halved A 907c monocyte survival was reached when cultured with 
4-OHCY at an optimal concentration of 2 7 ц§/т1 
Modulation by anticancer drugs of receptor expression on 9-day cultured 
human monocytes. Parallel to the above described viability study the same long term 
cultured drug treated monocyte populations were screened for induced phenotypic 
alterations By culturing monocytes with Dox (4 ng/ml) expression of FcyRI increased 
to 143 0 + 37% (mean! SD), and the expression of FcyRIII to 1465 + 31 2% (Fig 1) 
Bleo did not alter the quantitative expression of surface molecules on long term cultured 
monoevtes A small decrease in expression of Ϊ cyRl and FcyRIII was observed when 
cells were treated either with a s DDP (2 5 μg/ml), or 4 OHCY (10 8 μg/ml) FdSm 
(all concentrations) did, more or less reduce the membrane expression of all three 
FcyR classes, CD14, and HLA DR In addition co culture for the last 40 h with 5 FU 
decreased FcyRI and FcyRHI expression in a dose-dependent manner and slightly 
reduced HLA DR antigen expression I inally, the most striking reductions in antigen 
expression observed were induced at concentrations of ш DDP 4 OHCY, and EdSm, 
which also detrimentally affected cell viability (Table I) Furthermore, these harmful 
effects did vary with the different tested surface molecules (Fig 1) 
Effect of anticancer drugs on FcTR-mediated cytotoxicity by 9-day cultured 
human monocytes. Next we investigated whether FcyRI and FcyRII expression is 
manifested in functional activities of 9 day cultured monocyte derived macrophages 
ADCC activity of FcyRI and FcyRll can be independently assayed using E sensitized 
with hlgG or mlgGl, respectively In previous studies the specificity of monocyte and 
macrophage FcyRI and FcyRII mediated cytotoxicity has been evaluated, using unique 
anti FcyR mAb (2,37,42) 
Monocytes were cultured for 9 days in medium alone or co-cultured for the last 40 h 
with Dox (40 ng/ml), Bleo (2 μg/ml) as DDP (2 5 μ^ΓηΙ) 4 OHCY (10 8 μ|/πι1), 
EdSm (0 6 μΜ), or 5 FU (63 μ|/ιη1) Cytotoxicity towards EA hlgG and EA-mlgGl 
targets was evaluated with at least 90% viable effector cells In Figure 2 it is depicted 
that, despite a decreased receptor expression, both FcyRI and FcyRII mediated ADCC 
activity was not affected after culture with cytostatics 
Modulation by anticancer drugs of receptor expression on 40-h cultured human 
monocytes. Next we evaluated the effects of anticancer drugs on monocyte phenotype 
in an early stage of maturation Expression of FcyRI, FcyRII, CD14, and HLA-DR was 
analyzed on short term cultured monocytes (40 h) which were co cultured with Dox 
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15 
1 
05 
Relative expression -
• 4 ng/mT 
I D M • iO 'ng/ml 
Relative expression -
• Ûîpj/ml 
Bleo ^ 2 ' pg/ml 
20 μ^πιΙ 
о UBI—mm—мж , ι—ин—і о 
FcyRI fcyRII FcyRIII CD14 HLA DR Fcfftl FcyRII FcyRIII CD14 Н1Л DR 
Relative expression 
• OSpg/ml 
• I pg/ml 
(is DDp mlSpi/ni 
LT 5" pg/ml 
50 (tç/ml 
Relative expression -
• 2 7 |)j/ml 
• 5 4 ua/mj 
4 0HCY •lOBps/ml 
a 27' μ^ΊπΙ 
^ 270 jig/ml 
FcyRI FcyRII FCTRIII CDl 4 HLA DR 
Relative expression -
• 01 μΜ 
• 03 μΜ 
EdSm mit μΜ 
• Γ μΜ 
= 10 μΜ 
M I FcyRII FcyRIII CDl 4 HLA DR 
Relative expression -
• 6 3 m/d 
5 FU тіГт/т\ 
^ б З О і у т І 
FcyRI FcyRII FcyRIII CDl 4 HLADR FcyRI FcyRII FcyRIII CDl 4 H U I 
Figure I . 
Dose effect of onhconcer drugs on 9-doy cultured monocytes Monocytedenved macrophages were obtained by culturing 
monocytes for 9 days in medium alone (control), or in medium supplemented with different concentrations of the indi­
cated anticancer drugs for the last 40 h of culture (* concentration comporable to the serum concentrahons found in the 
clinical setting) Expression of FcyRI, FcyRII, FcyRIII, CDl 4, ond HLA DR was evaluated by immunofluorescence staining 
with specific mAb Relative expression of the surface molecules was calculoted os described in Matenols ond Methods 
Results represent mean + SD from three experiments with cells from different donors 
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• Control 
_ DoxMOng/ml) 
o Bleo(2pj/ml) 
• f/s-DDP(2 5pg/ml) 
/ 7 4-OHCY(10.8|jg/nil) 
• EdSm(06pM) 
Δ 5-FU(63pg/ml) 
Cytotoxicity 
10° m 4 
hlgG dilution 
figure 2. 
Effect of onticoncer drugs on monocyte-
denved macrophage FcyR mediated 
ADCC activity ADCC activity was as­
sessed after culturmg monocytes for 9 
days in medium alone (control), or in 
medium supplemented with the indicat­
ed anticancer drugs for the last 40 h of 
culture ADCC tests were performed as 
described in Matenols and Methods, 
using target E sensitized with variable 
amounts of either hlgG anti-Rhesus D 
1 0 3 i o 2 olloseium,ormlgG 1 anti-glycophonnA 
mlgGl dilution mAb (optimal Ε I ratio of 0 5) Results 
represent data from three individual 
experiments with cells from different 
donors SD were all smaller than 10% 
(40 ng/ml), Bleo (2 μg/ml), ra-DDP (2.5 ng/ml), 4-OHCY (2.7 ng/rnl), EdSm (2 μΜ), 
or 5-FU (63 μ|/πι1). Effect on FcyRIII expression was not evaluated, because this 
receptor was expressed at a negligible level on 40 h cultured monocytes (43). 
As shown in Figure 3, EdSm cultured monocytes were decreased in the expression 
of FcyRI (to 68.7 ± 13.7%), FcyRlI (to 40 6 ± 6.5%), and CD14 (68.7 + 10 2%). when 
compared with 40-h cultured control monocytes. On the other hand, EdSm treatment 
did not influence the expression of HLA-DR molecules Monocytes responded to 
4-OHCY with an increase in expression of CD14 molecules (to 145.1 ± 26.5%). Dox, 
Bleo, ш-DDP, and 5-FU did not influence the quantity of surface molecules expressed 
on short-term cultured monocytes. 
Effect of anticancer drugs on FcyR-mediated cytotoxicity by 40-h cultured 
human monocytes. Freshly isolated, and 40-h (anticancer drug) cultured monocytes 
were evaluated for cytotoxicity towards EA-hlgG and EA-mlgGl, using an optimal 
effector to target cell ratio 1.5 When uncultured monocytes were tested for FcyRl· 
mediated ADCC activity against optimally with hlgG sensitized E, cytotoxicity was 
52 ± 6%. However, when cultured for 40 h, either without drug (control), or with Dox 
(40 ng/ml), Bleo (2 Mg/ml), ш-DDP (2.5 Ц|/т1), 4-OHCY (2.7 μg/ml), EdSm (0.6 μΜ), 
or 5-FU (63 μg/ml), FcyRI-mediated ADCC activity never exceeded a 107r cytotoxicity 
level (not shown). 
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•DoxMOng/ml) 
• Bleo(2pg/ml) 
• asOOP(2 5pg/ml) 
• 4 0HW(2 7pg/nil) 
-Ε(ΐ5πι(06μΜ) 
y 5 FU (63 pg/ml) 
Relative expression figure 3. 
Effect of different onticancer drugs on 
40 h cultured monocyte surface antigen 
expression Monocytes were cultured for 
4 0 h in medium olone (control), or in 
medium supplemented with flie mdicat 
ed onticoncer drugs Expression of 
Fc-yRI Fc-yRII.CDRandHlADRwas 
evaluated by immunofluorescence stain­
ing with specific mAb Relative expres 
sion of the surface molecules was calcu­
lated as described in Matenak ond 
Methods Results represent mean ± SO 
from three experiments with cells from 
different donors 
• Control 
« Monocytes 
- DoxMOng/ml) 
o Bleo(2pg/ml) 
A f/sDDP(2 5pg/ml) 
- 4 0HCY(2 7pgi/nil) 
• EdSrn(0 6pM) 
л 5FU(63pg/ml) 
Cytotoxicity Figure 4. 
ADCC activity of short term anticancer 
drug cultured monocytes against mlgGl 
sensitized human E Freshly isolated 
monocytes, monocytes cultured for 
40 h in either medium alone (control), 
or medium supplemented with the indi­
cated onticancer drugs, were evaluated 
for cytotoxic ochvily ADCC tests were 
performed as described in Motemls ond 
Methods, using lorget E sensitized with 
variable omounts of mlgGl onti-glyco-
10 2 phonn A mAb (optimal Ε Τ ratio of 1 5 ) 
mlgGl dilution Results are mean doto from three individ­
ual experiments wild cells from different 
donors SD were all smaller than 8 % 
Monocyte FcyRII-mcdiatcd ADCC activity against optimally sensitized EA-mlgGl 
was reduced from 65 8 ± 5 1% to 41 7 ± 3 3 7c, as a consequence ol short-term culture 
in medium alone, and was further reduced to 9 7 ± 0 77г when со cultured with EdSm 
(Fig 4) 
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Monocytes cultured in the presence of Dox, Bleo, or 4 OHCY showed an almost simi­
lar lysis of target cells when compared with untreated 40 h cultured monocytes Cis-
DDP and S-FU treated effector populations were slightly affected in the FcyRII medi­
ated ADCC activity, by either an increase from 41 7 ± 3 3 % to 50 I ± 3 9 7c, or a 
decrease to 27 3 ± 2 1% cytotoxicity, respectively 
Table II. 
Analysis of TNF-a and IL-1 β production by short-, and long-term anticancer drug cultured 
monocytes 
(onlrol Dox Bleo os DDP 4 OHCY ÉdSrñ 5>U 
Donor (40ng/ml) (2ц/ml) _|25pg/ml) (2 7 д / т І ) (06\Щ_ (63 д / т ! ) 
THF a present m supernatant of 40 h cultured monocytef (ng/ml) 
A Ш 0 4 4 ^ 0 29 Ö3Ö~ <019 <(П9 <1lW~ 
В 024 <019 <019 020 <019 <019 <019 
С <019 <019 <019 <019 <019 <019 <019 
/Í Iß present m supernatant of 40 Л wltureá monocytes (ng/ml) 
A 017 
В 0 1 1 
С 0 1 4 
014 
011 
0 32 
013 
016 
<0 0B 
016 
011 
011 
THF a present m supernatant of 9 day cultured monocyte derived ι 
D 0 3 0 
E 0 4 2 
F 167 
6 0 93 
042 
042 
-
068 
027 
0 44 
-
0 80 
0 25 
0 48 
-
0 87 
<0 08 
012 
<0 08 
013 
on 
0 09 
nacrophage? (ng/ml) 
024 
041 
150 
-
0 28 
0 55 
175 
-
016 
014 
<0 08 
0 33 
0 36 
177 
-
IL I ß present m supernatant of 9 day cultured monocyte derived macrophages (ng/ml) 
D O i l 
E 019 
F 199 
G 0 53 
011 
021 
-
0 47 
008 
021 
-
0 39 
020 
022 
-
040 
014 
016 
175 
-
014 
0 32 
196 
-
009 
015 
191 
-
° Supematont wos obtained from monocytes (3 χ 10s/ml) cultured in suspension for 40 h with or without 
anticancer drug 
' Supernatant from monocytedenved macrophages was obtained by in suspension cultunng of monocytes 
(3 χ 10s/ml) for 9 doys in medium or medium supplemented with an anticancer drug for the lost 40 h of culture 
' Concentrations of IL Iß and JUF a in the supernatonts of cultured cells were measured by speak RIA 's, as 
described previously (39 4 Ì) 
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Effect of anticancer drugs on the production of I M β and TNF-a by cultured 
human monocytes. Production and secretion of IL-lß and TNF-a by monocytes and 
monocyte-denved macrophages is not constitutive but is induced by a variety of endog-
enous and exogenous stimuli Under appropriate conditions, it was possible to induce a 
profound IL Iß and TNF-α synthesis/release via stimulation with LPS (unpublished 
results) Monocytes were incubated in suspension for 40 h or 9 days, either in the 
absence, or presence of anticancer drugs, as described in Materials and Methods Com­
pared with the anticancer drug-free populations, neither Dox (40 ng/ml), Bleo (2 μg/ml), 
ш-DDP (2 5 μg/ml), 4 OHCY (monocytes 2 7 μg/ml, monocyte-denved macro­
phages 10 8 μg/ml), EdSm (0 6 μΜ) nor 5-FU (63 μg/ml) induced any IL-lß or TNF-a 
secretion by cultured monocytes at different stages of maturation, as detected in the 
various culture supernatanls by the specific RIA (Tabic II) 
Interactions of anticancer drugs with cells of the immune system, and the influence 
of such interactions on the fate of functional activities mediated by these cells, are of 
therapeutic significance Most of the anticancer drugs are generally considered to exert 
their effects through antiproliferative and cytotoxic actions Biochemical characteris-
tics of cytostatics are incontestablv determinative for their selectivity of action on only 
certain cell types, or on cells at only certain stages of development (21) As a part of 
our investigations on the influence of cytostatics in combination with biological 
response modifiers (e g , interleukms, interferons, colony-stimulating factors) on the 
mononuclear phagocyte system, we assessed in this study modulatory effects of anti-
cancer drugs on human blood monocytes, which represent a first-line defense against 
the spread of neoplastic cells (1) We studied the effects of major groups of anticancer 
drugs on monocyte differentiation at two stages of m vitro maturation, ι e . on 40-h, 
and 9-day cultured monocytes 
Monocytes cultured in utro under appropriate conditions differentiate into mature 
macrophages (10,44,45) Normally, when placed in culture in Teflon foil bags, a sub-
population of monocytes (11) loosely attach to the surface, and the majority of these 
cells flatten and spread out It is apparent that different cytostatics vary in their capaci­
ty to affect Teflon-allachment of monocytes during culture in vitro Adherence capaci­
ty of cells was affected more or less, by co-culture with ш-DDP, 4-OHCY, EdSm 
and 5-FU Effects varied from the loss off spreading and adhering capacities when 
short-term cultured Cell clumping was observed when long-term cultured monocyte-
denved macrophages were co-cultured with EdSm or 5-FL' Previously, we already 
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described the phenomenon of monoqte clumping during prolonged co-culture (9 days) 
with rIFN-γ (10) The selective enhancement of adhesion molecules by rIFN-γ turned 
out to be responsible for the induced homolypic monocyte adhesion Especially, the 
EdSm induced clumping of cells is difficult to explain by a putative increase in the 
expression of newly formed integnns, as this drug is a potent inhibitor of nbosomal 
protein synthesis 
Many anticancer drugs are known to suppress and/or augment the host defense system 
(21) Immunomodulation m vitro by chemotherapeutics may be dependent on the type 
of 'target' and immune function, variation in dose, time of administration, or nature 
(structure) of the drug The 'target' in use in this study is a highly versatile cell type 
In vivo, an active dose of anticancer drugs may either affect monocytes which have 
recently left the peripheral blood circulation, and reside since a short time in the tissues, 
and monocytes already differentiated into tissue macrophages Therefore, immuno-
modulalion was studied on phenotype and function of both short-, and long-term cul­
tured monocytes A slight augmentation of FcyRI and FcyRIII expression on 9-day cul­
tured cells was observed when co-cultured for the last 40 h with a suboptimal dose of 
Dox Previously, this drug has been described to augment the host defense system 
under suboptimal response conditions only (46) The mechanism of Dox is not fully 
understood, and it is not clear which of the multiple effects of Dox in target cells are 
responsible for immunomodulation or antitumor actions (22) C I Í - D D P and 4-OHCY 
were observed to reduce FcyRI and FcyRIII expression on 9 days cultured monocyte-
derived macrophages. In addition, the antimetabolite 5-FU reduced both the expression 
of FcyR and HLA-DR molecules However, ш-DDP, 4-OHCY, and 5-FU did not 
influence all these cell surface molecules, indicating those drugs did not cause a general 
non-specific reduction of receptor expression In contrast, EdSm caused a reduction in 
the amount of all measured cell surface molecules Most intriguing were the unchanged 
FcyR-mediated ADCC activities of the with anticancer drug cultured monocyte-derived 
macrophages These results suggest that lowered FcyR expression levels do not have to 
be reflected in a changing functional activity of the long-term cultured monocytes 
With respect to the effects of anticancer drugs on short term cultured (40 h) mono­
cytes, it is important to note that freshly isolated human monocytes express only FcyRI 
and FcyRII (6,43) It has been previously shown that, upon 40 h of culture, both FcyRI 
and FcyRII expression levels were decreased with 75% and 50%, respectively (37,43) 
The drop in the specific ADCC activity against EA-hlgG and EA-mlgGl was related 
with the observed changes in FcyR expression levels Expression of FcyRIII was still 
negligible The mechanism by which short-term culture reduced the expression of FcyR 
remains unclear up to now EdSm was the only of the tested drugs which could further 
decrease FcyRI expression An effect on the expression of FcyRII was observed when 
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short-term co-cultured with EdSm (a 60% decrease), and ш-DDP, 4-OHCY, or 5-FU 
(a 20% increase) In contrast to long-term cultured monocytes, effects of EdSm and 
ш-DDP on short-term cultured cells were paralleled by an equivalent alteration in 
FcyRII-mediated cytotoxicity Furthermore, in spite of a small increased FcyRII 
expression on 40 h cultured monocyte, со culture with 4-OHCY or 5-FU slightly 
decreased FcyRII mediated ADCC activity From the drugs tested, only CÍÍ-DDP could 
positively influence ADCC activity (Fig 4) Some authors showed already that ш-
DDP could stimulate spontaneous human monocyte-meduted cytotoxicity directly 
(12,47,48) No information is, however, available on the mechanism by which EdSm 
influences phenotypc and function of highly purified, and in \itro cultured monocytes 
Under the conditions described in this study, monocytes cultured in medium in­
duced neither IL Iß, nor INF-ot secretion This finding is of importance, because both 
IL-1 and TNF induce monocytes to produce colony-stimulating factors and other cyto-
kines (49). which in turn may interfere with the added anticancer drug 
In conclusion, the results indicate that ш \itro co-culture of monocytes or monocyte-
derived macrophages with anticancer drugs, to be used in cancer chemotherapy, can be 
heterogeneous for the effects on phenotype and function The observed influences can­
not always be explained by pharmacokinetic data With respect to FcyRll-mediated 
ADCC activity, it is of interest that short-term cultured freshly isolated monocytes, in 
contrast to mature monocyte-denved macrophages, may be sensitive to drug treatment 
1 Heppner GH and Fulton AM (eds). 1988 In: Macrophages and cancer Boca 
Raton, Florida. CRC Press Ine 
2 Van Schie RCAA, Verstraten HGG, van de Winkel JGJ, Tax WJM and de 
Mulder PHM. 1992 Effect of recombinant I FN y(rlFN y) on the mechanism of 
human macrophage IgG FcRI-mediated tuotoxiah rIFN ydecreases inhibition 
b\ ntophilic human IgG and chances the ntohtic mechanism J Immunol 48 169 
3 \dams DO and Hamilton T\. 1984 The cell biolog\ of macrophage activation 
Annu Rev Immunol 2 283 
4 Unkelcss JC, Scigliano E and Freedman VH. 1988 Structure and function of 
human and murine receptors for IgG Annu Rev Immunol 6 251 
5 Van de Winkel JGJ and Anderson CL. 1991 Biolog\ of human Immunoglobulin 
G Fe receptors J Leukocyte Biol 49 511 
6 Clarkson SB and Or> PA. 1988 CD16 De\elopmentall\ regulated IgG Fc recep­
tors on cultured human monocMes J Exp Med 167 408 
CHAPTER 7 
IN I I I [ M C E OF A N T I C A N C E R D R I K J S O K M U V A N V O N O C Y T T S 
7 Fanger MW, Shen L, Graziano RF and Guyre PM. 1989 C\toloxicil\ mediated 
b\ human Ft receptors for IgG Immunol Today 10 92 
8 Matsushita S, Muto M, Suemura M, Saito Y and Sasuzuki T. 1987 HLA-hnked 
nonrespoiunenew to Cryptomem japónica pollen antigen I Nonresponmeness is 
mediated b\ antigen-specific suppressor Τ cell J Immunol 138 109 
9 Wright SD, Ramos RA, Tobias PS, Ule\ itch RJ and Mathison JC. 1990 CD/4, 
a receptor for complexes ofhpopoh saccharide (LPS) and LPS binding protein 
Science 249 1411 
10 Van Schie RCA A, dc Mulder PHM, Verstraten HGG, van Rennes Η and 
Wagener DJTh. 1991 In vilro studies on the influence of doxorubicin in combina 
tum ніг/і recombinant interferon-gamma on human monocytes Anticancer Res 
11 1245 
11 Van Schie RCAA, de Mulder PHM, van Rennes Η, Verstraten HGG and 
Wagener DJTh. 1990 Lffetts of doxorubicin on the maturation process of human 
monocytes in adherent and non-adherent cultures Eur J Cancer 26'581 
12 Kleinerman ES, Zwelling LA and Muchmore AV. 1980 Enhancement ofnatu-
ralh occurring human spontaneous monoc\le-mediated c\totoxicit\ by cis-diam-
minedichloroplatmum (II) Cancer Res 40 3099 
11 Kleinerman ES, Zwelling LA, Schwartz R and Muchmore AV. 1982 Effect of 
l-phemlalanine mustard, Adriam\cin, actmomycin D, and4 -(Ç-acndimlamino) 
methanesulfon-m-amsidide on naturale occurring human spontaneous moiwc\te-
mediated c\totoxictt\ Cancer Res 42 1692 
14 Eppstein DA, van der Pas RA, Marsh YV, Bruno NA and Kurahara CG. 1988 
Enhanced antitumor efficac\ of adriam\cin m combination nith mterferon-f 
Effects on macrophages J Interferon Res 8 263 
15 Athlin L and Domeilof L. 1987 Response of human monocyte phagocytosis to 
FAM (fluorouraal, adriam\cin, mitomycin) Acta Chir Scand 153 279 
16 Kleinerman ES, Zwelling LA, Howser D, Barlock A, Young RC, Decker JM, 
Bull J and Muchmore AV. 1980 Defective monocyte killing in patients with 
malignancies and restoration of function during chemotherapy Lancet 2 1102 
17 Arinaga S, Akiyoshi Τ and Tsuji H. 1986 Augmentation of the generation of 
cell-mediated cytotoxicity after a single dose of Adnamyan m cancer patients 
Cancer Res 46 4213 
18 Nielsen H. 1984 Effect of c\s-platinum on human blood monocyte function in 
vitro Cancer Immunol Immunother 18 223 
19 Cesario TC, Slater LM, Kaplan HS, Gupta S and Corse GJ. 1984 Effect of 
antineoplastic agents on γ-interferon production in human peripheral blood mono­
nuclear cells Cancer Res 44 4962 
CHAPIER 7 
I N F I U С Ν ( t 0 е A K T I ^ A N C F R Ü R J C ^ O N H I ] V A N V О N О С Y ' Г S 
20 Mantovani Α. 1982 The interaction of cancer chemotherapy agents wth mononu­
clear phagotUes Adv Pharmacol Chemother 19 35 
21 Mihich E and Ehrke MJ. 1991 Immunomodulatwn b\ anticancei drugs In: 
DeVita VT, Hellman S and Rosenberg SA (eds) Biologic therap\ of tancer 
Philadelphia, J В Lippmott Company, ρ 776 
22 Speth PAJ, van Hoesel QGCM and Haanen С 1988 Clinical pharmacokinetics 
of doxorubicin Clin Pharmacokinet 15 15 
23 Lown JW and Sim S. 1977 The mechanism of the bleomycin induced cleavage of 
DNA Biochem Biophys Res Commun 77 1150 
24 Sausville EA, Peisach J and Horwitz SJ. 1976 A role for ferrous ion and ox\gen 
in the degradation of DNA b\ bleomycin Biochem Biophys Res Commun 73 184 
25 Pinto AL and Lippard SJ. 1985 Binding of the antitumor drug cis dtammine-
dichloroplatinum(ll) (asplatm) to DNA Biochem Biophys Acta 780 167 
26 Hill DL (ed) 1975 In: A reuen of cyclophosphamide Springfield, Thomas 
27 Pinedo HM and Peters GFJ. 1988 Fluorouracil Bwchemistn and pharma­
cology J Clin Oncol 6 1653 
28 Van den Broek LAGM, Lázaro E, Zylicz Ζ, Fennis PJ, Missler FAN, Lelieveld 
Ρ, Garzotto M, Wagener DJTh, Ballesta JPG and Ottenheijm HCJ. 1989 
Lipophilic analogues of sparsomytin as strong inhibitors of protein synthesis and 
tumor growth A structure-activity relationship stud) J Med Chcm 32 2002 
29 Goldberg IH and Mitsugi K. 1966 Sparsomycin, an inhibitor ofaminoacyl trans­
fer to polypeptide Biochem Biophys Res Commun 23 453 
30 De Mulder PHM, Wessels JMC, Rosenbrand DA, Smeulders JBJM, Wagener 
DJTh. and Haanen С 1981 Monocyte purification игЛ counterflow centnfu-
gation monitored b\ continuous flow cytometry J Immunol Methods 47 31 
31 Shah VO, McCarly DL and Weiner RS. 1984 Antibody dependent cell-mediated 
cytotoxicity of cryopreserved human monocytes Cryobiology 21 475 
32 Bennet ZL, Mitchel JR and Sheiner LB. 1990 Pharmacokinetics The dynamics 
of drug absorption, distribution, and elimination In: Goodman Gilman A, 
Goodman LS, Nies AS and Taylor Ρ (eds) The pharmacological basis of therapeu­
tics New York, Pergamon Press Ine, ρ 3 
33 Guyre PM, Graziano RF, Vance BA, Morganelli PM and Fanger MW. 1989 
Monoclonal antibodies that bind to distinct epitopes on FcyRl are able to trigger 
receptor function J Immunol 143 1650 
34 Rosenfeld SI, Looney RJ, Leddy JP, Phipps DC, Abraham GN and Anderson 
CL. 1985 Human platelet Fc receptor for immunoglobulin G Identification as a 
40,000-molecular- weight protein shared by monocytes J Clin Invest 76 2317 
CHAPTER 7 
I N F I L N C L O f Λ Ν Τ Ι Α Ν с l· ? D R U G S " I N ι и A M O N C r v T ' c 
35 Fleit HB, Wright SD and Unkeless JC. 1982 Human neutrophil Fe receptor dn 
tribution and чігисіиге Prot Natl Acad Sci USA 79 3275 
36 Bogman MJJT, Dooper IMM, van de Winkel JGJ, Tax WJM, Hoitsma AJ, 
Assmann KJM, Ruiter DJ and Koene RAP. 1989 Diagnosis of renal allograft 
rejection b\ тастрНаце ¡mmunostaimng with a CDI4 monoclonal antibod\, 
\VT14 Lancet 8657 235 
37 Van Schie RCAA, Verstraten HGG, Tax WJM, van den Berkmortel FWPJ, 
van de Winkel JGJ and de Mulder PHM. 1992 bffeci ofrlhN yon antibody-
mediated tMotoxicit\ \ia human monot\te IgG Ft receptor II (CDU) Scant! J 
Immunol 36 385 
38 Van de Winkel JGJ, Tax WJM, Groenevcld A, Tamboer WPM, de Mulder 
PHM and Capel PJA. 1988 А леи radiometric assa\ for the quantitation of sur­
face bound IgG on sensitized er\throc\tes J Immunol Mclhods 108 95 
39 Lisi PJ, Chu C-VV, Koch GA, Endrcs S, Lonnemann G and Dinarello CA. 
1987 De\elopment and use of a radiütmmunoasw\ for human niter/eukin-lß 
Lymphokmc Res 6 229 
40 Endres S, Ghorbani R, Lonnemann G, van der Meer JWM and Dinarello CA. 
1988 Measurement ofimmunoreactne interleukm Ι β from human mononuclear 
cells optimization of recoven, mtrauibject consistenti and comparison with 
interleukm la and tumor necrosis factor Clin Immunol Immunopath 49 424 
41 Van der Meer JWM, Endres S, Lonnemann G, Cannon JG, Ikejima T, 
Okusawa S, Gelfand JA and Dinarello CA. 1988 Contentiations ofimmunore-
active human tumor necrosis factor alpha produced b\ human mononuclear tells 
in vitro J Leukocyte Biol 43 216 
42 Van de Winkel JGJ, Booncn GJJC, Janssen PLW, Vlug A, Hogg N and 
Tax WJM. 1989 Activih of two t\ pes of Ft receptors, FcyRl and FcyRll, in 
human monocyte c\totoxicit\ to sensitized entthrontes Scand J Immunol 29 23 
43 Van Schie RCAA, Verstraten HGG, Pennings A and de Mulder PHM. 1992 
Modulation b\ cMokmes ofphenonpe and FtyR mediated t\totoxicit\ of in vitro 
cultured human monoc\tes Submitted for publication 
44 De Mulder PHM, van Rennes Η, Mier PD, Bergers ME, de Pauw BE and 
Haanen С 1983 Characterization ofmonot\te maturation in adherent and non­
adherent cultures and its application to stud\ monocyte differentiation in 
Hodgkin's disease Clin Exp Immunol 54 681 
45 Dougherty GJ and McBride WH. 1989 Mononte differentiation in vitro In: 
Zembala M and Asherson GL (eds) Human monocytes London, Acad Press Ltd. ρ 49 
46 Ehrke MJ, Cohen SA and Mihich E. 1982 Selectn e effects ofAdnanncm on 
murine host defence s\stems Immunol Rev 65 54 
CHAPTÍR 7 
Ι Ν Γ I l ( - \ C О Г Л М П С / Ч ^ R R U G ^ C K H L V A K V O N C ^ Y T l l 
47 Kleinerman ES and Zwelling LA. 1984 Effects ofmplatm, bleoimun and DTIC 
on immune function in vitro and in \i\o In: Mitchell MS and Fahey JL (eds) 
Clinic s in Immunolog\ andAllerg\, Vol 4, No 2, Immune Suppression and 
Modulation London, Saunders, ρ 279 
48 Collins JL and KaoM-S. 1989 The anticancer drug, asplatin increases the 
naturalh ouurrmg cell-mediated hsis of tumor cells Cancer Immunol 
Immunother 29 17 
49 DinarelloCA. 1991 Interleukin-1 andInterleukm-l antagonism Blood77 1627 
CHAPTER 7 
GENERAL DISCUSSION 
concluding remarks and recommendations 
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CHAPTER 8 
G F N l R \ l D s C J S s ^ N 
The studies presented in this thesis describe several new aspects of the m \itro 
modulation by cytokines and anticancer drugs of human peripheral blood monocucs at 
various stages in the differentiation to mature macrophages (i e , monocyte-derived 
macrophages) Monocytes and their immature and mature counterparts have been iden 
tified to be potent effectors of natural and specific immune responses against tumors 
(1-5) The earliest step in the specific destruction of neoplastically transformed cells 
may occur under the condition that monocytes/macrophages selectively recognize 
tumor cells either directly via a tumongenic phcnolype (5,6) or indirectly via opso­
nized immunoglobulin (Ig) Specific sensitization vuth antitumor antibodies causes 
neoplastic cells to become susceptible to antibody dependent cell-mediated cytotoxicity 
(ADCC) (7) It is noteworthy that the specificity of the ADCC event will be determined 
in the first place by the antigen binding site of the antibody Secondly, the heavy-chain 
isotype of a specific antitumor antibody is defining the Fc receptor that will be cross-
linked and initiated for its mode of action Three closely related classes of human 
receptors for the Fc moiety of IgG (FcyR) have been defined, FcyRI, FcyRII and FcyRIII, 
each of which is able to mediate ADCC (8,9) 
A part of these studies focused on the monocyte/macrophage FcyRI- and FcyRII-
mediated ADCC activity, with special curiosity about the mechanism of cytolysis 
Macrophagc-mediated ADCC activity, measured by the release of ^ Cr, is the end result 
of both extracellular lysis and phagocytosis (10,11) In chapter 2, a new and highly intri­
guing phenomenon of monocyte/macrophage mediated ADCC was described, which 
suggests the heterogeneity of monocyte populations with respect to cytotoxicity due to 
maturation and activation While freshly isolated monocytes mediated both extracellu­
lar lysis and phagocytosis, those maintained for 9 days in basal medium resulted in a 
population which exhibited phagocytosis, with only marginal extracellular lysis Short 
term (40 h) activation of monocyte-denved macrophages at day 7 of culture with 
recombinant interferon (IFN)-y reversed this, yielding a population which mediated 
both phagocytosis and extracellular lysis However culture with IFN γ for a longer 
period (9 days) resulted in a population which displayed extracellular lysis In addition, 
cytospin preparations indicated that, although the population of monocyte-derived 
macrophages exhibits phagocytosis, almost half the cells do not participate This could 
not be explained by mixed culture or loss of viability since cell fractions were over 
95% pure and more than 98% viable Moreover both freshly isolated monocytes and 
those exposed for a short time to IFN-y mediated both extracellular lysis and phago­
cytosis Whether or not these activities involve the same cells or different cells requires 
further investigation Another striking feature of FcyRI w as observed w hen cither mono­
cytes, or their derived macrophages were cultured in the presence of IFN γ (chapter 2) 
The results clearly showed that IFN-y is able to reverse the inhibitory effects ol mono-
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mene human (h)IgG on FcyRI-mediated ADCC In mo. IgG-mediated effector responses 
occur in an environment with excess hlgG, and since FcyRl is the only class of FcyR 
with high affinit) for monomenc hlgG. this receptor will be continuously saturated 
with serum IgG (12) Indeed FcyRI may have an important physiological role since 
inhibition by monomenc IgG is overcome after culture with IFN-γ It is therefore pos­
sible that the responses of both circulating monocytes and resting tissue macrophages 
which are executed via FcyRl will be hindered by high amounts of hlgG Thus, mono­
cytes/macrophages appear initially 'restrained' from attacking every opsonized anti­
genic particle, cell or microorganism However, at any site of inflammation or tumor, 
T-lymphocytcs might produce a number of polypeptides (e g , IFN-γ), which induce 
activation of the relatively dormant tissue macrophages (13) After prolonged stimula­
tion by IFN γ, the IgG inhibition can be counteracted most probably by increasing the 
density of FcyRI on the surface, and the cytolytic mechanism will be also subject to 
alteration Consequently, macrophages may become very efficient 'killers' of neoplas-
tically transformed cells, because extracellular lysis has no longer to be combined with 
the slower process of phagocytosis 
Until now, it was generally accepted that IFN-γ could potentiate FcγRII-medlatcd 
cytotoxicity, without altering receptor levels (14) However, this phenomenon appears 
to be related to their age and the length of time cells were exposed to IFN-γ (chapter 3) 
Compared to freshly isolated monoqtes, short-term (40 h) cultured cells exhibit a sig­
nificantly lower FcγRll expression, and a reduced ADCC activity However, co-culture 
with IFN-γ (40 h) completely reverses this decrease in both receptor level expression 
and FcγRΠ-mcdιated cytotoxicity When analyzing the mechanism of cytolysis medi­
ated via FcγRII, it was observed that uncultured monocytes, and those cultured for 40 h 
either in the absence or presence of IFN-γ exhibited a comparable phagocytic capacity 
(chapter 3, Table 2) Therefore the impaired ADCC activity in short-term control cul­
tured cells may be due to a decrease in extracellular lysis Remarkably, in contrast to 
the effect of IFN-γοη the FcγRI expression level (chapter 2), the cytokine only prevented 
a decrease in the number of receptors expressed on monocytes when cultured for a short 
time Since FcγRII expression on monocyte-denved macrophages is less amenable to 
modulation by IFN-γ, an immunologically active dose of this cytokine might induce 
alterations in FcγRII expression and function, especially on monocytes which have 
recently entered the tissue before becoming full-grown macrophages 
An obvious inference from these observations is that further investigation of the 
initial signals transmitted to the cell via these FcγR is necessary Moreover, it is im­
perative to clarify the molecular biology by employing cDNA probes to examine the 
modulation of FcγRI and FcγRII mRNA by physiologic and pharmacologic signals 
(e g , IFN-γ, anticancer drugs) Recently such probes encoding for FcγRI (15), ^cγRII (16) 
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and FcyRIII (17) have been isolated and cloned Time course experiments using inhibi­
tors of protein synthesis, together with Northern blot analysis and flow cytometry 
might help elucidate the kinetics of receptor level regulation However, as monocytes 
and (monocyte-denved) macrophages are heterogeneous with respect to phenotype and 
function (18-20, chapter 2,4), it is crucial to evaluate the modulation of both mono­
cyte/macrophage mRNA and protein transcripts at the single cell level Hybndohisto-
chcmistry (i e, RNA ш situ hybridization) combined with immunohistochemistry may 
offer more refined information and will be complement the examination of single cells 
for both the expression of mRNA and protein transcripts on the cell surface (21.22) 
Doxorubicin was investigated in chapter 4 to assess its influence on the maturation 
and differentiation of monocytes Initially, we wondered whether or not non-dividing 
monocytes/macrophages really had the capability to escape cell death after they had 
been treated, since uptake of doxorubicin appears to be cell-cycle dependent Mono­
cytes were cultured by adherence to plastic flat-bottomed tubes and in suspension using 
Teflon foil bags Two different non-toxic incubation schedules were employed to 
mimic both continuous and bolus infusion reflecting the current dosages and schedules 
used clinically However, the optimal schedule with respect to tumor cytotoxicity and 
dose-limiting side effects has never been investigated in a prospective, randomized 
manner (23) The capacity to adhere, the yield and enzyme activities that reflect growth 
and intermediary metabolism were similar under all conditions However the number 
of adherent monocytes increased proportionally with duration of culture (chapter 4) 
This phenomenon corroborates the concept that the monocyte/macrophage lineage is a 
heterogeneous population (19), and that functional heterogeneity is, to a large extent, a 
reflection of their state of differentiation (24,25) For this reason it is important to 
ascertain that a cell population, isolated by adherence (26), represents only a selection 
or subpopulation of the monocyte/macrophage lineage Isolation by counterflow centn-
fugation is ideally suited to this task since selection is minimal (27) 
The effects of cytokines and anticancer drugs on the immune system must be known 
before combining in a clinical setting IFN-γ appears to be the major cytokine that acti­
vates monocytes (28,29, chapter 2,3), and doxorubicin has a very broad antitumor spec­
trum, compared with other anticancer drugs (23) The modulation induced by doxo­
rubicin on the activation of human monocytes provoked by IFN-γ was the subject of 
investigation in chapter 5 which focused on putative alterations in the cellular mor­
phology, intracellular enzyme activities, FcyR expression, and cytotoxicity The results 
indicated that neither the control populations, nor the IFN-γ activated monocyte-denved 
macrophages were significantly influenced by either short- or long-term exposure to 
doxorubicin On the contrary, IFN-γ appeared responsible for the extraordinary altera­
tions in morphology (e g, smaller cell size, flattened lobed and more juxta membranal 
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located nucleus, homotypic monocyte clumping) as well as a significant decrease in most 
enzyme levels This gave a clear indication that the combined approach did not negative­
ly influence the activation of the monocyte/matrophage population induced by IFN-γ 
A common characteristic of monocytes/macrophages is that these cells need to be 
appropriately activated to optimally fulfil their function (30) Monocytes and macro­
phages can be activated both ш m o and in utro by various biological response modifiers 
(BRM) (31,42) The BRM used in the study described in chapter 6, seem to be involved 
in regulating the functional state of the cells The effects observed varied with the type 
of cytokine and depended upon the stage of maturation of the human monocytes Culture 
for 9 days showed that changes in Fc/RI and FcvRIl expression levels were not related 
per se to FcyR-mediatcd functional activities The most obvious explanation for this 
phenomenon must be the initiation of additional changes in mechanisms which are 
independent of the number of FcyR which was thought responsible for tunclion Study­
ing short-term cultured (40 h) monocytes initially demonstrated that the FcyRII expres­
sion level is decreased as a consequence of culture This was reversed either complete­
ly by culturmg monocytes with IFN-γ (see also chapter 3) and GM CSF. or partially, 
when cultured in the presence of TNF-ct However, in contrast to the culture with IFN-γ, 
GM-CSF and TNF-ct did not restore ADCC activity The mechanism by which cyto­
kines affect FcγR expression remain unclear 
Chapter 7 dealt with the immunomodulatory effects induced by anticancer drugs on 
human monocytes cultured in utro. using a design framework similar to that presented 
in chapter 6 The results suggested that the drugs used for cancer treatment might specifi­
cally affect the morphology, phenotype, and function of monocytes cultured m vitro 
The effects depended mainly on the class and dose of the drugs but the stage of monocyte 
differentiation seemed also to play a principal part, since (functional) immunomodulation 
occurred mainly in short-term cultured monocytes Furthermore, immunomodulation is 
unlikely to be elicited optimally using anticancer drugs at concentrations close to the 
maximal tolerated dose since this will invariably result in cell death Remarkably, elhyl-
deshydroxysparsomycm (EdSm) (33,34) was the only experimental anticancer drug to 
cause homotypic cell adhesion (clumping) and a profound decrease in the number of 
FcγR ADCC activity of the short term cultured monocytes was impaired and there was 
downregulation of the cell surface expression of CD 14 This drug may prove valuable as 
an inhibitor of protein synthesis for investigating the biology of the monocyte/macrophage 
Clearly, much remains to be done and many more questions have been raised than 
could be answered Nevertheless, it is hoped that the work presented here will form the 
basis of a continuing program of research which will make a valuable contribution to 
both our knowledge and understanding of the biology ot the immune response to can­
cer and the ability to improve its treatment 
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SUMMARY 
Stimulation of the immune system by means of biological response modifiers (BRM) 
or cytokines is becoming increasingly important in the treatment of metastatic cancers 
In spite of this, complete remissions remain limited, and are related to the tumor load Dur­
ing the past few years expérimental therapy of different types of cancer, however, improved 
by combining immunotherapy with conventional chemotherapy As a consequence the qucs 
Hon was raised, whether or not chemotherapeutic drugs could detrimentally affect the 
human immune system This system depends on the participation of a large number of 
highly specialized white blood cells in both peripheral blood and tissues such as lympho 
cytes, granulocytes, natural killer cells, monocytes, and macrophages Cells of the mono 
cytc/macrophage lineage play a central role in both the afferent and efferent arms of the 
immune system A role of importance in the body's defense against neoplasms was pos-
tulated Monocytes/macrophages may destroy tumor cells upon establishment of cell-cell 
contact Binding occurs either via selective recognition of tumongenic antigens, or via 
receptors that bind immunoglobulins present on target cells For this purpose, human 
monocytes and macrophages possess three classes of receptors for the he moiety of IgG 
(FcyRI, II. and III) which specifically bind the Fc part of IgG antibodies The latter 
mechanism may be followed up by cytolysis, known as antibody-dependent cell mediated 
cytotoxicity (ADCC), and was selected for further investigations The purpose of this 
thesis was to study the ш vitro effects of cytokines and anticancer drugs on human periph­
eral blood monocytes, at various stages in the differentiation to mature macrophages 
The background to the studies is presented in Chapter 1 (General Introduction) 
Human peripheral blood monocytes originate in the bone marrow, and become mature 
macrophages upon migration into extravascular tissues and body cavities In this thesis 
monocyte cultures were used as a model system to study macrophage development, as 
monocytes differentiated in vitro largely resemble tissue macrophages Large numbers 
of monocytes were isolated from peripheral blood by counterflow centnfugation, and 
consecutively cultured in Teflon bags Due to both the isolation procedure, and the 
hydrophobicity of the culture system, it was possible to establish suspension cultures 
with over 95% pure cells which were easily recoverable at different differentiation 
stages Upon harvesting the monocyte-denved macrophages were of excellent quality, 
with a viability higher than 98% Although the precise signals responsible for initiation 
of monocyte maturation in vitro remain largely unknown, preliminary examinations 
showed that best results were obtained using a culture medium supplemented with 5-10% 
heat-inactivated (pooled) human serum Cytotoxic activity of both monocytes and 
in vitro differentiated macrophages were tested in 5lCr-release assays in which anti­
body-coated human erythrocytes served as targets 
The study described in Chapter 2 focused on macrophage FcyRI-mcdiated ADCC 
activity, cultured in the absence or presence of low doses human (h)IgG It is well 
known that the in vivo IgG-mediated effector responses occur in an environment with 
excess hlgG, and since FcyRl is the solely class of FcyR with high-affiniiy for mono-
meric hlgG, this receptor may be continuously saturated with serum IgG However, a 
striking observation was made forFcyRI when monocytes, or macrophages were cul­
tured in the presence of the cytokine IFN-γ The experiments showed that prolonged 
stimulation by IFN-γ, both enhanced the cell surface density of FcγRI, and reversed the 
inhibitory effects of monomenc hlgG on FcγRI-mcdIated ADCC In addition, the 
mechanism of monocyte/macrophage FcγRI-medιated cytotoxicity was analyzed. 
Freshly isolated monocytes were found to mediate both extracellular lysis and phago­
cytosis, while cells maintained for 9 days in culture medium exhibited predominantly 
phagocytosis, and only a marginal level of extracellular lysis Short-term (40 h) activa­
tion of monocyte-denved macrophages at day 7 of culture with IFN-γ reversed this 
mechanism of cytotoxicity, and resulted in cells which mediated both phagocytosis. 
and extracellular lysis Prolonged stimulation with IFN-γ for 9 days resulted in a cell 
population which displayed predominantly extracellular lysis In conclusion, the results 
showed macrophages to become quite efficient in FcγRI-mcdlated cytotoxicity upon 
culture with IFN-γ 
In Chapter 3. effects were studied of IFN-γ on monocyte/macrophage FcγRII 
expression levels and ADCC Furthermore, the study focused on specific effects of this 
cytokine at various stages of differentiation (i e , freshly isolated monocytes, and those 
cultured for 40 h and 9 days) The effects on FcγRII expression levels and ADCC activ­
ity induced by IFN-γ were found to be less striking, than those on FcγRI In addition, 
the shift in the mechanism of cytolysis observed for FcyRI did not occur for FcγRII 
Compared with freshly isolated monocytes, short-term (40 h) cultured cells exhibited a 
significantly lower ^cγRII expression, and reduced ADCC activity However, co-cul­
ture with IFN-γ (40 h) completely rev erscd the decrease of receptor expression levels, 
and FcγRII-medlated cytotoxicity The impaired ADCC activity in short-term control 
cultured cells was found to be entirely associated with decreased FcγRII-medlated extra­
cellular lysis Two allotypic variants of FcγRIIa were recognized with respect to their 
ability to bind murine IgGl complexes Cells from different donors bound these com­
plexes either strongly [high-responders (FcyRIIaHR)] or weakly [low-responders 
(FcγRIIa"t)]. For both allotypic forms similar results were observed In conclusion, 
IFN-γ may affect FcγRII expression and function of monocytes which have recently 
entered the tissue before becoming full-grown macrophages. 
In Chapter 4 the effect was evaluated of doxorubicin as a prototypic anticancer 
drug on maturation and differentiation of monocytes In the first studies it was verified 
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whether the (non-dividing) monocytes/macrophages were escaping cell death upon cul­
ture with doxorubicin Monocytes were cultured by adherence to plastic tubes, and in 
suspension using Teflon bags Two different incubation schedules were used to mimic 
continuous, and bolus intusion, reflecting the dosages and schedules currently used in 
the clinic The adherence capacity, yield, and enzyme activities that reflect growth and 
intermediary metabolism were found similar under all conditions evaluated Remarka­
bly, independently of doxorubicin, the number of adherent monocytes increased pro­
portionally with duration of culture 
The above studies (Chapters 2 to 4) sen ed to characterize our monocyte culture 
system, and provided a rationale for further investigations (Chapters 5 to 7) to evaluate 
the extent cytokines and anticancer drugs affect phenotypic and functional characteris­
tics of monocytes at various stages of maturation in vitro 
The effects of cytokines and anticancer drugs on the immune system need to be 
known before combining them in a clinical setting As IFN-γ appears to be the major 
monocyte activating cytokine, and doxorubicin possesses a wide spectrum of antitumor 
activity (compared with other anticancer drugs), the combination of these two com­
pounds was assessed in Chapter 5 The data on cellular morphology, intracellular 
enzyme activities, Fc/R expression, and cytotoxicity indicated that neither the control 
populations, nor the IFN-γ activated monocyte-derived macrophages were significantly 
affected by exposure to doxorubicin However, culture with IFN-γ resulted in some 
extraordinary alterations in morphology (e g , a smaller cell size, a flattened and more 
juxta membranally located nucleus, homotypic monocyte clumping), and significant 
decreases in most enzyme levels These results provided a clear indication that in the 
combined approach, doxorubicin did not negatively affect the effects of IFN-γ on the 
monocyte/macrophage population 
Monocytes/macrophages require activation for optimal functioning Chapter 6 
deals with the modulation by cytokines, such as IFN-γ, tumor necrosis factor (TNF)-a, 
interleukin (IL)-4, macrophage colony stimulating factor (M-CSF), granulocyte-macro­
phage (GM) CSF, and IL-2 Co-culture resulted in both strong and minimal effects on 
expression of cell surface antigens Specific modulation vaned with the type of cytokine 
used, and depended upon the stage of maturation of monocytes The most profound 
effects on either phenotype and functional activities were induced by co-culture of 
cells with IFN-γ and IL-4 Changes in FcγRI and FcγRII expression levels were not 
always found to be reflected in FcγR-medlatcd ADCC When monocytes were cultured 
for 40 h, FcγRII expression levels decreased dramatically This reduction reversed ei­
ther completely by cultunng monocytes with IFN-γ and GM-CSF, or partially, when 
cultured in the presence of TNF-a However, in contrast to the cells cultured with IFN-γ, 
both GM-CSF- and TNF-a cultured monocytes did not exhibit a restored ADCC 
In the past, anticancer drugs were thought to exert their effects through antiprohf 
erative and cytotoxic actions Nowadays, it has become apparent that they can induce 
both immunosuppression, and relatively specific immunoaugmenlalion Chapter 7 
deals with the immunomodulatory effects induced by various classes of cytostatics, 
such as antibiotics, alkylating agents, antimetabolites, and protein synthesis inhibitors, 
on in vitro cultured human monocytes A similar design as that presented in Chapter 6 
was used The results show that effects of chemotherapeutic agents on monocyte mor-
phology, phenotype, and function, to be dependent on the class of drugs, and the stage 
of monocyte differentiation Most obvious was the detrimental effect induced by the 
protein synthesis inhibitor ethyldeshydroxysparsomycm (EdSm) on FcyRlI-mediated 
cytotoxicity of 40 h cultured monocytes 
In Chapter 8 a general discussion is presented, including recommendations for 
further research on analyzing specific effects of cytokines and anticancer drugs on in 
vitro cultured human monocytes 
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De behandeling van kankerpatiënten waarbij de primaire (oorspronkelijke) tumor 
reeds is gemetastaseerd (uitgezaaid) baart de behandelende medici veel zorgen Op het 
moment dat een tumor wordt gediagnostiseerd, is bij een groot aantal patiënten al sprake 
van dergelijke metastasen Terwijl een primaire tumor meestal nog via chirurgie ver 
wijderd, of door middel van radiotherapie bestreden, kan worden, is het gewoonlijk 
uiterst moeilijk eenzelfde therapie toe te passen op metastasen omdat deze op verschil-
lende en soms lastig bereikbare plaatsen terechtkomen De belangrijkste vorm van 
behandeling van patiënten met uitgezaaide tumoren is chemotherapie, waarbij ze een of 
meerdere keren behandeld worden met één of meerdere cytostatica (stoffen die remmend 
werken op snel delende tumorcellen) Helaas worden hierbij vaak lang niet alle tumor-
cellen gedood Veel factoren spelen hierbij een rol. zoals het ontwikkelen van resisten-
tie legen de gebruikte cytostatica 
Onder andere hierom wordt op dit moment de rol van immunothérapie, ofwel sti-
mulatie van het immuunsysteem (afweersysteem) door middel van i\tokinen uitgebreid 
onderzocht bij patiënten met kanker Cytokinen zijn eiwitten die door lichaamscellen 
worden geproduceerd om de onderlinge communicatie en stimulatie van witte bloed 
cellen te verzorgen die betrokken zijn bij het afweer van het lichaam tegen infecties en 
mogelijk ook tegen tumorcellen Deze eiwitten kunnen tegenwoordig ook in het labora-
torium geproduceerd worden via de recombinant DNA technologie Hierdoor 7ijn ze nu 
in zuivere vorm en grote hoeveelheden beschikbaar gekomen voor zowel klinische toe-
passingen, als voor onderzocksdoeleinden Cytokinen worden meer recent ook gebruikt 
in combinatie met, of voorafgaand aan chemotherapie De toepassing van deze behan-
delingswijze roept echter de vraag op, in hoeverre de gebruikte cytostatica nadelige 
effecten hebben op de goede werking van het immuunsysteem Binnen het immuunsys-
teem bevinden zich een grool aantal witte bloedcellen zoals lymfocyten, granulocyten, 
'natura! killer' cellen, monocyten en macrofagen. die ieder een eigen rol vervullen bij 
de afweerreacties De monocyten en macrofagen behoren tot een type van afweercellen 
dat op veel fronten actief is (Hoofdstuk 1) De meest algemeen bekende activiteit van 
deze cellen is het opruimen van 'afval' Daarnaast wordt verondersteld dat ze een 
belangrijke rol spelen bij de vernietiging van tumorcellen Om een kankercel onschade-
lijk te kunnen maken, moet er eerst een cel-cel contact tot stand komen tussen de 
monocyt of macrofaag en de te vernietigen doelcel De binding kan ontstaan, enerzijds 
via een selectieve herkenning van een antigeen dat specifiek voorkomt op de tumorcel. 
anderzijds via receptoren die binden met Immunoglobulinen (Ig), welke aanwezig kun 
nen zijn op de doelcel Voor dit doeleinde beschikken monocyten en macrofagen over 
drie klassen van receptoren voor het Fe deel van IgG (FC7RI, FcyRII en FcyRIII) 
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De laatstgenoemde binding kan I)sis (uiteenvallen) van de doelcel tot gevolg hebben 
Aan dit proces van antilichaam afhankelijke celdoding (ADCC) werd in dit onderzoek 
uitgebreid aandacht besteed (voor begeleidende illustratie zie blz 11) Het doel van dit 
proefschrift was het bestuderen van de effecten die cytokincn en cytostatica kunnen 
veroorzaken op de functies van humane (van de mens afkomstige) monocyten uit het 
perifere bloed Daarbij was er speciale belangstelling voor de verschillende stadia bij 
de ontwikkeling van monocyt tot macrofaag 
De perilcrc bloed monocyten vinden hun oorsprong in het beenmerg Nadat ze hun 
weg gevonden hebben naar de diverse weefsels en organen van hel lichaam, groeien ze 
uit tot macrofagen In deze studies werd de celkweek als modelsysteem gebruikt, om 
deze ontwikkeling te bestuderen Dit is verantwoord omdat de ontwikkeling van mono 
cyt tot macrofaag in een kweeksysteem veel gelijkenis vertoont met de ontwikkeling, 
zoals die zich in de weefsels van het menselijk lichaam afspeelt Uil het perifere bloed 
van gezonde vrijwilligers werden, door middel van tcgenstroomccntnfugatie grote 
aantallen monocyten geïsoleerd, die vervolgens gekweekt werden in Teflon zakjes 
Dankzij de gebruikte scheidingstechniek en het hydrofobe karakter van het Teflon was 
het mogelijk om 95% zuivere monocytenpopulaties in suspensie (zwevend) te kweken 
die, op elk gewenst moment van ontwikkeling, op eenvoudige wijze ie oogsten waren 
De zo verkregen macrofagen waren na het oogsten van uitstekende kwaliteit, met een 
levensvatbaarheid van 98% 
Tot op heden is het nog steeds onduidelijk welke signalen in de monocytenkweek 
verantwoordelijk zijn voor de ontwikkeling tot macrofagen Inleidende studies wezen 
uit dat de beste resultaten werden verkregen door gebruik te maken van een kweekme-
dium waaraan 5 tot 10% humaan serum was toegevoegd 
Het celdodend vermogen van zowel monocyten als van de in kweek ontwikkelde 
macrofagen, werd bepaald in een ADCC test waarbij met IgG antilichamen bedekte 
humane rode bloedcellen als doelcel fungeerden 
In de studie, die beschreven staat in Hoofdstuk 2, werden macrofagen onderzocht 
op de via FcyRI verlopende ADCC activiteit De testen werden uitgevoerd in zowel 
afwezigheid als aanwezigheid van een lage dosis IgG, afkomstig uit humaan serum 
Hel is een algemeen bekend gege\en dat humaan IgG, in feite de antilichamen, in hoge 
concentraties aanwezig is in het bloed en de weefselvloeistoffen Omdat FcyRI de enige 
klasse van FcyR is met een hoge affiniteit voor humane IgG moleculen, zal deze receptor 
hiermee voortdurend verzadigd zijn Het gevolg van deze verzadiging is dat de via FcyRI 
verlopende ADCC-activiteit altijd geblokkeerd zal zijn, eenvoudigweg omdat de bindings 
plaatsen voor IgG bezet worden gehouden Een opvallende waarneming werd gedaan 
met betrekking tot FcyRI nadat monocyten gekweekt waren in de aanwezigheid van 
het cytokine interferon (IFN) γ De experimenten lieten duidelijk zien dat, als gevolg 
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van een langdurige stimulatie met IFN-γ, zowel hel aantal FcyRI sterk toenam en te\ens 
de remming van de ADCC-activiteit was \erdwenen Bovendien werd het mechanisme 
bestudeerd waarmee FcyRI de rode bloedcellen kan Ijseren Vers geïsoleerde monocy 
ten bleken deze doelcellcn zowel uitwendig (extracellulaire lysis), als inwendig (fago-
cytose) te kunnen lyscren, terwijl de gedurende 9 dagen gekweekte monocy ten \oorna 
meiijk bleken te fagocyteren Indien op de Τ dag van een kweek alsnog gedurende 40 
uur IFN-γ werd toegevoegd, dan leverde dit een populatie van macrofagen op die, merk­
waardig genoeg, weer in staat was tot de beide vormen van lysis De monocytenkweek 
met IFN-γ, gedurende de totale kweekpenode van 9 dagen resulteerde in een celpopu 
latie die bijna alleen nog maar in staal bleek tot exlracellulaire lysis De resultaten laten 
zien dat, na stimulatie met IFN-γ, de macrofagen uiterst efficiente celdoders werden 
In Hoofdstuk 3 werden de effecten van IFN γ bestudeerd op het expressie nncau 
en ADCC van FcyRM Dit onderzoek was met name gericht op verschillende ontwikke­
lingsstadia van de monocyten (vers geïsoleerde, 40 uur en 9 dagen gekweekte cellen) 
De effecten van IFN-γ, op de expressie en ADCC van ΡιγΚΙΙ waren minder uitgespro­
ken dan die op FcγRI Bovendien, een verandering in het mechanisme van cytolysis 
zoals die werd waargenomen voor FcγRI vond niet plaats voor FcγRII In vergelijking 
met de vers geïsoleerde monocyten was, bij de gedurende 40 uur gekweekte monocyten, 
de hoeveelheid FcγRII en de ADCC gehalveerd Echter, indien IFN-γ constant aanwezig 
was tijdens de kweekpenode van 40 uur, dan werd de verlaging \an zowel het receptor 
aantal als van de ADCC helemaal tenietgedaan De verminderde celdodingscapaciteit 
van de 40 uur gekweekte monocyten bleek uiteindelijk gekoppeld te zijn aan een verla­
ging van de extracellulaire lysis Omdat er geen effecten van IFN γ op het aantal 
FcγRII en ADCC werden waargenomen bij de 9 dagen gekweekte macrofagen, zou 
geconcludeerd kunnen worden dat er m het menselijk lichaam alleen veranderingen 
plaatsvinden bij perifere bloed monocyten en cellen die kort daarvoor gestart zijn met 
de ontwikkeling tot volwassen macrofagen 
In Hoofdstuk 4 werden de effecten geëvalueerd die het cytostaticum doxorubicine 
had op de ontwikkeling van monocyten In eerste instantie werd aan de hand van een 
monocytenkweek bekeken of deze cellen in staal waren om zich aan de eeldodende 
werking van doxorubicine te onttrekken Monocyten werden zowel in plastic buisjes 
(hechtend), als in Teflon zakjes (in suspensie) gekweekt Bij de experimenten met 
doxorubicine werd er naar gestreefd om, zowel met de dosis, als de toedieningswijze, 
een klinische situatie na te bootsen De hechtingscapaciteit van monocyten/macrofagen 
aan plastic, de cel opbrengst na kweken en de enzymactiviteiten die een afspiegeling 
vormen van zowel de groei als het metabolisme, bleken onder alle omstandigheden 
gelijk te zijn Wel is het opmerkelijk dat, los \an de behandeling met doxorubicine. het 
aantal adhérente monocyten toenam naarmate er langer gekweekt werd 
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De hiervoor beschreven studies (Hoofdstukken 2 t/m 4) zijn een karakterisering 
van het gebruikte kwccksysteem Ze vormden de uiteindelijke basis voor een verdere 
evaluatie (Hoofdstukken 5 t/m 7) van de mate waarin fenotype en functionele karakte­
ristieken van monocyten, in verschillende stadia van de ontwikkeling tot macrofagen, 
beïnvloed kunnen worden door zowel cytokinen als cytostatica 
Het is van belang dat de effecten die cytokinen en cytostatica op het immuunsys-
teem kunnen uitoefenen bekend zijn, ahorens ze in combinatie met elkaar toe te pas-
sen Omdat IFN-γ het belangrijkste cytokine is voor de activatie van de monocyt en 
doxorubicine (vergeleken met andere cytostatica) een breed antitumorspectrum heeft, 
werd de combinatie van deze stoffen onderzocht op de mogelijke effecten die ze 
teweegbrengen bij monocyten (Hoofdstuk 5) De resultaten met betrekking tot de mor 
fologie (vorm) van de cellen, de intracellulaire (binnenin de cel) enzymactiviteiten, de 
expressie van FcyR en de celdodingscapaciteiten duidden erop dat noch de controle 
populaties noch de met IFN-γ geactiveerde macrofagen beïnvloed werden na blootstel-
ling aan doxorubicine Echter, indien afzonderlijk met IFN-γ werd gekweekt, leidde dit 
tot uitzonderlijke morfologische veranderingen (o a kleiner, platter, kern meer tegen 
de cclwand gelegen, celklontcnng) en duidelijk verminderde enzymactiviteilen 
Gesteld kan worden dat bij deze combinatie doxorubicine geen veranderingen aan­
brengt in de effecten die IFN γ uitoefent op de monocyten/macrofagen populatie 
Om bepaalde functies optimaal te kunnen uitvoeren moeten monocyten/macro­
fagen geactiveerd worden Hoofdstuk 6 gaat over deze activatie door middel van cyto­
kinen, zoals IFN-γ, tumor necrose factor (TNF)-a, interlcukine (IL)-4, macrofaag 
kolonie-stimulerende factor (M-CSF), granulocyt-macrofaag (GM)-CSF en IL-2 Mono-
cytenkweken met daaraan toege\ocgd diverse soorten cytokinen, resulteerden in nogal 
sterk wisselende effecten op de expressie van oppervlakteantigenen Specifieke effec­
ten varieerden met de gebruikte cytokinen en de leeftijd van de gekweekte monocyt 
De meest uitgesproken effecten werden veroorzaakt door IFN γ en IL-4 De na 40 uur 
kweken gehalveerde expressie van ΡΰγϋΙΙ (zie ook beschrijving van hoofdstuk 3) kon, 
behalve met IFN-γ, ook in zijn geheel worden opgeheven met GM-CSF en gedeeltelijk 
met behulp van TNF-a Verder was het opmerkelijk dat de verminderde celdoding 
onveranderd laag bleef, ook nadat monocyten 40 uur in de aanwezigheid van deze 
laatste twee genoemde cytokinen gekweekt waren 
In het verleden werd altijd verondersteld dat cytostatica hun werking te danken 
hadden aan de remming van de celdeling en hun giftige uitwerking op de cellen 
Tegenwoordig is het duidelijk geworden dat ze ook in staat zijn om het immuunsys­
teem specifiek te beïnvloeden Hoofdstuk 7 handelt over de beïnvloeding van mono-
cyten door verschillende klassen van cytostatica zoals antibiotica, alkylcrende mid-
delen, antimetdbolieten en een eiwitsyntheseremmer Evenals voor de effecten van de 
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cytokinen, geldt voor de verschillende cytostatica dat hun uitwerking op de monocyten 
sterk afhangt van het soort cvtostaticum, de gebruikte concentraties en het stadium van 
ontwikkeling waarin de monocyt/macrofaag zich bevindt op het moment van de bloot­
stelling Meest in het oog springend waren de nadelige effecten die veroorzaakt werden 
door de eiwitsyntheseremmcr ethyldeshydroxysparsomycine (EdSm), op de via FcyRII 
verlopende ADCC van 40 uur gekweekte monocyten. 
Een algemene discussie en aanbevelingen voor verder onderzoek zijn beschreven 
in Hoofdstuk 8 
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STELLINGEN BEHORENDE BIJ HET PROEFSCHRIFT 
"HUMAN MONOCYTES IN VITRO MODULATION 
BY CYTOKINES AND ANTICANCER DRUGS'7 
Voor het optimaal uitoefenen van een antilichaam afhankelijke cyto-
toxische activiteit door monocyten is de dichtheid van de Fcy receptoren 
op het celoppervlak belangrijker dan het aantal. 
dit proefschrift 
Monomeer Immunoglobuline G, dat aanwezig is in het plasma en de 
interstitiële vloeistoffen, speelt een belangrijke rol bij de homeostatische 
regulatie van de activiteiten van Fcy receptor I. 
Segal et al. Mol Immunol 20:1177,1983 
Non-adherente monocyten kunnen als gevolg van in vitro maturatie 
veranderen in adhérente macrofagen. 
dit proefschrift 
Bij het meten van de antilichaam afhankelijke cytotoxiciteit (ADCC) 
van monocyten en macrofagen, met behulp van een 51Cr-release assay, 
verdient het aanbeveling om een duidelijk onderscheid te maken tussen 
fagocytose en extracellulaire lysis. 
dit proefschrift 
De komende jaren zullen combinaties van cytokinen en cytostatica een 
belangrijke rol gaan spelen bij de behandeling van patiënten met uit-
gezaaide tumoren. 
De verklaring voor de gunstige effecten die gezien worden bij patiënten 
met chronische granulomateuze ziekte na behandeling met IFN-γ, moet 
mede gezocht worden in een quantitatieve toename van Fcy receptor I op 
de monocyt. 
Het ontwikkelingsstadium waarin monocyten verkeren, is sterk bepalend 
voor de effecten die kunnen optreden na stimulatie met cytokinen en of 
cytostatica. 
dit proefschrift 
Lymfocyten spelen de mu/iek maar de macrofaag geeft de toon aan. 
Solbach et al. Immunol Today 12:4, 1991 
Heeft men voorlopig niet genoeg waarnemingen, maar mochten deze 
later nog gedaan worden, dan moet men aan deze waarnemingen meer 
geloof schenken dan aan de theorie en deze laatste slechts, als zij tot 
hetzelfde resultaat voert als de verschijnselen. 
Aristoteles (384-322 voor Christus) 
"You have the world, leave us the forest". 
Magoh, Penan headman (Sarawak, Borneo) 
Uit het feit, dat kranten dagelijks berichten over verkeersongevallen 
veroorzaakt door zowel dronken als nuchtere verkeersdeelnemers en 
nimmer melding maken van ongelukken waarbij mensen betrokken zijn 
na gebruik van marihuana, zou men kunnen afleiden dat dit genotmiddel 
een zeker gunstig effect heeft op de verkeersveiligheid. 
Politiek Den Haag begint voorzichtig bepaalde vormen van celdeling te 
accepteren. 
Nijmegen, 28 september 1992 
Rob van Schie 
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